WO2002046752A2 - Optical determination of glucose utilizing boronic acid adducts - Google Patents

Optical determination of glucose utilizing boronic acid adducts Download PDF

Info

Publication number
WO2002046752A2
WO2002046752A2 PCT/US2001/046658 US0146658W WO0246752A2 WO 2002046752 A2 WO2002046752 A2 WO 2002046752A2 US 0146658 W US0146658 W US 0146658W WO 0246752 A2 WO0246752 A2 WO 0246752A2
Authority
WO
WIPO (PCT)
Prior art keywords
dye
polymer
group
quencher
fluorophore
Prior art date
Application number
PCT/US2001/046658
Other languages
French (fr)
Other versions
WO2002046752A9 (en
WO2002046752A3 (en
Inventor
Bakthan Singaram
Ritchie A. Wessling
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Priority to AU2002220230A priority Critical patent/AU2002220230B2/en
Priority to EP01999808A priority patent/EP1340076A2/en
Priority to JP2002548438A priority patent/JP4222503B2/en
Priority to CA002436590A priority patent/CA2436590A1/en
Priority to NZ526787A priority patent/NZ526787A/en
Priority to AU2023002A priority patent/AU2023002A/en
Publication of WO2002046752A2 publication Critical patent/WO2002046752A2/en
Publication of WO2002046752A9 publication Critical patent/WO2002046752A9/en
Publication of WO2002046752A3 publication Critical patent/WO2002046752A3/en
Priority to US10/456,895 priority patent/US20040028612A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Definitions

  • This invention relates to an improved optical method and or sensor for polyhydroxy substituted organic molecules that measure the concentration of these molecules in aqueous or organic media.
  • the method and sensor monitor the concentration of sugars, i.e. glucose or fructose, in aqueous solution in vitro.
  • the method and sensor monitor the concentration of sugars, i.e. glucose or fructose, in aqueous solution in vivo.
  • the determination of glucose in fluids in vivo and in vitro - is of importance.
  • the in vivo sensing device is implanted in a human being.
  • Patents of interest include but are not limited to: Russell, US Patent 5,137,833 (1992)
  • Nan Antwerp and Mastrototaro US Patent 6,011,984 (2000)
  • Related U.S. patents of interest include:
  • This present invention concerns an optical method and an optical device for determining the concentration of polyhydroxyl compounds in aqueous media, especially for determining in vivo, especially sugars such as glucose or fructose, in physiological media.
  • These compounds, the analytes are in a system with a fluorescence sensing device comprised of a light source, a detector, and the active components including a fluorophore D (fluorescent dye), a quencher and an optional polymer matrix M.
  • a fluorophore D fluorescent dye
  • quencher optional polymer matrix M.
  • Some components are inventions in their own right. When excited by light of appropriate wave length, the fluorophore emits light (fluoresces). The intensity of the light is dependent on the extent of quenching.
  • the fluorophore and quencher Q are preferably independent entities, optionally they are immobilized in or covalently attached to a polymeric matrix which is permeable to or in contact with the compounds of interest to be detected and quantified.
  • the present invention comprises a class of fluorescence quenching compounds that are responsive to the presence of polyhydroxyl compounds such as glucose in aqueous media at or near physiological pH. In other words, the quenching efficiency is controlled by the concentration of these compounds in the medium.
  • the quencher is comprised of a viologen substituted with at least one boronic acid group wherein the adduct is inrmobilized in or covalently bonded to a polymer.
  • the quencher, dye and polymer may also be covalently bonded to each other.
  • the present invention is a class of polymeric fluorescent dyes which are susceptible to quenching by the viologen/boronic acid adduct.
  • Useful dyes include pyranine derivatives (e.g. hydroxypyrene trisulfonamide derivatives and the like). (See Figures IA, IB and 1C),
  • the dye is comprised of a hydroxypyrene trisulfonamide moiety bonded to a polymer. Converting sulfonic acid groups to sulfonamide groups shifts the pKa of pyranine into a range more suitable for measurement at physiological pH. This conversion also shifts the absorbance of the dye to longer wavelengths thereby allowing it to be more efficiently excited by light from a blue LED which is a preferred light source for an implanted sensor. These derivatives are typically prepared by reacting a trisulfonyl chloride intermediate with 1 ) a poly amine, 2) an amine functional ethylenically unsaturated monomer which adduct is subsequently polymerized, 3) or an amine functional polymer. In one embodiment, the dye is a fully substituted derivative having no residual free sulfonic acid groups on the pyrene ring.
  • the present invention is a composite water- compatible polymer matrix, preferably a hydrogel, which comprises the dye and quencher moieties.
  • the matrix is a water-swellable copolymer, preferably crosslinked, to which the dye and quencher moieties are covalently bonded by a linking group L.
  • the matrix is an interpenetrating polymer network (IPN) with the dye incorporated in one polymer network and the quencher in the other polymer network.
  • the matrix is a semi-IPN wherein the dye component is a high molecular weight water-soluble or dispersible polymer trapped in a crosslinked network comprised of quencher monomer and suitable hydrophilic comonomers.
  • the quencher may be in the water-compatible or dispersible component and the dye within the network. Further both dye and quencher may be separately incorporated in water-soluble or dispersible polymers wherein dye and quencher are both trapped in an inert polymer matrix.
  • the components are separated from the analyte solution by a membrane which is impermeable to the components, but permeable to the analyte.
  • the matrix is molecularly imprinted to favor association between dye and quencher, and to enhance selectivity for specific sugars, e.g. glucose, over other polyhydroxy compounds.
  • the preferred method for enhancing interaction between dye and quencher is to functionalize the dye moiety with negatively charged groups such as carboxylate, sulfonate, phosphonate, and phosphate.
  • the present invention concerns a device for measuring the concentration of glucose in vivo by means of an optical sensor.
  • the specific device is comprised of a visible light source, preferably a blue LED light source, a photodetector, a light conduit (optical wave guide) such as an optical fiber assembly, and a water-insoluble polymer matrix comprised of a fluorophore susceptible to quenching by a viologen, a viologen/boronic acid quencher, and a glucose permeable polymer, wherein the matrix is in contact with said conduit and with the medium containing the analyte.
  • the present invention relates to an optical method for the in vivo detection of polyhydroxyl-substituted organic molecules as the analyte between about 430 and 600 nm detection, which method comprises:
  • D which is compatible with the analyte solution
  • D is selected from: (a) D 1 which is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 600 nm, iii. Resistant to photobleaching under the conditions of analysis, iv. A Stokes shift of about or greater than 30 nm, v. Compatibility with said analyte solution, and wherein said vi.
  • Dye D 1 is quenched by methyl viologen to produce an experimentally determined apparent Stern-Nolmer quenching constant (Ksv) greater than or equal to 50, wherein the fluorophore dye D 1 which is neutral or negatively charged is: (i) a discrete compound having a molecular weight of 1 ,000 daltons or greater, with the proviso that if the dye is substituted with negatively charged groups the molecular weight is 500 daltons or greater; (ii) a pendant group or chain unit in a water-soluble or dispersible polymer having a molecular weight greater than about 10,000 daltons, and optionally said polymer is non-covalently associated with a water-insoluble polymermatrix M 1 and is physically immobilized within said polymer matrix M 1 wherein said polymer matrix M 1 is permeable to or in contact with said analyte solution; and optionally where D 1 is negatively charged and the polymer is immobilized as a complex with a cationic water-soluble polymer, said
  • D 2 is a fluorophore dye having the properties of i.
  • a fluorophore ii. An excitation in the range greater than 430 nm and less than 800, iii. A Stokes shift of about or greater than 30 nm, iv. Resistant to photobleaching under the conditions of analyses, v. Compatibility in the analyte solution, and wherein vi.
  • Said Dye D 2 is quenched by methyl viologen to produce an apparent Stern- Nolmer quenching constant (Ksv) greater than or equal to 50, wherein D 2 is covalently bonded to an insoluble polymer matrix M 1 wherein said polymer matrix M 1 is permeable to or in contact with said analyte; wherein said fluorophore dye D 2 is a part of the structure: M'-L'-D 2 with the proviso that D 2 which is polyfunctional is bonded to matrix M 1 at one, two or three sites; L 1 is a hydrolytically stable covalent linking group selected from the group consisting of a direct bond, lower alkylene having 1 to 8 carbon atoms optionally ten-ninated with or including one or more divalent connecting groups selected from sulfonamide, amide, ester, ether, sulfide, sulfone, phenylene, urethane, urea, and amine, and B.
  • Ksv Stern- Nolmer
  • Q is comprised of a conjugated nitrogen-containing heterocyclic, aromatic bis-onium salt having the properties of compatibility in said analyte solution and produces a detectable change in the emission of the dye in the presence of said analyte, selected from: (i) quencher Q 1 which is a discrete compound having a molecular weight of about 400 daltons or greater or is a pendant group or a chain unit in a water-soluble or water-dispersible polymer having a molecular weight greater than 10,000 daltons and said polymer optionally is non-covalently associated with the optional polymer matrix M 1 when present, and is physically immobilized in said polymer matrix, or optionally said polymer is immobilized as a complex with a negatively charged water-soluble polymer, or
  • the invention is a device which incorporates the components listed above which work together to determine the analyte.
  • the term "polymer" to which D 1 and D 2 are attached excludes those polymers which react or combine with dihydroxy compounds.
  • the useful polymers maybe anionic, cationic or neutral, and hydrolytically stable and compatible with in vivo fluid.
  • the Dye D 1 is selected from a discrete molecule or polymer of pyr'ahine derivatives having the structure of:
  • R 1 , R 2 and RL are each -NH-CH 2 -CH 2 (-O-CH 2 -CH 2 ) n -X'; wherein X 1 is selected from -CH 2 -OCH 3 , -CO 2 H, -CONH 2 , -SO 3 H, or -NH 2 ; and n is between about 70 and 10,000, and preferably between 100 and 1,000.
  • the Dye D 1 or D 2 is prepared from pyranine derivatives having the structure of:
  • a dye moiety D 1 as a discrete compound or a pendant group is selected from:
  • R' 8 is -H or L 3 -A where L 3 is selected from L 2 above and A is selected from -COOH and -SO 3 H;
  • R 19 is -H or is selected from R 5 above with the proviso that when the dye is D 2 at least one of R 18 or R 19 is a polymerizable group and each sulfonamide group is substituted with one -H.
  • Q ' is a discrete compound with a molecular weight (M W) at least twice the MW of the analyte which is water soluble or dispersible having at least one boronic acid substituent wherein said compound is isolated from the body by a semi- permeable membrane.
  • M W molecular weight
  • Q 1 as a discrete compound contains two boronic acid substituents.
  • the quencher Q 1 is selected from:
  • the quencher Q 1 or Q 2 is prepared from a quencher precursor selected from the group consisting of:
  • N 2+ is a nitrogen containing conjugated heterocyclic aromatic group selected from isomers of dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, or diazafluorenes; wherein the two nitrogen atoms are each in a different aromatic ring and the nitrogens are in all positions capable of forming an onium salt and where Z 1 or Z 2 is a sustituent on nitrogen and is either a polymerizable ethylenically unsaturated group selected from:
  • Q 1 is a discrete compound or a pendant group or a chain unit (linear or branched) oof a water-soluble or dispersible polymer.
  • the insoluble polymer matrix M 1 -L 2 -Q 2 is preferably a crosslinked network polymer.
  • Q 1 or Q 2 is prepared from a precursor selected from:
  • FIGURES Figure IA is the structural formula of (8-hydroxypyrene - 1,3,6-N, N', N" -tris- (methoxypolyethoxyethyl (n ⁇ 125) sulfonamide) (HPTS-PEG).
  • Figure IB is the structural formula of 8-acetoxypyrene - 1,3,6-N, N', N" -tris- (methacrylpropylamidosulfonamide) (acetoxy-HPTS-MA).
  • Figure IC is the structural formula of 8-hydroxypyrene-l,3,6-N,N',N"-tris (carboxypropylsulfonamide) (HPTS-CO 2 ).
  • Figures 2 A to 2G are schematic representations of structures of quenchers Q 1 as the dihalide salts.
  • Figure 2 A is trans- 1 ,2-bis(4,4'-N,N '-(benzyl-4-boronic acid)-pyridinium)ethylene dibromide;
  • Figure 2B is l,7-N,N'-bis(benzyl-3 -boronic acid)-phenanthrolinium dibromide
  • Figure 2C is benzyl viologen (BN)-a comparative quencher
  • Figure 2D is 4,4'-N,N'-bis-(benzyl-2-boronic acid)-dipyridinium dibromide (o- BBN);
  • Figure 2E is 4,4'-N,N-bis-(benzyl-3-boronic acid)-dipyridinium dibromide (m- BBN);
  • Figure 2F is 4,4'-N,N-bis-(benzyl-4-boronic acid)-dipyridinium dibromide (p- BBN);
  • Figure 2G is N, N'-bis (benzyl-(2, 3, or 4)-boronic acid-4,7-phenantholinium halide (4,7-phen-o, m, or p-BBN);
  • Figure 3 A is an unsymmetrical glucose responsive viologen
  • Figures 3B to 31 are schematic representations of structures of quencher precursors:
  • Figure 3 A is 4-N-(benzyl-2 -boronic acid)-4'-N'-(benzyl)-dipyridmium bromide chloride;
  • Figure 3B is 4-N-(benzyl-3 -boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridini ⁇ m bromide chloride (rn-SBBN);
  • Figure 3C is 4-N-(benzyl-2-boronic acid)-4'-N-(benzyl-4-ethenyl)-dipyridinium bromide chloride (o-SBBN); and Figure 3D is 4-N-(benzyl-4-boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridinium bromide chloride (p-SBBN).
  • Figure 3E is tr ⁇ «_?-l,2-bis-4-N-(benzyl-4-boronic acid)-4'-N'-(benzyl-4-ethenyl)- dipyridinium-4-ethylene dibromide;
  • Figure 3F is 4-N-(benzy 1-3 -boronic acid)-4'-N'-(benzyl-3-ethenyl)-3 phenanthrolinium dibromide;
  • Figure 3G is 4,4'- ⁇ , ⁇ -bis-[benzyl-(3-methylene-4-vinyl-pyridinium bromide)-5- (boronic acid)]-dipyridinium dibromide) (m-BBNBP);
  • Figure 3H is 4- ⁇ -(benzyl-3-(boronic acid)-7-n-[benzyl-3-(methylene-(l-oxy-3- (oxybenzylvinyl)-propane))-5-boronic acid]-4,7-phenanthrolinium dibromide;
  • Figure 31 is 4,4'-N,N-bis-[benzyl-(3-methylene-4-vinylpyridiniumbromide)-5- (boronic acid)] ⁇ 4,7-phenanthrolinium dibromide;
  • Figures 4A and 4B are schematic representations of the structures of the interpenetrating polymer network (IPN) polymers and semi-IPN polymers respectively of the invention.
  • IPN interpenetrating polymer network
  • Figure 5 is a graphic representation of the response of benzyl viologen (0.001M) and 4,4'-N,N'-bis-(benzy 1-3 -boronic acid)-dipyridinium dibromide (m-BBN) showing modulation of m-BBN quenching efficiency toward HPTS-PEG (1 xlO "5 M) as a function of glucose concentration.
  • Figure 6 is a graphic representation of the response of ortho-, meta-, and para- benzyl boronic acid viologen (BBN) (0.001M) showing modulation of quenching efficiencies to HPTS-PEG (Ixl0 "5 -M) as a function of glucose concentration.
  • Figure 7 is a Stern-Nolmer plot of m-BBN quenching of HPTS-PEG in pH 7.4 phosphate buffer.
  • Figure 8 is a schematic representation of one embodiment of the in vitro probe as it would be used in a process stream and is also an embodiment illustrating the use of the sensing polymer assembly.
  • Figure 9 is a schematic representation of a second embodiment of the in vitro probe as it would be used in a process stream to monitor for polyhydroxyl organic compounds, e.g. glucose or fructose.
  • Figure 10 is a schematic cross-sectional representation of the in vitro probe of Figure 9. It is also a representation of the in vivo sensing polymer assembly of Figure 9.
  • Figure 11 is a graphic representation of the two component system of 4,7-phen m-SBBN and HPTS-MA, plotting fluorescence intensity versus time in seconds in a pH 7.4 buffer.
  • Figure 12A is a graphic representation of the fluorescence emission spectra of 8- hydroxypyrene-l,3,6-N,N',N"- (carboxypropyl sulfonamide) (HPTS-CO 2 ) with increasing m-BBN. It plots fluorescence intensity versus wavelength (nm) from 0 to 1 mM..
  • Figure 12B is a graphic representation of the fluorescence emission response to glucose of 8-hydroxypyrene-l,3,6- ⁇ , ⁇ ', ⁇ "- (carboxypropyl sulfonamide) (HPTS- CO 2 )/m-BBN. It plots fluorescence intensity versus wavelength (nm) for 0 to 1800 mg/dL.
  • Figure 13 is a graphic representation of the glucose response of 8-hydroxypyrene- 1 ,3,6- ⁇ , ⁇ ', ⁇ "- (carboxypropyl sulfonamide) (HPTS-CO 2 ) with m-BBN. It plots F/F 0 versus glucose (mg/dL).
  • Figure 14 is a graphic representation of fluorescence intensity versus time (sec) for a two component system of m-BBNBP and HPTS-MA.
  • Bosenonic acid refers to a structure -B(OH) 2 . It is recognized by those skilled in the art that a boronic acid may be present as a boronate ester at various stages in the synthesis of the quenchers of this invention. Boronic acid is meant to include such esters.
  • Detector refers to a device for monitoring light intensity such as a photo diode.
  • Fluorophore or “ fluorophore dye” or “dye” refers to a compound, an aromatic group or a heteroaromatic group that when exposed to light of appropriate wavelength emits light, i.e., it fluoresces.
  • Fluorophore D is selected from a discrete compound or a reactive intermediate which is convertible to a second discrete compound, or to a polymerizable compound; or D is pendant group or chain unit in a polymer prepared from said reactive intermediate or polymerizable compound, which polymer is water-soluble or water- dispersible or is a water-insoluble polymer, said polymer which is optionally crosslinked.
  • HEMA refers to 2-hydroxyethylmethacrylate.
  • Light source or “excitation light source” refers to a device that emits electromagnetic radiation such as a xenon lamp, medium pressure mercury lamp, a light emitting diode (LED) all of which are commercially available.
  • LED light emitting diode
  • Linking group refers to L,L' or L 2 which are divalent moieties, that covalently connect the sensing moiety to the polymer or matrix.
  • Quencher refers to a compound that reduces the emission of a fluorophore when in its presence. Quencher Q is selected from a discrete compound, a reactive intermediate which is convertible to a second discrete compound or to a polymerizable compound or Q is a pendant group or chain unit in a polymer prepared from said reactive intermediate or polymerizable compound, which polymer is water-soluble or dispersible or is an insoluble polymer, said polymer is optionally crosslinked.
  • IPN Interpenetrating polymer network
  • “Pyridinium” refers to structures (linking groups or pendant groups comprised of units, i.e. pyridine rings substituted on the nitrogen and optionally on carbons in other positions on the ring. Substituents on carbon include vinyl groups and substituents on nitrogen include the methylene group of a benzyl boronic acid.
  • “Semi-IPN” or semi-interpenetrating polymer network” refers to a combination of polymers in which one component is soluble and the other polymer is a network (see Sperling above).
  • Onium refers to a heteroaromatic ionic compound having a formal positive charge on the heteroatom, which in the case of viologen is a nitrogen.
  • PEG or “polyethylene glycol” refers to polymer or chain segments which contain oxyethylene (-OCH 2 -CH 2 -) repeating units.
  • PEGDMA refers to polyethylene glycol terminated with two methacrylate groups.
  • PEGMA refers to polyethylene glycol terminated with one methacrylate group.
  • Physiological pH refers to the pH range of 7.3-7.5 normally existing in the blood of a living human being.
  • Vehicle light range refers to light in the spectrum between about 400 and 800 nm.
  • Viologen refers generally to compounds having the basic structure of a nitrogen containing conjugated N-substituted heterocyclic aromatic bis-onium. salt, such as 4,4'-N,N' bis-(benzyl) bipyridium dihalide (i.e., dichloride, bromide chloride), etc. Viologen also includes phenanthroline compounds.
  • the present invention concerns a number of important advances. These include but are not limited to a method and an in vivo device for determining carbohydrate, 1,2-diol or 1,3-diol levels in liquids selected from aqueous or organic liquids or combinations thereof or in a physiological fluid, respectively.
  • a series of fluorophore dyes, a series of boronic acid substituted quenchers, and combinations of interacting water-compatible and water-soluble and organic solvent-compatible and organic solvent-soluble organic polymers are used. These aspects are discussed in more detail below. The components are discussed first, and their combination to produce the method and the device follows.
  • the moiety that provides glucose recognition in the present invention is an aromatic boronic acid. More specifically, the boronic acid of this invention is covalently bonded to a conjugated nitrogen-containing heterocyclic aromatic bis-onium structure, e.g. a viologen, (see for example Figures 3 A to 31) in which the boronic acid has a pKa less than about 7 and reacts reversibly with glucose in aqueous media to form boronate esters. The extent of reaction is related to glucose concentration in the medium.
  • a conjugated nitrogen-containing heterocyclic aromatic bis-onium structure e.g. a viologen, (see for example Figures 3 A to 31) in which the boronic acid has a pKa less than about 7 and reacts reversibly with glucose in aqueous media to form boronate esters.
  • the extent of reaction is related to glucose concentration in the medium.
  • Bis-onium salts of this invention are prepared from conjugated heterocyclic aromatic dinitrogen compounds.
  • the conjugated heterocyclic aromatic dinitrogen compounds are selected from dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, and diazaffuorenes, wherein the nitrogen atoms are in a different aromatic ring and are able to form an onium salt. It is understood that all isomers of said conjugated heterocyclic aromatic dinitrogen compounds in which both nitrogens can be substituted are useful in this invention.
  • Bis-onium salts derived from 4,4'-dipyridyl and 4,7-phenantholine are preferred.
  • the viologen boronic acid adducts are discrete compounds or are water-compatible pendant groups or units in a chain of a water-soluble or water-dispersible polymer with a molecular weight greater than 10,000 or are bonded to an insoluble polymer matrix.
  • One or more boronic acid groups are attached to the viologen moieties.
  • the polymeric quencher precursors three options are available for the boronic acid moiety to be attached to two different nitrogens in the heteroaromatic centrally located group.
  • viologens with one boronic acid group include the following: 1. boronic acid substituted viologen of the structure:
  • n 0-3, preferably n is 1, and where L is a linking group, i.e. L 1 or L 2 as defined herein and M is a polymer matrix as defined herein, and where Y 2 is phenyl boronic acid (m- and p-isomers) or naphthyl boronic acid, preferably a phenyl boronic acid, and
  • the viologen is contemplated to include combinations of the above.
  • the precursor from which the viologen/boronic acid is derived is an unsymmetrically substituted viologen, such as with a boronic acid functional group on one end and a polymerizable group, such as a vinyl group, on the other (see Figures 3A-3I).
  • the viologen/boronic acid moiety is a pendant group or a chain unit in a water soluble or dispersible polymer, or a unit in a crosslinked, hydrophilic polymer or hydrogel sufficiently permeable to glucose to allow equilibrium to be established.
  • Dyes useful in this invention are excited by light of wavelength about or greater than 430 nm, with a Stokes shift large enough that the excitation and emission wavelengths are separable, by at least 10 nm, and preferably greater than or equal to about 30 nm. These dyes are susceptible to quenching by electron acceptor molecules, such as viologens, are resistant to photo-bleaching, and are stable against photo- oxidation, hydrolysis, and biodegradation. Dyes useful in the present invention have an apparent Stern- Volmer quenching constant when tested with methyl viologen of about 50 or greater and preferably greater than 100. A general description of the Stern- Volmer test is found below in Preparation A.
  • Preferred dyes include polymeric derivatives of hydroxypyrene trisulfonic acid. In some cases, the dye is bonded to a polymer through the sulfonamide functional groups.
  • the polymeric dyes are water-soluble, water-insoluble but swellable or dispersible in water or may be crosslinked.
  • a preferred dye as a polymer is for example, a water soluble PEG adduct of 8-hydroxypyrene-l,3,6-N,N',N"- tris(methoxypolyethoxylethyl (n ⁇ 125) sulfonamide) (formed by reaction of acetoxypyrene trisulfonyl chloride with aminoethyl PEG monomethyl ether.
  • the resulting dye polymer has a molecular weight of at least about 10,000 such that, when it is trapped in a hydrogel or network polymer matrix, it is incapable of diffusing out of the matrix into the surrounding aqueous medium.
  • Representative dyes as discrete compounds are the tris adducts fo ⁇ ned by reacting 8-acetoxypyrene-l,3,6-trisulfonylchloride (HPTS-C1) with an amino acid, such as amino butyric acid.
  • Hydroxypyrene trisulfonamide dyes bonded to a polymer and bearing one or more anionic groups are most preferred, such as copolymers of 8-hydroxypyrene-l-N- (methacrylarmdopropylsulfonamido)-N N"-3,6-bis(carboxypropylsulfonarnide)HPTS-CO 2 - MA with HEMA, PEGMA, etc.
  • soluble copolymers of 8-acetoxypyrene-l,3,6-N, N', N"- tris(methacrylamidopropylsulfonamide) with HEMA, PEGMA, or other hydrophilic comonomers include soluble copolymers of 8-acetoxypyrene-l,3,6-N, N', N"- tris(methacrylamidopropylsulfonamide) with HEMA, PEGMA, or other hydrophilic comonomers.
  • the phenolic substituent in the dye is protected during polymerization by a blocking group that can be removed by hydrolysis after completion of polymerization.
  • blocking groups which are suitable for example acetoxy, trifluoroacetoxy, and the like are well known in the art.
  • the sensing moieties (analyte, dye, quencher) must be in close physical proximity to allow interaction, i.e. mixed on a molecular level and in equilibrium with the species to be detected. While not bound by any theory or mechanism, in most cases the molecules may have to collide or the molecule centers are less than 10 angstroms apart for quenching to occur. However the distance dependent quenching falls of rapidly if the molecules are further apart. It appears that the intensity of the fluorescence emitted by the dye is attenuated by photo-induced intermolecular electron transfer from dye to viologen when viologen/boronic acid adduct and the dye are in close proximity.
  • the boronate ester interacts with the viologen thereby altering its quenching efficacy according to the extent of glucose binding.
  • the specific nature of this interaction is not yet established, but it may involve electron transfer from boronate to viologen or boronate formation may shift the reduction potential of the viologen.
  • the reduction potential is an indicator of the ability of a quencher to accept an electron.
  • the senor is used in a moving stream of physiological fluid which contains one or more polyhydroxyl organic compounds or is implanted in tissue such as muscle which contains said compounds. Therefore, it is essential that none of the sensing moieties escape from the sensor assembly.
  • the sensing components are part of an organic polymer sensing assembly. Soluble dyes and quenchers can be confined by a semi-permeable membrane that allows passage of the analyte but blocks passage of the sensing moieties.
  • sensing moieties soluble molecules that are substantially larger than the analyte molecules (molecular weight of at least twice that of the analyte or greater than 1000 preferably greater than 5000); and employing a selective semipermeable membrane such as a dialysis or an ultrafiltration membrane with a specific molecular weight cutoff between the two so that the sensing moieties are quantitatively retained.
  • the sensing moieties are immobilized in an insoluble polymer matrix which is freely permeable to glucose, see Figure 8.
  • the polymer matrix is comprised of organic, inorganic or combinations of polymers thereof.
  • the matrix may be composed of biocompatible materials.
  • the matrix is coated with a second biocompatible polymer that is permeable to the analytes of interest.
  • the function of the polymer matrix is to hold together and immobilize the fluorophore and quencher moieties while at the same time allowing contact with the analyte, and binding of the analyte to the boronic acid.
  • the matrix must be insoluble in the medium, and in close association with it by establishing a high surface area interface between matrix and analyte solution.
  • an ultra-thin film or microporous support matrix is used.
  • the matrix is swellable in the analyte solution, e.g. a hydrogel matrix is used for aqueous systems.
  • the sensing polymers are bonded to a surface such as the surface of a light conduit, or impregnated in a microporous membrane.
  • the matrix must not interfere with transport of the analyte to the binding sites so that equilibrium can be established between the two phases.
  • hydrogel polymers are preferred for this invention.
  • hydrogel refers to a polymer that swells substantially, but does not dissolve in water.
  • Such hydrogels maybe linear, branched, or network polymers, or polyelectrolyte complexes, with the proviso that they contain no soluble or leachable fractions.
  • hydrogel networks are prepared by a crosslinking step which is performed on water soluble polymers so that they swell but do not dissolve in aqueous media.
  • the hydrogel polymers are prepared by copolymerizing a mixture of hydrophilic and crosslinking monomers to obtain a water swellable network polymer.
  • Such polymers are formed either by addition or condensation polymerization, or by combination process.
  • the sensing moieties are incorporated into the polymer by copolymerization using monomeric derivatives in combination with network-forming monomers.
  • reactive moieties are coupled to an already prepared matrix using a post polymerization reaction.
  • Said sensing moieties are units in the polymer chain or pendant groups attached to the chain.
  • the hydrogels useful in this invention are also monolithic polymers, such as a single network to which both dye and quencher are covalently bonded, or multi-component hydrogels.
  • Multi-component hydrogels include interpenetrating networks, polyelectrolyte complexes, and various other blends of two or more polymers to obtain a water swellable composite which mcludes dispersions of a second polymer in a hydrogel matrix and alternating microlayer assemblies.
  • Monolithic hydrogels are typically formed by free radical copolymerization of a mixture of hydrophilic monomers, including but not limited to HEMA, PEGMA, methacrylic acid, hydroxyethyl acrylate, N- vinyl pyrrolidone, N,N'-dimethyl acrylamide, and the like; ionic monomers include methacryloylaminopropyl frimethylammonium chloride, diallyl dimethyl ammonium, chloride, vinyl benzyl trimethyl ammonium chloride, sodium sulfopropyl methacrylate, and the like; crosslinkers include ethylene dimethacrylate, PEGDMA, trimethylolpropane triacrylate, and the like.
  • hydrophilic monomers including but not limited to HEMA, PEGMA, methacrylic acid, hydroxyethyl acrylate, N- vinyl pyrrolidone, N,N'-dimethyl acrylamide, and the like; ionic monomers include methacryloyla
  • the dye moiety is derived from an ethylenically unsaturated derivative of a dye molecule, such as 8-acetoxypyrene- 1,3,6-N, N', N"-tris(methacrylamidopropylsulfonamide),
  • the quencher moiety is derived from an ethylenically unsaturated viologen such as 4-N-(benzyl-3-boronic acid)-4'-N'- (benzyl-4ethenyl)-dipyridinium dihalide (m-SBB V) and the matrix is made from HEMA and
  • PEGDMA concentration of dye is chosen to optimize emission intensity.
  • the ratio of quencher to dye is adjusted to provide sufficient quenching to produce the desired measurable signal.
  • a monolithic hydrogel is formed by a condensation polymerization.
  • acetoxy pyrene trisulfonyl chloride is reacted with an excess of PEG diamine to obtain a tris- (amino PEG) adduct dissolved in the unreacted diamine.
  • a solution of excess trimesoyl chloride and an acid acceptor is reacted with 4-N-(benzyl-3 -boronic acid)- 4'-N'-(2hydroxy ethyl) bipyridinium dihalide to obtain an acid chloride functional ester of the viologen.
  • the two reactive mixtures are brought into contact with each other and allowed to react to form the hydrogel, e.g.
  • polymers that are capable of reacting with boronic acids to form boronate esters under the conditions of this method are not useful as matrix polymers.
  • Such polymers have 1,2- or 1,3- dihydroxy substituents, including but not limited to cellulosic polymers, polysaccharides, polyvinyl alcohol and its copolymers and the like.
  • Multi-component hydrogels wherein the dye is incorporated in one component and the quencher in another are preferred for making the sensor of this invention. Further, these systems are optionally molecularly imprinted to enhance interaction between components and to provide selectivity for glucose over other polyhydroxy analytes.
  • the multi- component system is an interpenetrating polymer network (IP ⁇ ) or a semi-interpenetrating polymer network (semi-IP ⁇ ).
  • IP ⁇ polymers are typically made by sequential polymerization. First, a network comprising the quencher is formed. The network is then swollen with a mixture of monomers including the dye monomer and a second polymerization is carried out to obtain the IP ⁇ hydrogel.
  • the semi-IP ⁇ hydrogel is formed by dissolving a soluble polymer containing dye moieties in a mixture of monomers including a quencher monomer and polymerizing.
  • a soluble quencher polymer is dissolved in a monomer mixture containing the dye monomer and the mixture polymerized.
  • the molecular weight of the soluble component must be sufficiently high (about or greater than 10,000) that it cannot diffuse out of the network, i.e. it becomes physically bound in or trapped by the matrix.
  • one group of polymer chains 41 , 42, 43 and 44 contain the quencher, for example quencher Q 2 .
  • a second group of polymer chains 45, 46 and 47 containing the dye, for example, dye D 2 is formed at about the same time or sequentially.
  • the points of crosslinking of the polymers are designated as 48 and 49.
  • one group of polymer chains 51, 52, 53 and 54 contain the quencher, for example, quencher Q 2 .
  • Dye D 1 is to a pendant group on a second polymer 56. Crosslinking points 57 are designated.
  • the polymers of this invention are molecularly imprinted.
  • an organic salt is formed from a manometric quenched cation and a manometric dye anion.
  • the organic salt is then copolymerized, under conditions such that the ion pairs remain at least partially associated, to form a monolithic hydrogen matrix.
  • the quenched monomer is polymerized to form a first polymer which is then ion exchanged to obtain a polyelectrolyte with anionic dye countering.
  • the latter is then copolymerized with suitable monomers to form an interpenetrating dye polymer which is associated through ionic bonding with the quenched polymer.
  • the combination is either an IPN polymer or a semi-IPN polymer.
  • the polymers of this invention are molecularly imprinted to enhance selectivity for glucose over other polyhydroxyl compounds, such as fructose, by first forming a bis boronate ester of glucose with a polymerizable viologen boronic acid. This ester is then copolymerized and hydrolyzed to obtain a glucose imprinted polymer. This polymer is subsequently used to form an IPN with a dye polymer.
  • m-SBB V is mixed with glucose in about a 2: 1 molar ratio in aqueous organic solvent, e.g. water/dioxane.
  • aqueous organic solvent e.g. water/dioxane.
  • the product bis-boronate ester is recovered by distilling off the solvents under vacuum.
  • the product is next copolymerized with HEMA and
  • PEGDMA to obtain a first hydrogen following the procedures described in Example 14. Glucose is then leached from the hydrogen by conditioning in dilute hydrochloric acid. After conditioning in deionized water, the hydrogen is contacted with the dye monomer of Example 28 to form a complex between the anionic dye and the cationic quenched polymer. A second stage polymerization with more HEMA and PEGDMA is then carried out to form a molecularly imprinted IPN hydrogen.
  • the individual components in a multi-component hydrogen are made by the same or a different polymerization scheme.
  • a first network is formed by free radical polymerization, the second by condensation polymerization.
  • the soluble component is formed by condensation polymerization and the network by free radical polymerization.
  • a quenched polymer such as poly 4,4'-N,N-bis(l,3-xylylene-5-boronic acid) bipyridinium dihalide is formed by condensing 4,4'-dipyridyl with 3,5-bis-bromomethyl phenylboronic acid.
  • the quenched polymer is dissolved in a reaction mixture containing 8-acetoxypyrene- 1,3,6-N, N', N"-tris(methacrylamidopropylsulfonamide) as described above, and the solution is polymerized to obtain the semi-IPN hydrogen.
  • the combination of components described herein produces a device for the determination of polyhydroxy substituted organic molecules in physiological fluids.
  • a high molecular weight water-soluble dye is prepared by condensing acetoxypyrene trisulfonyl chloride with aminoethyl PEG monomethyl ether to obtain the 8-hydroxypyrene-l,3,6-N,N',N"-tris-(methoxypolyethoxyethyl (n ⁇ 125) sulfonamide).
  • the PEG dye polymer is dissolved in a mixture comprised of HEMA, PEGDMA, 4-N-(benzyl-3-boronic acid)-4'-N '-(benzyl-4-ethenyl)-dipyridinium dihalide (m- SBBV), aqueous alcohol and free radical initiator and polymerized to obtain a semi-IP ⁇ hydrogen.
  • HEMA hydrogen
  • PEGDMA 4-N-(benzyl-3-boronic acid)-4'-N '-(benzyl-4-ethenyl)-dipyridinium dihalide
  • m- SBBV 4-N-(benzyl-3-boronic acid)-4'-N '-(benzyl-4-ethenyl)-dipyridinium dihalide
  • m- SBBV 4-N-(benzyl-3-boronic acid)-4'-N '-(benzyl-4-ethenyl)-dipyridinium dihalide
  • free radical initiator free radical initiator and polymer
  • the sensor is placed in the tip of a catheter which is inserted in the body in the desired location.
  • the sensor is excited by light of about 475 nm and the fluorescence intensity monitored at about 520 nm.
  • the level of glucose in the body fluid is determined from the intensity of the emission.
  • the invention is a boronic acid substituted viologen covalently bonded to a fluorophore.
  • a single component viologen sensor as a discrete compound is shown as Example 39.
  • the adduct is a polymerizable compound or is a unit in a polymer.
  • One such adduct is prepared by first forming an unsymmetrical viologen from 4,4'-dipyridyl by attaching a benzyl-3 -boronic acid group to one nitrogen and an aminoethyl group to the other.
  • the viologen is condensed sequentially first with 8-acetoxy-pyrene-l,3,6-trisulfonyl chloride in a 1:1 mole ratio followed by reaction with excess PEG diamine to obtain a prepolymer mixture.
  • An acid acceptor is included in both steps to scavange the byproduct acid.
  • the prepolymer mixture is crosslinked by reaction with a polyisocyanate to obtain a hydrogen.
  • the product is treated with base to remove the blocking group. Incomplete reaction products and unreacted starting materials are leached out of the hydrogen by exhaustive extraction with deionized water before further use.
  • the product is responsive to glucose when used as the sensing component as described herein.
  • said adducts are ethylenically unsaturated monomers for example dimethyl bis-bromomethyl benzene boronate is reacted with excess 4,4-dipyridyl to form a half viologen adduct. After removing the excess dipyridyl, the adduct is further reacted with an excess of bromoethylamine hydrochloride to form the bis-viologen adduct.
  • This adduct is coupled to a pyranine dye by reaction with 8-acetoxypyrene trisulfonyl chloride in a 1 : 1 mole ratio in the presence of an acid acceptor followed by reaction with excess aminopropylmethacrylamide. Finally, any residual amino groups are reacted with methacrylol chloride. After purification the dye/viologen monomer is copolymerized with HEMA and PEGDMA to obtain a hydrogen.
  • Measurements are carried out in a conventional luminescence spectrometer.
  • the sample is excited by light of wavelength suitable for the dye being used and the fluorescence intensity measured.
  • a fixed amount of the unknown glucose containing solution is added to the solution and the measurement is repeated.
  • the change in intensity is used to calculate glucose concentration by reference to a calibration curve determined separately by measuring a standard series of glucose solutions and plotting the results as intensity change as a function of concentration.
  • the sensing components need to be stable only for the time of the test, and the reaction with glucose need not be reversible.
  • a flow-through cell is fabricated for the luminescence spectrometer.
  • a sensing polymer is mounted in the cell such that it is exposed on one surface to the excitation light and on the other to the process stream.
  • a baseline is established by passing the process stream free of glucose tlirough the cell and measuring the steady state fluorescence.
  • the process stream is then passed through the cell and the fluorescence intensity monitored as a function of time.
  • Glucose concentration is determined by reference to a calibration curve as described above. In this method, the sensor must be stable over time of operation and the reaction with glucose must be reversible. Further, the sensing moieties must be immobilized and not leach out into the process stream. DEVICE CONFIGURATION
  • Figure 8 is a schematic representation of the device as used for one time or continuous monitoring for sugar, i.e. glucose.
  • the sensing polymer 81 which contains the dye and quenched may be attached to an optional support 82.
  • an optional semi-permeable polymer membrane 83 A is present.
  • the light source 84 is connected to an optical filter 85 to an optical fiber 86 to the sensing polymer 81.
  • Detector 87 is connected to an optical filter 88 to an optical fiber 89 which connects to sensing polymer 81.
  • Light source 84 and detector 87 are both connected to electronic controller 90.
  • the system can detect changes in the sensing polymer based on the glucose content of the physiological fluid.
  • Figure 9 shows the optical device.
  • Figure 10 is the cross sectional representation of the probe.
  • light source 11 visible
  • optical fiber 12 is connected by optical fiber 12 to active cell 13.
  • Semipermeable membrane 14 allows the analyte to enter and exit freely from cell 13.
  • Optical fiber 15 conveys the altered light to filter 16, and optional photomultiplier to 17 to produce the analyte spectrum for analysis.
  • cell 13 includes the selectively permeable membrane such that the mixture of polymer 21, dye 22, and quenched 23 are retained in cell 13 under the conditions of analysis.
  • the light enters cell 14 via optical fiber 12.
  • thepolymer21, dye 22 and quenched 33 contact analyte 24 which has selectively entered the cell causing a quantitative and reproducible change in the spectrum.
  • This modified light signal travels optical fiber 15 to photomultiplier 17 to be analyzed.
  • the serving moieties of this invention can be used in other implantable fluorescence sensing devices known in the art. EXPERIMENTAL Reagents and solvents are used as received from commercial supplier unless otherwise noted. (See Chem Sources USA which is published annually.)
  • the apparent Stern- Volmer quenching constant is derived from the slope of a Stern- Volmer plot of relative fluorescence intensity (F 0 /F) versus concentration of quenched (M).
  • the concentration of the dye is generally adjusted so that the optical density of the dye, at excitation ⁇ max ⁇ 0.5 absorption units.
  • a stock dye solution is prepared in which the concentration is 5 times greater than that desired in the final measurements. For example, a dye for which the desired final concentration, which gives an optical density of excitation ⁇ max ⁇ 0.5 absorption units, is 1 x 10 "5 M, would require a stock solution in which the concentration is 5 x 10 "5 M.
  • 10 mL of dye stock solution of the appropriate concentration is made by weighing out the appropriate mass of dye and placing the solid into a 10 mL volumetric flask. The flask is then filled to the 10 mL mark with 0.
  • a stock solution of methyl viologen (25 mL, 0.0025 M) was prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0. 1 ionic strength). Seven different solutions containing methyl viologen were then prepared in pH 7.4 phosphate buffer as described below in Table 1 :
  • Each sample is then in-turn analyzed in a luminescence spectrometer set at the appropriate excitation wavelength and the appropriate emission wavelength range for the corresponding dye.
  • the instrumental settings slit widths, scan speed, optical filters, excitation wavelength, emission wavelength range) are held constant throughout the analysis of the series of samples).
  • the emission fluorescence intensity is then determined as the integration of the fluorescence intensity over the emission wavelength range by the trapezoidal rule approximation method.
  • the integrated values are plotted on the y-axis and the quenched concentrations are plotted on the x-axis and the slope of the resulting line is calculated by linear regression as the Stern- Volmer quenching constant.
  • the Stern- Volmer plot may not result in a linear relationship.
  • the apparent Stern- Volmer quenching constant is calculated and used for comparison.
  • Trisodium-8-acetoxy-pyrene-l,3,6-trisulfonate (acetoxy-HPTS, 11.33 g, 20 mmol) was suspended in 30 mL of thionyl chloride to which 5 drops of dimethylformamide was added. The suspension was refluxed for 3 hr. , during which time it became a brown solution. The solution was then cooled to 25°C under an argon atmosphere. Thionyl chloride was then distilled off under vacuum (2 Torr) leaving a yellow residue. The yellow residue was transferred to three separate centrifuge tubes along with 60 mL of dichloromethane. The suspensions were then centrifuged and the supernatant solutions transferred to a dry round bottom flask.
  • DIPYRIDINIUM DIBROMIDE An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 4,4' -dipyridyl (0.234 g, 1.5 mmols). The tube was sealed with a septum and charged with anhydrous CH 3 OH (7 mL). The homogenous solution was stirred at room temperature while freshly prepared dimethyl-(4-bromomethyl)-benzeneboronate (1.09 g, 4.5 mmols) was added via syringe. After stirring the solution for 15 hours, the reaction vessel was centrifuged (4 min at 3200 RPM) and the CH 3 OH cannulated to a separate flask.
  • This compound was used to quench the fluorescence of the dye of Example 8 and to respond to glucose.
  • Diisopropylethylamine (0.6 mL, 129.24 MW, 0J42 g/mL, 3.4 mmol) was added to the flask and the mixture allowed to stir for an additional hour.
  • the flask was cooled to room temperature and filtered through an air sensitive glass fritted filtration apparatus to remove excess CaH 2 and Ca(OH) 2 .
  • the THF solution was placed back into a 250 mL round bottom flask with magnetic stir bar and heated to 30°C with stirring.
  • 8-acetoxy-pyrene- 1,3,6-trisulfonyl chloride (0. 185 g, 624.8 g/mol, 0.3 mmol) was added to the warm THF solution.
  • EXAMPLE 8 8-HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS- (METHOXYPOLYETHOXYETHYL (n-125 ⁇ SULFONAMIDE ⁇ )
  • the supernatant was transferred to a 500-mL round bottom flask and the potassium carbonate was washed with 50-mL acetonitrile which was then combined in the 500-mL round bottom flask.
  • a yellow solution of acetoxy-HPTS-Cl (1.03 g, 1.8 mmol), 200-mL acetonitrile, and 20-n ⁇ L dichloromethane was added under argon to the 500-mL round bottom flask containing the free amine in acetonitrile causing the solution to turn dark red with precipitate formation.
  • the solution was stirred for 1 hr and the supernatant was transferred and concentrated under vacuum to give a dark residue.
  • AIB ⁇ 2,2'- azobisisobutyronitrile
  • isopropyl alcohol: ater 5 mL
  • the flask was equipped with a magnetic stir bar and a condenser, and deoxygenated with argon for one hour.
  • the entire manometric solution was taken-up by syringe and 1 mL was added, through the sidearm, to the AIB ⁇ solution.
  • the AIB ⁇ reaction vessel was then placed in a 70°C oil bath and the remaining manometric mixture added via syringe pump over 6 hrs (1.5 mL/hr).
  • the polymeric film was leached and stored under pH 7.4 phosphate-buffer. This product was used in Example 12.
  • the polymerization chamber was comprised of (1) An IR cell-holder: two stainless steel plates fashioned to contain the cell and the LUER LOC® ports; (2) A Cell: two glass plates containing a TEFLON ® 0.02" spacer in between, with holes drilled through the top plate and spacer; and (3) A Gasket: a precision-cut rubber spacer used to the seal the cell to the cell-holder.
  • a 10-mm path length, 5 -mL glass cuvet, which was open on both sides was equipped with two disposable polyethylene cuvet caps. Holes were drilled through the caps such that the threads of a 10/32 standard thread, 1/8" I.D. hose end adapter were screwed into place. A thin sheet of plastic was then cut into a 35 x 9 mm rectangle and a window 6x 15 mm was cut out of the center. Two fittings were constructed from small septa to put pressure on the plastic mask to hold the polymer in place within the cuvet. The height of the septa was 9 mm. The flow-through-cell was then assembled such that the polymer film was in the center of the cuvet and the plastic mask directly over it, effectively framing the film with its window.
  • the pressure fittings were then put in place using tweezers, one at the bottom of the cell and one at the top.
  • the outside walls of the cuvet caps, which sits inside the cuvet, were coated with vacuum grease and inserted into the cuvet to seal the cell.
  • the cell was placed into a Perkin-Elmer LS50B spectrophotometer equipped with a front surface adapter. The cell was oriented so that its side, touching the polymer, was facing the excitation beam of the instrument (face-first in the front surface adapter). 1/8" TYGON ® PTFE tubing was connected to the hose adapters of the flow-through-cell. The orientation of the front surface adapter was optimized so that the emission detector was sensing only the surface of the polymer.
  • a peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0J) through the cell at a rate of 30 mL per minute.
  • the time drive function of the Perkin- Elmer LS50B software was used to acquire fluorescence intensity readings every ten sec for an integration time of two sec.
  • the excitation frequency was set at 475 nm and the emission slit width at 536 nm.
  • the excitation and emission slit widths were set at 2.5 nm.
  • a base line value of 358 (fluorescence intensity) was established with buffer solution.
  • the peristaltic pump was stopped and the pumping solution was changed to 1800 mg/dl glucose in pH 7.4 phosphate buffer.
  • EXAMPLE 13 8-HYDROXYPYRENE-1.3.6-N. N'. N"- TRISfMETHACRYLAMIDOPROPYLSULFONAMIDE) HYDROGEN POLYMER
  • a 16-mm NMR tube modified with a female 14/20 ground glass joint was charged with a mixture of isopropyl alcohol/water (1:1, 1.5 mL), HEMA (750 mg), polyethylene glycoldimethacrylate (PEGDMA, n ⁇ 25) (200mg), 3-(methacrylamido) propyltrimethyl ammonium chloride (TMAC) (50 mg), 8-acetoxy ⁇ yrene-l,3,6-N, N', N"- tris(methacrylamidopropylsulfonamide) (acetoxy-HPTS-MA) (1 mg, 1.2 x 10" 6 mols), and (2,2'-azobis-2(2-imidazolin-2-yl) propane) hydrochloride (VA-044 free radical initi
  • the NMR tube was then fitted with a male 14/20 ground glass joint TEFLON ® stop cock to vacuum adapter. The mixture was then de-oxygenated via 4 freeze/pump/thaw cycles (-78°C, 1 torr, 5 min. and thawed under nitrogen. The NMR tube was then heated in a water bath at 40°C ( ⁇ 0.5°C for 12 hr . The glass NMR tube was carefully broken to free the polymer plug.
  • the polymer was dialyzed in 200 mL of de-ionized water with triethylamine (5 drops) (de-ionized water and amine solution was changed every 24 hr for 7 days) to remove the acetoxy protecting group on the acetoxy-HPTS-MA.
  • the resulting polymer plug was cut into about 5-mm slices and analyzed by fluorescence spectroscopy.
  • Excitation and emission spectra of the gels are substantially identical to spectra obtained for the PEG adduct (Example 12).
  • Samples of the polymer gel suspended in pH 7.4 buffer are visibly fluorescent when examined in daylight. The fluorescence is noticeably diminished when m-SBBV, o-SBBV, or p-SBBV was added to the aqueous phase. The fluorescence was recovered when glucose is added to the solution.
  • Similar gels were prepared with dye concentrations of 0.05 to 5 mg/g polymer (dry weight). All were yellow- green to orange in color and were visibly fluorescent when examined in day (natural) light. The fluorescence was quenched when the hydrogels were exposed to aqueous o-, m-, and -BBV (benzyl boronic acid viologens).
  • Polymeric Dye Powder A 10-mL volumetric flask was charged with 2-hydroxy ethyl methacrylate (27.08 mmols, 3.525 g), 3-((methacryloylamino)propyl) trimethyl ammonium chloride (1.36 mmols, 0.3 g), polyethylene glycol dimethacrylate (1. 11 mmols, 1.
  • the film was leached with 500 mL of distilled water (pH 5) for six hours; fresh water was replaced every two hours.
  • the thin film was then dried under reduced pressure (40°C, 20 in Hg, 3 hours), brought to -196°C and crushed into a fine powder using a mortar and pestle.
  • Interpenetrating network copolymer A 50-mL round-bottom flask was charged with manometric quenched-solution (5.2 mL) and polymeric dye-powder (0.169 g). The mixture was vigorously stirred on the vortex mixer for 10 minutes to allow the liquid to be imbibed by the dye particles and then deoxygenated with argon for 15 minutes. The heterogeneous solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber* (*See Example 11). The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity.
  • the chamber was sealed with TEFLON ® plugs and wrapped in a ZIPLOC ® freezer bag. The entire unit was transferred to an oven and heated to 40°C for 14 hrs. The polymerization chamber was removed from the oven and the bag, and subsequently disassembled to afford a thin, orange, gel-integrated polymeric film. The film was placed in a pH 8-NaOH solution for 12 hours, then leached and stored in pH 7.4 phosphate-buffer.
  • Example 21 The entire unit was submerged in a 40°C water-bath and heated for 12 hrs.
  • the polymerization chamber was removed from the bath and the bags, and subsequently disassembled to afford a thin green polymeric film.
  • the polymeric film was placed in a pH 8 NaOH solution for 12 hours, then leached and stored in pH 7.4 phosphate buffer. This product was used in Example 21.
  • HPTS-PEG BBV standard standard buffer HPTS-PEG (m-BBV)(M)
  • the instrumental settings (slit widths, scan speed, optical filters, excitation wavelength, emission wavelength range) were held constant throughout the series analysis.
  • the emission fluorescence intensity was then quantified by integration (the trapezoidal rule approximation method) of the fluorescence intensity curve between 480 and 630 nm.
  • the apparent Stern-Nolmer quenching constant was determined to be 520 M "1 (see Figure 7).
  • HPTS- PEG ANALYZED BY FLUORESCENCE SPECTROSCOPY (a) A stock solution of HPTS-PEG (10 mL, 5 x 10 "5 M) was prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0J ionic strength).
  • a m-BBV solution 25 rnL, 0.0025 M
  • ⁇ -D-Glucose 10 mL, 0.250 M
  • Seven different solutions containing HPTS-PEG, m-BBV, and ⁇ -D-Glucose were then prepared in pH 7.4 phosphate buffer as described below in Table 3:
  • HPTS-PEG in- -BBV Glucose buffer HPTS-PEG (m-BBV) (Glucose) stock (mL) stock (mL) s t o c k (mL) (M) (M) (mg/dL)
  • Example 16 The pH of each sample was independently determined using a pH meter to assure that the pH was constant throughout the series to within ⁇ 0.02 pH units. Each sample was then analyzed on the Perkin-Elmer LS50-B luminescence spectrometer. The instrumental settings were the same as Example 16.
  • ETHENYD-DIPYRIDINIUM BROMIDE CHLORIDE (m-SBB V) m-SBB V (50 mL, 2.5 mM) copolymer from Example 10 was prepared in pH 7.4 phoshate buffer and pH balanced ( ⁇ 0.02 pH units) with NaOH solution.
  • Six different solutions of poly m-SBBV (the analyte, 0, 0.10, 0.15, 0.25, 0.50, 0.75, 1.0 mM) containing
  • HPTS-PEG (dye, 1 x 10 "5 M) were then prepared and analyzed on the spectrofluorimeter.
  • the analyte/dye solutions were contained in a standard 10-mm path length, quartz cuvet, and the spectrofluorimeter was set to an excitation and emission frequency of 473 and 533, respectively.
  • the excitation and emission slit widths were set to 0 nm.
  • additional spectra of the analyte/dye solutions were obtained in the presence and absence of glucose and fructose.
  • the apparent differences in spectra were quantified as areas under the curve. The difference in areas was then determined to be representative of the polymer response to glucose or fructose, e.g., in the absence of glucose or fructose the representative area under the curve was determined to be 26479.45.
  • the areas changed accordingly as indicated in Table 4.
  • a peristaltic pump was used to circulate 7.4 phosphate buffer (ionic strength 0.1) through the cell at a rate of 30 mL per minute.
  • the time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten seconds with an integration time of two seconds.
  • the excitation frequency was set at 475 nm and the emission frequency was set at 536 nm.
  • the excitation and emission slit width were set at 15 nm and 20 nm, respectively.
  • a base line value of 249 (fluorescence intensity) was established with buffer solution.
  • the peristaltic pump was stopped and the pumping solution was changed to 1800 mg/dl glucose in pH 7.4 phosphate buffer.
  • a peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0.1) through the cell at a rate of 30 mL per minute.
  • the time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten sec with an integration time of two sec.
  • the excitation frequency was set at 475 nm and the emission frequency was set at 536 nm.
  • the excitation and emission slit widths were set at 7 nm.
  • a base line value of 490 (fluorescence intensity) was established with buffer solution.
  • the peristaltic pump was stopped and the pumping solution was changed to 400 mg/dl glucose in pH 7.4 phosphate buffer.
  • the process of switching solutions was repeated.
  • the buffer gave an expected base line of 490.
  • the base line dropped to the expected value of 490 when buffer was pumped through the system.
  • HPTS-PEG HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS-(METHOXYPOLYETHOXYETHYL CN-125) SULFONAMIDE)
  • HPTS-PEG A stock solution of HPTS-PEG (10 ml, 5 x 10 "5 M) is prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0J ionic strength). Similarly, a m-BBV solution (25 mL, 0.0025 M) and ⁇ -D-Glucose (10 mL, 0.250 M) solution are prepared. Seven different solutions containing HPTS-PEG, m-BBV, and ⁇ -D-Glucose are then prepared in pH 7.4 phosphate buffer as described below in Table 5. TABLE 5
  • HPTS-PEG m-BBV Glucose buffer [HPTS-PEG] [m-BBV] [Glucose] stock stock stock (mL) (M) (M) (mg/dL)
  • the pH of each sample is independently determined using a pH meter to assure that the pH is constant throughout the series to within +.0.02 pH units. See Example 17 for the analysis procedures.
  • Two mL of an aqueous glucose solution of unknown concentration are placed in a 5-mL volumetric flask to which is added 1 mL of HPTS-PEG stock solution and 2 mL of m-BBV stock solution.
  • the sample is mixed, placed into an appropriate cuvet and the fluorescence emission intensity of the sample is analyzed as previously described.
  • the fluorescence emission intensity is then quantified by integration (using the trapezoidal rule approximation method) of the fluorescence emission intensity curve between 480 and 630 nm.
  • the glucose concentration for the unknown can be determined by comparison of the quantified value for the fluorescence emission intensity of the sample of unknown glucose concentration to the calibration curve on the y-axis and reading the corresponding glucose concentration on the x-axis.
  • the glucose concentration read off the calibration chart is then adjusted-for the 5/2 dilution factor to determine the glucose concentration of the unknown sample.
  • the glucose concentration for the unknown sample is circulated through the flow through cell and the fluorescence emission intensity observed until it stabilizes.
  • the glucose concentration for the. unknown can be determined by comparison of its quantified value for the stable fluorescence emission intensity to the calibration curve on the _v-axis and reading the corresponding glucose concentration on the -axis.
  • the final determined glucose concentration for the unknown sample is adjusted for any dilution factor caused by adjusting the pH of the sample.
  • N-Benzyl-4-ethenyl- 4,7-phenanthrolinium chloride (0.243 g, 0J30 mmols) was suspended in CH 3 CN (2 mL) in a flame dried, sidearmed 25-mL round bottom flask, equipped with a magnetic stirring bar and reflux condenser.
  • Dimethyl-(3-bromomethyl)- benzeneboronate (2.8 g, 11.5 mmols) was added via syringe through the side area and the suspension heated to reflux for 64 h under argon (g). The solution was cooled to room temperature and precipitated with diethyl ether (10 mL). The suspension was allowed to settle and the supernatant removed via cannula.
  • N-(3- aminopropyl) methacrylamide HCl was placed into a small test tube with 5 ml of THF and 0.55 ml of I M aqueous NaOH. The suspension was vortexed for a short period and taken up into a 10 ml plastic syringe. The solution in the 100 mL round bottom flask was stirred rapidly and charged with 5.2 ml deionized water, followed by dropwise addition of the
  • DMSO DMSO (20 mL) was added via double ended needle, and after a few minutes of stirring, the first solution containing 8-acetoxy-l,3,6-pyrene trisulfonylchloride in DMSO was cannulated in drop wise to give a deep red homogeneous solution. After six hours approximately one third of the solution was removed, and DMSO was distilled off under vacuum. The resulting brown material was washed with a small amount of acetonitrile, which was filtered through cotton and dripped into Et 2 O to precipitate a small amount (48 mg) of brown/red hygroscopic solid.
  • Example 30 The material from Example 30 was retained in a 100-mL round bottom flask with a side arm, and the flask was equipped with a magnetic stirring bar and a reflux condenser. The flask was charged with 4-N-(benzyl-3-(dimethyl)boronate)-4,7-phenanthrolinium bromide (4,7-Phen-m-BV) (0.797, 1.88 mmols), DMF (4 mL), and CH 3 OH (3 mL). The suspension was heated to 100°C for 48 hrs and kept under a blanket of argon throughout the reaction. The reaction mixture was cooled to room temperature under argon and kept stirring.
  • the suspension was cannulated into ice cold diethyl ether (100 mL) and allowed to precipitate over one hr.
  • the supernatant was cannulated to a separate vessel and the beige/red residue was triturated with THF (50 mL).
  • the mixture was sonicated at 40°C for 120 min and the resultant fine powder was washed with diethyl ether (3 x 50 mL).
  • the solids were collected on a fritted funnel under argon and dried under reduced pressure (0.929 g, 49.4% yield).
  • Abase line value of 441 (fluorescence intensity) was established with buffer solution.
  • the peristaltic pump was stopped and the pumping solution was changed to 400 mg/dl glucose in pH 7.4 phosphate buffer.
  • the fluorescence intensity increased twelve units to a value of 453, corresponding to a 2.7% signal increase.
  • the process of switching solutions was repeated.
  • the solution was changed to 400 mg/dl fructose in pH 7.4 phosphate buffer.
  • the buffer gave a base line of 443.
  • the fluorescence intensity increased fourteen units to a value of 457, corresponding to. a 3.2% signal increase.
  • pH 7.4 phosphate buffer was pumped through the system to achieve a baseline of 446.
  • the glucose response was measured using 180 mg/dL, the fluorescence intensity changed from 257 to 291.
  • Example 36 The solution was stirred at room temperature for 72 hr and the resultant suspension cannulated, via a plastic cannula, to an acetone: diethyl ether solution (1:1, 300 mL). The precipitate was filtered through an air sensitive fritted funnel and washed multiple times with diethyl ether under a blanket of argon. The bright yellow solids were dried under reduced pressure and isolated under argon. Yield: 1.632 g, 1.92 mmols, 76%. The compound was used in Example 36.
  • m-BBVBP An oven-dried, side-armed 50-mL round botttom flask equipped with a magnetic stirring bar and reflux condenser was cooled under argon, and charged with m-BBVBBr (500 mg, 0.587 mmols). The solid was dissolved in the minimum amount of anhydrous CH 3 OH (6 mL) and 4-vinylpyridine (63 mg, 0.60 mmols) was added through the side arm. The solution was stirred at room temperature for 15 h and then heated to reflux for six hr. Additional 4-vinylpyridine (63 mg, 0.60 mmols) was added and the mixture refluxed for 4 days.
  • the green film was stored in pH 7.4 phosphate buffer until used in Example 38.
  • the fluorescence was measured according to the procedures of Example 12.
  • the time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten seconds with an integration time of two seconds.
  • the excitation frequency was set at 463 nm and the emission frequency was set at 518 nm.
  • the excitation slit width was set at 15 nm and the emission at 4.3 nm.
  • a base line value of 451 (fluorescence intensity) was established with buffer solution.
  • the peristaltic pump was stopped and the pumping solution was changed to 360 mg/dl glucose in pH 7.4 phosphate buffer.
  • the fluorescence intensity increased 29 units to a value of 458, corresponding to a 1.6% signal increase.
  • the process of switching solutions was repeated.
  • the buffer gave an expected base line of 451.
  • EXAMPLE 39 A SINGLE COMPONENT VIOLOGEN SENSOR HPTS-BV
  • THF -(5 mL) was added via double ended needle, and after a few minutes of stirring, the solution containing 4,4'-bipyridine in THF was added drop wise to the 3- bromomethylphenylboronic acid solution. After 30 minutes some yellow precipitate begins to form, the solution was stirred at room temperature overnight and a large amount of precipitate formed. The solution was then centrifuged and the supernatant transferred via double ended needle. The yellow solid was washed with THF (3x10 mL) and dried under vacuum- (100 mtorr, 3 h) to give 0.88 grams (79% yield) mBV.
  • a peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0J) through the cell at a rate of 30 mL per minute.
  • the time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings.
  • the sample was irradiated using the pulse function (every two seconds) and readings captured every ten seconds with an integration time of two sec.
  • the excitation frequency was set at 475 nm and the emission frequency was set at 525 nm.
  • the excitation slit width was set at 15 nm and the emission at 4 nm.
  • a base line value of 464 (fluorescence intensity) was established with buffer solution.

Abstract

The present invention concerns an improved optical method and optical sensing device for determining the levels of polyhydroxyl-substituted organic molecules in vitro and/or in vivo in aqueous media. In particular, a sensory devise is implemented in a mammal to determine sugar levels. Specifically, a dye is combined with a conjugated nitrogen-containing heterocyclic aromatic boronic acid-substituted bis-onium compound in the presence of a sugar, such as fructose or glucose. The viologens are preferred as the aromatic conjugated nitrogen-containing boronic acid substituted compounds. The method is useful to determine sugar levels in a human being.

Description

OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS BACKGROUND OF THE INVENTION Related Application This application is a continuation-in-part of U.S. Ser. No. 09/731,323, filed 5
December 2000. This application is incorporated herein by reference in its entirety. Field of the Invention
This invention relates to an improved optical method and or sensor for polyhydroxy substituted organic molecules that measure the concentration of these molecules in aqueous or organic media. In one application, the method and sensor monitor the concentration of sugars, i.e. glucose or fructose, in aqueous solution in vitro. In particular, the method and sensor monitor the concentration of sugars, i.e. glucose or fructose, in aqueous solution in vivo. The determination of glucose in fluids in vivo and in vitro - is of importance. The in vivo sensing device is implanted in a human being. Some of the novel components of the optical method and device are also considered to be inventions in their own right. Description of Related Art
There has been an ongoing effort over many years to use fluorescence techniques to measure polyhydroxyl compound (e.g. glucose) concentrations in body fluids. Although the term "glucose" is used herein below, it is to be understood that the concentration of most polyhydroxyl-containing organic compounds (carbohydrates, 1,2-diols, 1,3 -diols and the like) in a solution are determined. But in spite of the intense effort, no practical system has been developed and commercialized for in vivo monitoring. Several attempts have been made to detect glucose by fluorescence using dyes to which a boronic acid group has been attached. Boronic acids are known to bind sugars reversibly. When the boronic acid functional dye binds to a sugar, the properties of the dye are affected. These changes have been used in the past to measure sugar concentration.
One use of this approach to a glucose sensor was reported by Russell, U.S. Patent 5,137,833 (See also Russell & Zepp, U.S. Patent 5,512,246) which disclosed the use of a boronic acid functionalized dye that binds to glucose and generates a signal dependent on glucose concentration. James et al U.S. Patent 5,503,770 used the same principle but combined a fluorescent dye, an amine quenching functionality, and a boronic acid in a single complex moiety, the fluorescence emission from which varies with extent of glucose binding. Van Antwerp et al U.S. Patent 6,002,954 and U.S. 6,011,984 combined features of the previously cited references and also taught fabrication of a device that is purported to be implantable. A.E. Colvin, Jr. in U.S. Patent 6,304,766 disclosed optical-based sensing devices, especially for in-situ sensing in humans.
Patents of interest include but are not limited to: Russell, US Patent 5,137,833 (1992)
James et al, US Patent 5,503,770 (1996)
Russell & Zepp, US Patent 5,512,246 (1996)
Nan Antwerp et al, US Patent 6,002,954 (1999)
Nan Antwerp and Mastrototaro, US Patent 6,011,984 (2000) Related U.S. patents of interest include:
Wolfbeis et al, US Patent 4,586,518 (1986)
Gallop & Paz, US Patent 4,659,817 (1989)
Yafuso & Hui, US Patent 4,798,738 (1989)
Yafuso & Hui, US Patent 4,886,338 (1989) Saaski et al, US Patent 5,039,491 (1991)
Lanier et al, US Patent 5,114,676 (1992)
Wolfbeis et al, US Patent 5,232,858 (1993)
Colvin, US Patent 5,517,313 (1996)
Sundrehagen et al, US Patent 5,631,364 (1997) James et al, US Patent 5,763,238 (1998)
Siegmund et al, US Patent 5,711,915 (1998)
Barnard & Rouilly. US Patent 5,852,126 (1998)
Colvin, US Patent 5,894,351 (1999)
Alder et al, US Patent 5,922,612 (1999) Arnold et al, US Patent 6,063,637 (2000)
Song et al, US Patent 6,046,312 (2000) Kimball et al, US Patent 6,139,799 (2000) Clark et al., US Patent 6,040,194 (2000) Schultz, US Patent 6,256,522 (2001) Walt, et al., US Patent 6,285,807 (2001)
Colvin US Patent 6,304,266 (2001)
Nan Antwerp, et al., US Patent 6,319,540 (2001)
Related articles and publications of interest include: Yoon & Czarnik, J. Amer. Chem. Soc. (1992) 114, 5874-5875 James, Linnane, & Shinkai, Chem.Commun. (1996), 281-288 Suenaga et al, Tetrahedron Letters (1995), 36, 4825-4828 Eggert et al, J.Org.Chem. (1999), 64, 3846-3852 Wolfbeis et al, Analvtica Chimica Acta (1995), 304, 165-170
Wang et al, Organic Letters(1999 1, 1209-1212 Chen et al, Proc. Nat. Acad. Sci. (1999), 96, 12287-12292 P.D. Hale et al, Analvtica Chimica Acta (1999), 248, 155-161 A.E. Colvin, Jr. et al, Johns Hopkins Technical Digest. Vol. 12, # 17, p. 378 (1996) References of a general nature include:
A.W. Czarnik (ed), Fluorescent Chemosensors for Ion and Molecule Recognition. ACS Washington, D.C. 1992.
F.W. Scheller et al (eds), Frontiers in Biosensorics I Fundamental Aspects. Birkhduser Verlag, Basel 1997. J.R. Lakowicz, Principles of Fluorescence Spectroscopy. 2nd ed. Kluwer
Academics/Plenum Publishers, New York, New York (1999).
Haugland, R. P. Handbook of Fluorescent Probes and Research Chemicals 6th ed. Molecular Probes Inc. Eugene, Oregon (1996).
Gunter Wulff, et al., "Molecular Imprinting for the Preparation of Enzyme Analogous Polymers", pp. 10-28 in R.A. Bartsch and M. Maeda (eds) Molecular and Ionic Recognition with Imprinted Polymers. ACS Symposium 703 American Chemical Society 1998. Washington, D.C.
H. Murakami, et al, "Glucose Detection by Electrochemical Methods Using a Viologen Boronic Acid Derivative", Chem. Letters (Japan), (2000) (8) p. 940-1. All patents, articles, references, standards and the like cited in this application are incorporated herein by reference in their entirety.
All of these prior art sensors are deficient in one or more aspects, such as operability under physiological conditions, stability of operation, simplicity of design, reliability, implantability, and sensitivity. The present invention overcomes these deficiencies.
SUMMARY OF THE INVENTION This present invention concerns an optical method and an optical device for determining the concentration of polyhydroxyl compounds in aqueous media, especially for determining in vivo, especially sugars such as glucose or fructose, in physiological media. These compounds, the analytes, are in a system with a fluorescence sensing device comprised of a light source, a detector, and the active components including a fluorophore D (fluorescent dye), a quencher and an optional polymer matrix M. Some components are inventions in their own right. When excited by light of appropriate wave length, the fluorophore emits light (fluoresces). The intensity of the light is dependent on the extent of quenching. The fluorophore and quencher Q are preferably independent entities, optionally they are immobilized in or covalently attached to a polymeric matrix which is permeable to or in contact with the compounds of interest to be detected and quantified. In one aspect, the present invention comprises a class of fluorescence quenching compounds that are responsive to the presence of polyhydroxyl compounds such as glucose in aqueous media at or near physiological pH. In other words, the quenching efficiency is controlled by the concentration of these compounds in the medium. The quencher is comprised of a viologen substituted with at least one boronic acid group wherein the adduct is inrmobilized in or covalently bonded to a polymer. The quencher, dye and polymer may also be covalently bonded to each other.
The combination of boronic acid and viologen, and the resultant effect on viologen properties are important embodiments of the present invention.
In another aspect, the present invention is a class of polymeric fluorescent dyes which are susceptible to quenching by the viologen/boronic acid adduct. Useful dyes include pyranine derivatives (e.g. hydroxypyrene trisulfonamide derivatives and the like). (See Figures IA, IB and 1C),
In one embodiment, the dye is comprised of a hydroxypyrene trisulfonamide moiety bonded to a polymer. Converting sulfonic acid groups to sulfonamide groups shifts the pKa of pyranine into a range more suitable for measurement at physiological pH. This conversion also shifts the absorbance of the dye to longer wavelengths thereby allowing it to be more efficiently excited by light from a blue LED which is a preferred light source for an implanted sensor. These derivatives are typically prepared by reacting a trisulfonyl chloride intermediate with 1 ) a poly amine, 2) an amine functional ethylenically unsaturated monomer which adduct is subsequently polymerized, 3) or an amine functional polymer. In one embodiment, the dye is a fully substituted derivative having no residual free sulfonic acid groups on the pyrene ring.
In another aspect, the present invention is a composite water- compatible polymer matrix, preferably a hydrogel, which comprises the dye and quencher moieties. The matrix is a water-swellable copolymer, preferably crosslinked, to which the dye and quencher moieties are covalently bonded by a linking group L. In one embodiment, the matrix is an interpenetrating polymer network (IPN) with the dye incorporated in one polymer network and the quencher in the other polymer network. In another embodiment, the matrix is a semi-IPN wherein the dye component is a high molecular weight water-soluble or dispersible polymer trapped in a crosslinked network comprised of quencher monomer and suitable hydrophilic comonomers. Optionally, the quencher may be in the water-compatible or dispersible component and the dye within the network. Further both dye and quencher may be separately incorporated in water-soluble or dispersible polymers wherein dye and quencher are both trapped in an inert polymer matrix. Optionally, the components are separated from the analyte solution by a membrane which is impermeable to the components, but permeable to the analyte. Optionally, the matrix is molecularly imprinted to favor association between dye and quencher, and to enhance selectivity for specific sugars, e.g. glucose, over other polyhydroxy compounds. The preferred method for enhancing interaction between dye and quencher is to functionalize the dye moiety with negatively charged groups such as carboxylate, sulfonate, phosphonate, and phosphate.
In another aspect, the present invention concerns a device for measuring the concentration of glucose in vivo by means of an optical sensor. The specific device is comprised of a visible light source, preferably a blue LED light source, a photodetector, a light conduit (optical wave guide) such as an optical fiber assembly, and a water-insoluble polymer matrix comprised of a fluorophore susceptible to quenching by a viologen, a viologen/boronic acid quencher, and a glucose permeable polymer, wherein the matrix is in contact with said conduit and with the medium containing the analyte. In another embodiment the present invention relates to an optical method for the in vivo detection of polyhydroxyl-substituted organic molecules as the analyte between about 430 and 600 nm detection, which method comprises:
A. obtaining a fluorophore dye D, which is compatible with the analyte solution, wherein D is selected from: (a) D1 which is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 600 nm, iii. Resistant to photobleaching under the conditions of analysis, iv. A Stokes shift of about or greater than 30 nm, v. Compatibility with said analyte solution, and wherein said vi. Dye D1 is quenched by methyl viologen to produce an experimentally determined apparent Stern-Nolmer quenching constant (Ksv) greater than or equal to 50, wherein the fluorophore dye D1 which is neutral or negatively charged is: (i) a discrete compound having a molecular weight of 1 ,000 daltons or greater, with the proviso that if the dye is substituted with negatively charged groups the molecular weight is 500 daltons or greater; (ii) a pendant group or chain unit in a water-soluble or dispersible polymer having a molecular weight greater than about 10,000 daltons, and optionally said polymer is non-covalently associated with a water-insoluble polymermatrix M1 and is physically immobilized within said polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte solution; and optionally where D1 is negatively charged and the polymer is immobilized as a complex with a cationic water-soluble polymer, said complex formed is permeable to or in contact with said analyte solution;
(b) D2 is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 800, iii. A Stokes shift of about or greater than 30 nm, iv. Resistant to photobleaching under the conditions of analyses, v. Compatibility in the analyte solution, and wherein vi. Said Dye D2 is quenched by methyl viologen to produce an apparent Stern- Nolmer quenching constant (Ksv) greater than or equal to 50, wherein D2 is covalently bonded to an insoluble polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte; wherein said fluorophore dye D2 is a part of the structure: M'-L'-D2 with the proviso that D2 which is polyfunctional is bonded to matrix M1 at one, two or three sites; L1 is a hydrolytically stable covalent linking group selected from the group consisting of a direct bond, lower alkylene having 1 to 8 carbon atoms optionally ten-ninated with or including one or more divalent connecting groups selected from sulfonamide, amide, ester, ether, sulfide, sulfone, phenylene, urethane, urea, and amine, and B. Combining with a boronic acid-containing quencher moiety Q, wherein Q is comprised of a conjugated nitrogen-containing heterocyclic, aromatic bis-onium salt having the properties of compatibility in said analyte solution and produces a detectable change in the emission of the dye in the presence of said analyte, selected from: (i) quencher Q1 which is a discrete compound having a molecular weight of about 400 daltons or greater or is a pendant group or a chain unit in a water-soluble or water-dispersible polymer having a molecular weight greater than 10,000 daltons and said polymer optionally is non-covalently associated with the optional polymer matrix M1 when present, and is physically immobilized in said polymer matrix, or optionally said polymer is immobilized as a complex with a negatively charged water-soluble polymer, or
(ii) quencher Q2 which is covalently bonded by linking group L2 to M1 or to a second water insoluble polymer matrix M2 producing M2 -L2-Q2 wherein L2 is selected from the group consisting of a direct bond, a lower alkylene having 1 to 8 carbon atoms optionally terminated with or including one or more divalent connecting groups selected from sulfonamide, amide, quaternary ammonium, pyridinium, ester, ether, sulfide, sulfone, phenylene, urea, thiourea, andurethane, or amine, wherein said quencher Q1 or Q2 is mixed at a molecular level with said fluorophore dye D1 or D2, and with the proviso that Q2 when poly functional is linked to the matrix M2 at one or two sites, C. contacting a physiological fluid which contains analyte, a dye and a quenched in vivo with an excitation light source coupled with a detector;
D. producing a detectable and quantifiable signal in the range of about 430 to 600 nm; and
E. determining the concentration of said polyhydroxyl-substituted analyte in said physiological fluid.
In another embodiment, the invention is a device which incorporates the components listed above which work together to determine the analyte.
In the present invention, the term "polymer" to which D1 and D2 are attached excludes those polymers which react or combine with dihydroxy compounds. The useful polymers maybe anionic, cationic or neutral, and hydrolytically stable and compatible with in vivo fluid. In another aspect of the method, the Dye D1 is selected from a discrete molecule or polymer of pyr'ahine derivatives having the structure of:
Figure imgf000010_0001
where R1, R2 and RL are each -NH-CH2-CH2(-O-CH2-CH2)n-X'; wherein X1 is selected from -CH2 -OCH3, -CO2H, -CONH2, -SO3H, or -NH2; and n is between about 70 and 10,000, and preferably between 100 and 1,000.
In another aspect of the method, the Dye D1 or D2 is prepared from pyranine derivatives having the structure of:
Figure imgf000010_0002
or from a dye monomer selected from the group consisting of:
Figure imgf000010_0003
where R4 = -H, and
R5 is selected from: -R6-NH-(C=O)-(C=CH2)-R7, -R6-O-(C=O)- (C=CH2)-R7,
-CH2-C6H4-CH=CH2- or -CH2-CH=CH2- wher.e in R6 is a lower alkylene of 2 to 6 carbons and R7 = -H, or -CH3 where Z is a blocking group that is removed by hydrolysis selected from:
-(C=O)-R8-Y where R1 is a lower alkylene of 1 to 4 carbon atoms and Y is selected from -H, -OH, -CO2H, -SO3H, -(C=O)-NH-R9, or -CO2-R9 where R9 is a lower alkylene of 1 to 4 carbon atoms.
Preferably a dye moiety D1 as a discrete compound or a pendant group is selected from:
Figure imgf000011_0001
where R'8 is -H or L3-A where L3 is selected from L2 above and A is selected from -COOH and -SO3H; and
R19 is -H or is selected from R5 above with the proviso that when the dye is D2 at least one of R18 or R19 is a polymerizable group and each sulfonamide group is substituted with one -H.
In another aspect, Q ' is a discrete compound with a molecular weight (M W) at least twice the MW of the analyte which is water soluble or dispersible having at least one boronic acid substituent wherein said compound is isolated from the body by a semi- permeable membrane. Preferably Q1 as a discrete compound contains two boronic acid substituents. In another aspect the quencher Q1 is selected from:
Figure imgf000012_0001
Figure imgf000012_0002
or
Figure imgf000012_0003
wherein the boronic acid groups are in the meta- or para- positions. In another aspect of the method, the quencher Q1 or Q2 is prepared from a quencher precursor selected from the group consisting of:
» ^Q( }-c"z-ϊvf- r-
Figure imgf000012_0005
Figure imgf000012_0004
where (N)2+ is a nitrogen containing conjugated heterocyclic aromatic group selected from isomers of dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, or diazafluorenes; wherein the two nitrogen atoms are each in a different aromatic ring and the nitrogens are in all positions capable of forming an onium salt and where Z1 or Z2 is a sustituent on nitrogen and is either a polymerizable ethylenically unsaturated group selected from:
(i) -R10-CO2-C(R")=CH2, -R10-ΝH-(C=O)-C(R2)=CH2, or -CH2-C6H4-CH=CH2, here R10 is a lower alkylene or hydroxyalkylene of 2 to 6 carbon atoms and where R"= -H or -CH3; or (ii) a coupling group selected from: -R12-Z3 where R12 is -CH2C6H4- or alkylene of 2 to 6 carbon atoms and Z3 is -OH, -SH, -CO2H, or -NH2 . Q1 is a discrete compound or a pendant group or a chain unit (linear or branched) oof a water-soluble or dispersible polymer. The insoluble polymer matrix M1 -L2-Q2 is preferably a crosslinked network polymer.
In another aspect, Q1 or Q2 is prepared from a precursor selected from:
Figure imgf000013_0001
where N3 and Z4 or Zs are 2, 3 or 4-(CH=CH2)-pyridinium; -Ν-(CH2)w-O(C=O) C(CH3) =CH2); -O-(CH2)w, -O-CH2 -(CH=CH2); -O-(CH2)w-O-(C=O)CH(=CH2); and -O-(CH2)w-O-(C=O) C(CH3)=CH2; and w is a integer from 2 to 6, or Z4 and Z* have the same definitions as above for Z1 and Z2.
For the dye D, note that D1 and D2 are defined with the proviso that the dye D1 and D2 do not include a diazo linkage -N=N-.
For the quencher Q, Q1 and Q2 are defined with the proviso that the quencher Q1 and Q2 do not include a diazo linkage -N=N-.
For the in vivo applications, described herein, the ortho-benzylboronic acid derivatives in the presence of a polymer are excluded. BRIEF DESCRIPTION OF THE FIGURES Figure IA is the structural formula of (8-hydroxypyrene - 1,3,6-N, N', N" -tris- (methoxypolyethoxyethyl (n~125) sulfonamide) (HPTS-PEG).
Figure IB is the structural formula of 8-acetoxypyrene - 1,3,6-N, N', N" -tris- (methacrylpropylamidosulfonamide) (acetoxy-HPTS-MA).
Figure IC is the structural formula of 8-hydroxypyrene-l,3,6-N,N',N"-tris (carboxypropylsulfonamide) (HPTS-CO2).
Figures 2 A to 2G are schematic representations of structures of quenchers Q1 as the dihalide salts. Figure 2 A is trans- 1 ,2-bis(4,4'-N,N '-(benzyl-4-boronic acid)-pyridinium)ethylene dibromide;
Figure 2B is l,7-N,N'-bis(benzyl-3 -boronic acid)-phenanthrolinium dibromide; Figure 2C is benzyl viologen (BN)-a comparative quencher; Figure 2D is 4,4'-N,N'-bis-(benzyl-2-boronic acid)-dipyridinium dibromide (o- BBN);
Figure 2E is 4,4'-N,N-bis-(benzyl-3-boronic acid)-dipyridinium dibromide (m- BBN);
Figure 2F is 4,4'-N,N-bis-(benzyl-4-boronic acid)-dipyridinium dibromide (p- BBN); Figure 2G is N, N'-bis (benzyl-(2, 3, or 4)-boronic acid-4,7-phenantholinium halide (4,7-phen-o, m, or p-BBN);
Figure 3 A is an unsymmetrical glucose responsive viologen, and Figures 3B to 31 are schematic representations of structures of quencher precursors:
Figure 3 A is 4-N-(benzyl-2 -boronic acid)-4'-N'-(benzyl)-dipyridmium bromide chloride;
Figure 3B is 4-N-(benzyl-3 -boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridiniιιm bromide chloride (rn-SBBN);
Figure 3C is 4-N-(benzyl-2-boronic acid)-4'-N-(benzyl-4-ethenyl)-dipyridinium bromide chloride (o-SBBN); and Figure 3D is 4-N-(benzyl-4-boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridinium bromide chloride (p-SBBN).
Figure 3E is trα«_?-l,2-bis-4-N-(benzyl-4-boronic acid)-4'-N'-(benzyl-4-ethenyl)- dipyridinium-4-ethylene dibromide;
Figure 3F is 4-N-(benzy 1-3 -boronic acid)-4'-N'-(benzyl-3-ethenyl)-3 phenanthrolinium dibromide;
Figure 3G is 4,4'-Ν,Ν-bis-[benzyl-(3-methylene-4-vinyl-pyridinium bromide)-5- (boronic acid)]-dipyridinium dibromide) (m-BBNBP);
Figure 3H is 4-Ν-(benzyl-3-(boronic acid)-7-n-[benzyl-3-(methylene-(l-oxy-3- (oxybenzylvinyl)-propane))-5-boronic acid]-4,7-phenanthrolinium dibromide;
Figure 31 is 4,4'-N,N-bis-[benzyl-(3-methylene-4-vinylpyridiniumbromide)-5- (boronic acid)]~4,7-phenanthrolinium dibromide; Figures 4A and 4B are schematic representations of the structures of the interpenetrating polymer network (IPN) polymers and semi-IPN polymers respectively of the invention.
Figure 5 is a graphic representation of the response of benzyl viologen (0.001M) and 4,4'-N,N'-bis-(benzy 1-3 -boronic acid)-dipyridinium dibromide (m-BBN) showing modulation of m-BBN quenching efficiency toward HPTS-PEG (1 xlO"5 M) as a function of glucose concentration.
Figure 6 is a graphic representation of the response of ortho-, meta-, and para- benzyl boronic acid viologen (BBN) (0.001M) showing modulation of quenching efficiencies to HPTS-PEG (Ixl0"5-M) as a function of glucose concentration. Figure 7 is a Stern-Nolmer plot of m-BBN quenching of HPTS-PEG in pH 7.4 phosphate buffer.
Figure 8 is a schematic representation of one embodiment of the in vitro probe as it would be used in a process stream and is also an embodiment illustrating the use of the sensing polymer assembly. Figure 9 is a schematic representation of a second embodiment of the in vitro probe as it would be used in a process stream to monitor for polyhydroxyl organic compounds, e.g. glucose or fructose.
Figure 10 is a schematic cross-sectional representation of the in vitro probe of Figure 9. It is also a representation of the in vivo sensing polymer assembly of Figure 9. Figure 11 is a graphic representation of the two component system of 4,7-phen m-SBBN and HPTS-MA, plotting fluorescence intensity versus time in seconds in a pH 7.4 buffer. Figure 12A is a graphic representation of the fluorescence emission spectra of 8- hydroxypyrene-l,3,6-N,N',N"- (carboxypropyl sulfonamide) (HPTS-CO2) with increasing m-BBN. It plots fluorescence intensity versus wavelength (nm) from 0 to 1 mM.. Figure 12B is a graphic representation of the fluorescence emission response to glucose of 8-hydroxypyrene-l,3,6-Ν,Ν',Ν"- (carboxypropyl sulfonamide) (HPTS- CO2)/m-BBN. It plots fluorescence intensity versus wavelength (nm) for 0 to 1800 mg/dL.
Figure 13 is a graphic representation of the glucose response of 8-hydroxypyrene- 1 ,3,6-Ν,Ν',Ν"- (carboxypropyl sulfonamide) (HPTS-CO2) with m-BBN. It plots F/F0 versus glucose (mg/dL).
Figure 14 is a graphic representation of fluorescence intensity versus time (sec) for a two component system of m-BBNBP and HPTS-MA.
DETAILED DESCRIPTION OF THE INVENTION
AND PREFERRED EMBODIMENTS Definitions
As used herein:
"Boronic acid" refers to a structure -B(OH)2. It is recognized by those skilled in the art that a boronic acid may be present as a boronate ester at various stages in the synthesis of the quenchers of this invention. Boronic acid is meant to include such esters.
"Detector" refers to a device for monitoring light intensity such as a photo diode. "Fluorophore" or " fluorophore dye" or "dye" refers to a compound, an aromatic group or a heteroaromatic group that when exposed to light of appropriate wavelength emits light, i.e., it fluoresces. Fluorophore D is selected from a discrete compound or a reactive intermediate which is convertible to a second discrete compound, or to a polymerizable compound; or D is pendant group or chain unit in a polymer prepared from said reactive intermediate or polymerizable compound, which polymer is water-soluble or water- dispersible or is a water-insoluble polymer, said polymer which is optionally crosslinked.
"HEMA" refers to 2-hydroxyethylmethacrylate.
"Light source" or "excitation light source" refers to a device that emits electromagnetic radiation such as a xenon lamp, medium pressure mercury lamp, a light emitting diode (LED) all of which are commercially available.
"Linking group" refers to L,L' or L2 which are divalent moieties, that covalently connect the sensing moiety to the polymer or matrix. Examples of L,L' or L2 include those which are each independently selected from a direct bond or, a lower alkylene having 1 to 8 carbon atoms, optionally terminated with or interrupted by one or more divalent connecting groups selected from sulfonamide (-SO2NH-), amide -(C=O)N-, ester -(C=O)-O-, ether.-O-, sulfide -S-, sulfone (-SO2-), phenylene -C6H4-, urethane -NH(G=O)-O-, urea - NH(C=O)NH-, thiourea -NH(C=S)-NH-, amide -(C=O)NH-, amine -NR- (where R is defined as alkyl having 1 to 6 carbon atoms) and the like.
"Quencher" refers to a compound that reduces the emission of a fluorophore when in its presence. Quencher Q is selected from a discrete compound, a reactive intermediate which is convertible to a second discrete compound or to a polymerizable compound or Q is a pendant group or chain unit in a polymer prepared from said reactive intermediate or polymerizable compound, which polymer is water-soluble or dispersible or is an insoluble polymer, said polymer is optionally crosslinked.
"In vivo" refers to analysis in a living mammal, preferably a human being. In vivo measurements take place under physiological conditions of temperature, pressure, medium, analyte concentration and pH as found in a human body. "IPN" or "interpenetrating polymer network " refers to a combination of two or more network polymers synthesized in juxtaposition (see L.H. Sperling, Interpenetrating Polymer Networks, ACS Advances in Chemistry Series 239, 1994, from August 25-30,1991 New York ACS Meeting).
"Pyridinium" refers to structures (linking groups or pendant groups comprised of units, i.e. pyridine rings substituted on the nitrogen and optionally on carbons in other positions on the ring. Substituents on carbon include vinyl groups and substituents on nitrogen include the methylene group of a benzyl boronic acid.
"Semi-IPN" or semi-interpenetrating polymer network" refers to a combination of polymers in which one component is soluble and the other polymer is a network (see Sperling above).
"Onium" refers to a heteroaromatic ionic compound having a formal positive charge on the heteroatom, which in the case of viologen is a nitrogen. "PEG" or "polyethylene glycol" refers to polymer or chain segments which contain oxyethylene (-OCH2-CH2-) repeating units.
"PEGDMA" refers to polyethylene glycol terminated with two methacrylate groups. "PEGMA" refers to polyethylene glycol terminated with one methacrylate group.
"Physiological pH" refers to the pH range of 7.3-7.5 normally existing in the blood of a living human being.
"Visible light range" refers to light in the spectrum between about 400 and 800 nm.
"Viologen" refers generally to compounds having the basic structure of a nitrogen containing conjugated N-substituted heterocyclic aromatic bis-onium. salt, such as 4,4'-N,N' bis-(benzyl) bipyridium dihalide (i.e., dichloride, bromide chloride), etc. Viologen also includes phenanthroline compounds.
The present invention concerns a number of important advances. These include but are not limited to a method and an in vivo device for determining carbohydrate, 1,2-diol or 1,3-diol levels in liquids selected from aqueous or organic liquids or combinations thereof or in a physiological fluid, respectively. A series of fluorophore dyes, a series of boronic acid substituted quenchers, and combinations of interacting water-compatible and water-soluble and organic solvent-compatible and organic solvent-soluble organic polymers are used. These aspects are discussed in more detail below. The components are discussed first, and their combination to produce the method and the device follows.
Quencher
The moiety that provides glucose recognition in the present invention is an aromatic boronic acid. More specifically, the boronic acid of this invention is covalently bonded to a conjugated nitrogen-containing heterocyclic aromatic bis-onium structure, e.g. a viologen, (see for example Figures 3 A to 31) in which the boronic acid has a pKa less than about 7 and reacts reversibly with glucose in aqueous media to form boronate esters. The extent of reaction is related to glucose concentration in the medium.
Bis-onium salts of this invention are prepared from conjugated heterocyclic aromatic dinitrogen compounds. The conjugated heterocyclic aromatic dinitrogen compounds are selected from dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, and diazaffuorenes, wherein the nitrogen atoms are in a different aromatic ring and are able to form an onium salt. It is understood that all isomers of said conjugated heterocyclic aromatic dinitrogen compounds in which both nitrogens can be substituted are useful in this invention. Bis-onium salts derived from 4,4'-dipyridyl and 4,7-phenantholine are preferred. The viologen boronic acid adducts are discrete compounds or are water-compatible pendant groups or units in a chain of a water-soluble or water-dispersible polymer with a molecular weight greater than 10,000 or are bonded to an insoluble polymer matrix. One or more boronic acid groups are attached to the viologen moieties. For the polymeric quencher precursors, three options are available for the boronic acid moiety to be attached to two different nitrogens in the heteroaromatic centrally located group. These are: a) a polymerizable group on a first aromatic moiety is attached to one nitrogen and a second aromatic group containing at least one -B(OH)2 group is attached to the second nitrogen; b) one or more boronic acid groups are attached to a first aromatic moiety which is attached to one nitrogen and one boronic acid and a polymerizable group are attached to a second aromatic group which second aromatic group is attached to the second nitrogen; and c) one boronic acid group and a polymerizable group are attached to a first aromatic moiety which first aromatic group is attached to one nitrogen, and a boronic acid group and a polymerizable group are attached to a second aromatic moiety which is attached to the a second nitrogen. Representative viologens with one boronic acid group include the following: 1. boronic acid substituted viologen of the structure:
Figure imgf000020_0001
where n=0-3, preferably n is 1, and where L is a linking group, i.e. L1 or L2 as defined herein and M is a polymer matrix as defined herein, and where Y2 is phenyl boronic acid (m- and p-isomers) or naphthyl boronic acid, preferably a phenyl boronic acid, and
2. as a substituent on the heterocyclic ring of a viologen.
The viologen is contemplated to include combinations of the above. The precursor from which the viologen/boronic acid is derived is an unsymmetrically substituted viologen, such as with a boronic acid functional group on one end and a polymerizable group, such as a vinyl group, on the other (see Figures 3A-3I). The viologen/boronic acid moiety is a pendant group or a chain unit in a water soluble or dispersible polymer, or a unit in a crosslinked, hydrophilic polymer or hydrogel sufficiently permeable to glucose to allow equilibrium to be established. Fluorophore Dye
Dyes useful in this invention (See Fig. IA, IB and IC) are excited by light of wavelength about or greater than 430 nm, with a Stokes shift large enough that the excitation and emission wavelengths are separable, by at least 10 nm, and preferably greater than or equal to about 30 nm. These dyes are susceptible to quenching by electron acceptor molecules, such as viologens, are resistant to photo-bleaching, and are stable against photo- oxidation, hydrolysis, and biodegradation. Dyes useful in the present invention have an apparent Stern- Volmer quenching constant when tested with methyl viologen of about 50 or greater and preferably greater than 100. A general description of the Stern- Volmer test is found below in Preparation A. Preferred dyes include polymeric derivatives of hydroxypyrene trisulfonic acid. In some cases, the dye is bonded to a polymer through the sulfonamide functional groups. The polymeric dyes are water-soluble, water-insoluble but swellable or dispersible in water or may be crosslinked. A preferred dye as a polymer is for example, a water soluble PEG adduct of 8-hydroxypyrene-l,3,6-N,N',N"- tris(methoxypolyethoxylethyl (n~125) sulfonamide) (formed by reaction of acetoxypyrene trisulfonyl chloride with aminoethyl PEG monomethyl ether. The resulting dye polymer has a molecular weight of at least about 10,000 such that, when it is trapped in a hydrogel or network polymer matrix, it is incapable of diffusing out of the matrix into the surrounding aqueous medium.
Representative dyes as discrete compounds are the tris adducts foπned by reacting 8-acetoxypyrene-l,3,6-trisulfonylchloride (HPTS-C1) with an amino acid, such as amino butyric acid. Hydroxypyrene trisulfonamide dyes bonded to a polymer and bearing one or more anionic groups are most preferred, such as copolymers of 8-hydroxypyrene-l-N- (methacrylarmdopropylsulfonamido)-N N"-3,6-bis(carboxypropylsulfonarnide)HPTS-CO2- MA with HEMA, PEGMA, etc.
Other examples include soluble copolymers of 8-acetoxypyrene-l,3,6-N, N', N"- tris(methacrylamidopropylsulfonamide) with HEMA, PEGMA, or other hydrophilic comonomers. The phenolic substituent in the dye is protected during polymerization by a blocking group that can be removed by hydrolysis after completion of polymerization. Such blocking groups which are suitable for example acetoxy, trifluoroacetoxy, and the like are well known in the art.
It is essential that, for sensing to occur, the sensing moieties (analyte, dye, quencher) must be in close physical proximity to allow interaction, i.e. mixed on a molecular level and in equilibrium with the species to be detected. While not bound by any theory or mechanism, in most cases the molecules may have to collide or the molecule centers are less than 10 angstroms apart for quenching to occur. However the distance dependent quenching falls of rapidly if the molecules are further apart. It appears that the intensity of the fluorescence emitted by the dye is attenuated by photo-induced intermolecular electron transfer from dye to viologen when viologen/boronic acid adduct and the dye are in close proximity. When glucose binds to the boronic acid, the boronate ester interacts with the viologen thereby altering its quenching efficacy according to the extent of glucose binding. The specific nature of this interaction is not yet established, but it may involve electron transfer from boronate to viologen or boronate formation may shift the reduction potential of the viologen.
The reduction potential is an indicator of the ability of a quencher to accept an electron. POLYMER MATRIX FOR SENSORS
For in vivo applications, the sensor is used in a moving stream of physiological fluid which contains one or more polyhydroxyl organic compounds or is implanted in tissue such as muscle which contains said compounds. Therefore, it is essential that none of the sensing moieties escape from the sensor assembly. Thus, for use in vivo, the sensing components are part of an organic polymer sensing assembly. Soluble dyes and quenchers can be confined by a semi-permeable membrane that allows passage of the analyte but blocks passage of the sensing moieties. This can be realized by using as sensing moieties soluble molecules that are substantially larger than the analyte molecules (molecular weight of at least twice that of the analyte or greater than 1000 preferably greater than 5000); and employing a selective semipermeable membrane such as a dialysis or an ultrafiltration membrane with a specific molecular weight cutoff between the two so that the sensing moieties are quantitatively retained.
Preferably, the sensing moieties are immobilized in an insoluble polymer matrix which is freely permeable to glucose, see Figure 8. The polymer matrix is comprised of organic, inorganic or combinations of polymers thereof. The matrix may be composed of biocompatible materials. Alternatively, the matrix is coated with a second biocompatible polymer that is permeable to the analytes of interest.
The function of the polymer matrix is to hold together and immobilize the fluorophore and quencher moieties while at the same time allowing contact with the analyte, and binding of the analyte to the boronic acid. To achieve this effect, the matrix must be insoluble in the medium, and in close association with it by establishing a high surface area interface between matrix and analyte solution. For example, an ultra-thin film or microporous support matrix is used. Alternatively, the matrix is swellable in the analyte solution, e.g. a hydrogel matrix is used for aqueous systems. In some instances, the sensing polymers are bonded to a surface such as the surface of a light conduit, or impregnated in a microporous membrane. In all cases, the matrix must not interfere with transport of the analyte to the binding sites so that equilibrium can be established between the two phases. Techniques for preparing ultra-thin films, microporous polymers, microporous sol-gels, and hydrogels are established in the art.
Hydrogel polymers are preferred for this invention. The term, hydrogel, as used herein refers to a polymer that swells substantially, but does not dissolve in water. Such hydrogels maybe linear, branched, or network polymers, or polyelectrolyte complexes, with the proviso that they contain no soluble or leachable fractions. Typically, hydrogel networks are prepared by a crosslinking step which is performed on water soluble polymers so that they swell but do not dissolve in aqueous media. Alternatively, the hydrogel polymers are prepared by copolymerizing a mixture of hydrophilic and crosslinking monomers to obtain a water swellable network polymer. Such polymers are formed either by addition or condensation polymerization, or by combination process. In these cases, the sensing moieties are incorporated into the polymer by copolymerization using monomeric derivatives in combination with network-forming monomers. Alternatively, reactive moieties are coupled to an already prepared matrix using a post polymerization reaction. Said sensing moieties are units in the polymer chain or pendant groups attached to the chain.
The hydrogels useful in this invention are also monolithic polymers, such as a single network to which both dye and quencher are covalently bonded, or multi-component hydrogels. Multi-component hydrogels include interpenetrating networks, polyelectrolyte complexes, and various other blends of two or more polymers to obtain a water swellable composite which mcludes dispersions of a second polymer in a hydrogel matrix and alternating microlayer assemblies.
Monolithic hydrogels are typically formed by free radical copolymerization of a mixture of hydrophilic monomers, including but not limited to HEMA, PEGMA, methacrylic acid, hydroxyethyl acrylate, N- vinyl pyrrolidone, N,N'-dimethyl acrylamide, and the like; ionic monomers include methacryloylaminopropyl frimethylammonium chloride, diallyl dimethyl ammonium, chloride, vinyl benzyl trimethyl ammonium chloride, sodium sulfopropyl methacrylate, and the like; crosslinkers include ethylene dimethacrylate, PEGDMA, trimethylolpropane triacrylate, and the like. The ratios of monomers are chosen to optimize network properties including permeability, swelling index, and gel strength using principles well established in the art. In one embodiment, the dye moiety is derived from an ethylenically unsaturated derivative of a dye molecule, such as 8-acetoxypyrene- 1,3,6-N, N', N"-tris(methacrylamidopropylsulfonamide), the quencher moiety is derived from an ethylenically unsaturated viologen such as 4-N-(benzyl-3-boronic acid)-4'-N'- (benzyl-4ethenyl)-dipyridinium dihalide (m-SBB V) and the matrix is made from HEMA and
PEGDMA. The concentration of dye is chosen to optimize emission intensity. The ratio of quencher to dye is adjusted to provide sufficient quenching to produce the desired measurable signal.
Alternatively, a monolithic hydrogel is formed by a condensation polymerization. For example, acetoxy pyrene trisulfonyl chloride is reacted with an excess of PEG diamine to obtain a tris- (amino PEG) adduct dissolved in the unreacted diamine. A solution of excess trimesoyl chloride and an acid acceptor is reacted with 4-N-(benzyl-3 -boronic acid)- 4'-N'-(2hydroxy ethyl) bipyridinium dihalide to obtain an acid chloride functional ester of the viologen. The two reactive mixtures are brought into contact with each other and allowed to react to form the hydrogel, e.g. by casting a thin film of one mixture and dipping it into the other. Polymers that are capable of reacting with boronic acids to form boronate esters under the conditions of this method are not useful as matrix polymers. Such polymers have 1,2- or 1,3- dihydroxy substituents, including but not limited to cellulosic polymers, polysaccharides, polyvinyl alcohol and its copolymers and the like.
Multi-component hydrogels wherein the dye is incorporated in one component and the quencher in another are preferred for making the sensor of this invention. Further, these systems are optionally molecularly imprinted to enhance interaction between components and to provide selectivity for glucose over other polyhydroxy analytes. Preferably, the multi- component system is an interpenetrating polymer network (IPΝ) or a semi-interpenetrating polymer network (semi-IPΝ). The IPΝ polymers are typically made by sequential polymerization. First, a network comprising the quencher is formed. The network is then swollen with a mixture of monomers including the dye monomer and a second polymerization is carried out to obtain the IPΝ hydrogel.
The semi-IPΝ hydrogel is formed by dissolving a soluble polymer containing dye moieties in a mixture of monomers including a quencher monomer and polymerizing.
Alternatively, a soluble quencher polymer is dissolved in a monomer mixture containing the dye monomer and the mixture polymerized. In either case, the molecular weight of the soluble component must be sufficiently high (about or greater than 10,000) that it cannot diffuse out of the network, i.e. it becomes physically bound in or trapped by the matrix. In Figure 4A, one group of polymer chains 41 , 42, 43 and 44 contain the quencher, for example quencher Q2. A second group of polymer chains 45, 46 and 47 containing the dye, for example, dye D2, is formed at about the same time or sequentially. The points of crosslinking of the polymers are designated as 48 and 49. In Figure 4B, one group of polymer chains 51, 52, 53 and 54 contain the quencher, for example, quencher Q2. Dye D1 is to a pendant group on a second polymer 56. Crosslinking points 57 are designated.
Molecular Imprinting - Optionally, the polymers of this invention are molecularly imprinted. In one embodiment, an organic salt is formed from a manometric quenched cation and a manometric dye anion. The organic salt is then copolymerized, under conditions such that the ion pairs remain at least partially associated, to form a monolithic hydrogen matrix. Alternatively, the quenched monomer is polymerized to form a first polymer which is then ion exchanged to obtain a polyelectrolyte with anionic dye countering. The latter is then copolymerized with suitable monomers to form an interpenetrating dye polymer which is associated through ionic bonding with the quenched polymer. The combination is either an IPN polymer or a semi-IPN polymer. In another embodiment, the polymers of this invention are molecularly imprinted to enhance selectivity for glucose over other polyhydroxyl compounds, such as fructose, by first forming a bis boronate ester of glucose with a polymerizable viologen boronic acid. This ester is then copolymerized and hydrolyzed to obtain a glucose imprinted polymer. This polymer is subsequently used to form an IPN with a dye polymer.
In one aspect, m-SBB V is mixed with glucose in about a 2: 1 molar ratio in aqueous organic solvent, e.g. water/dioxane. The product bis-boronate ester is recovered by distilling off the solvents under vacuum. The product is next copolymerized with HEMA and
PEGDMA to obtain a first hydrogen following the procedures described in Example 14. Glucose is then leached from the hydrogen by conditioning in dilute hydrochloric acid. After conditioning in deionized water, the hydrogen is contacted with the dye monomer of Example 28 to form a complex between the anionic dye and the cationic quenched polymer. A second stage polymerization with more HEMA and PEGDMA is then carried out to form a molecularly imprinted IPN hydrogen.
The individual components in a multi-component hydrogen are made by the same or a different polymerization scheme. For example, in an IPN polymer, a first network is formed by free radical polymerization, the second by condensation polymerization. Likewise, in a semi-IPN polymer, the soluble component is formed by condensation polymerization and the network by free radical polymerization. For example, a quenched polymer, such as poly 4,4'-N,N-bis(l,3-xylylene-5-boronic acid) bipyridinium dihalide is formed by condensing 4,4'-dipyridyl with 3,5-bis-bromomethyl phenylboronic acid. The quenched polymer is dissolved in a reaction mixture containing 8-acetoxypyrene- 1,3,6-N, N', N"-tris(methacrylamidopropylsulfonamide) as described above, and the solution is polymerized to obtain the semi-IPN hydrogen. The combination of components described herein produces a device for the determination of polyhydroxy substituted organic molecules in physiological fluids.
In a specific embodiment, a high molecular weight water-soluble dye is prepared by condensing acetoxypyrene trisulfonyl chloride with aminoethyl PEG monomethyl ether to obtain the 8-hydroxypyrene-l,3,6-N,N',N"-tris-(methoxypolyethoxyethyl (n~125) sulfonamide). The PEG dye polymer is dissolved in a mixture comprised of HEMA, PEGDMA, 4-N-(benzyl-3-boronic acid)-4'-N '-(benzyl-4-ethenyl)-dipyridinium dihalide (m- SBBV), aqueous alcohol and free radical initiator and polymerized to obtain a semi-IPΝ hydrogen. After hydrolysis with dilute base and leaching with deionized water, the hydrogen is affixed to a bifurcated optical fiber light conduit such that it can be exposed to and equilibrate with the body fluid. The light conduit together with appropriate filters is connected to a blue light emitting diode (LED) light source and a silicon photodetector together with an electronic controller and associated measurement instrumentation. The sensor is placed in the tip of a catheter which is inserted in the body in the desired location. The sensor is excited by light of about 475 nm and the fluorescence intensity monitored at about 520 nm. The level of glucose in the body fluid is determined from the intensity of the emission.
A SINGLE COMPONENT VIOLOGEN SENSOR
In another embodiment the invention is a boronic acid substituted viologen covalently bonded to a fluorophore. An example of a single component viologen sensor as a discrete compound is shown as Example 39. Preferably, the adduct is a polymerizable compound or is a unit in a polymer. One such adduct is prepared by first forming an unsymmetrical viologen from 4,4'-dipyridyl by attaching a benzyl-3 -boronic acid group to one nitrogen and an aminoethyl group to the other. The viologen is condensed sequentially first with 8-acetoxy-pyrene-l,3,6-trisulfonyl chloride in a 1:1 mole ratio followed by reaction with excess PEG diamine to obtain a prepolymer mixture. An acid acceptor is included in both steps to scavange the byproduct acid. The prepolymer mixture is crosslinked by reaction with a polyisocyanate to obtain a hydrogen. The product is treated with base to remove the blocking group. Incomplete reaction products and unreacted starting materials are leached out of the hydrogen by exhaustive extraction with deionized water before further use. The product is responsive to glucose when used as the sensing component as described herein. Alternatively, said adducts are ethylenically unsaturated monomers for example dimethyl bis-bromomethyl benzene boronate is reacted with excess 4,4-dipyridyl to form a half viologen adduct. After removing the excess dipyridyl, the adduct is further reacted with an excess of bromoethylamine hydrochloride to form the bis-viologen adduct. This adduct is coupled to a pyranine dye by reaction with 8-acetoxypyrene trisulfonyl chloride in a 1 : 1 mole ratio in the presence of an acid acceptor followed by reaction with excess aminopropylmethacrylamide. Finally, any residual amino groups are reacted with methacrylol chloride. After purification the dye/viologen monomer is copolymerized with HEMA and PEGDMA to obtain a hydrogen.
The advantage of this group of viologens is that dye and quenched are held in close proximity by covalent bonds which could lead to increased sensitivity. The disadvantage is that making these adducts is a formidable synthetic challenge and changes in composition are difficult to implement. Characterization and purification of the product is equally difficult. Therefore, the embodiments in which dye and quenched are separate entities are preferred. BATCHOPTICALMETHOD OFANALYSIS FORGLUCOSE
Measurements are carried out in a conventional luminescence spectrometer. A solution containing a dye and quenched of this invention buffered to pH = 7.4 is prepared and loaded into a cuvet. The sample is excited by light of wavelength suitable for the dye being used and the fluorescence intensity measured. A fixed amount of the unknown glucose containing solution is added to the solution and the measurement is repeated. The change in intensity is used to calculate glucose concentration by reference to a calibration curve determined separately by measuring a standard series of glucose solutions and plotting the results as intensity change as a function of concentration. In this method, the sensing components need to be stable only for the time of the test, and the reaction with glucose need not be reversible. OPTICAL METHOD OF PROCESS STREAM ANALYSIS
A flow-through cell is fabricated for the luminescence spectrometer. A sensing polymer is mounted in the cell such that it is exposed on one surface to the excitation light and on the other to the process stream. A baseline is established by passing the process stream free of glucose tlirough the cell and measuring the steady state fluorescence. The process stream is then passed through the cell and the fluorescence intensity monitored as a function of time. Glucose concentration is determined by reference to a calibration curve as described above. In this method, the sensor must be stable over time of operation and the reaction with glucose must be reversible. Further, the sensing moieties must be immobilized and not leach out into the process stream. DEVICE CONFIGURATION
Figure 8 is a schematic representation of the device as used for one time or continuous monitoring for sugar, i.e. glucose. The sensing polymer 81 which contains the dye and quenched may be attached to an optional support 82. For some embodiments an optional semi-permeable polymer membrane 83 A is present. For other applications it may be useful to have an optimal biocompatible coating 83B covering the assembly. The light source 84 is connected to an optical filter 85 to an optical fiber 86 to the sensing polymer 81. Detector 87 is connected to an optical filter 88 to an optical fiber 89 which connects to sensing polymer 81. Light source 84 and detector 87 are both connected to electronic controller 90. Thus the system can detect changes in the sensing polymer based on the glucose content of the physiological fluid. The device useful in a process stream and for in vivo implanting and monitoring is shown in Figures 9 and 10. Figure 9 shows the optical device. Figure 10 is the cross sectional representation of the probe. For Figure 9, light source 11 (visible) is connected by optical fiber 12 to active cell 13. Semipermeable membrane 14 allows the analyte to enter and exit freely from cell 13. Optical fiber 15 conveys the altered light to filter 16, and optional photomultiplier to 17 to produce the analyte spectrum for analysis.
As shown in Figures 9 and 10, cell 13 includes the selectively permeable membrane such that the mixture of polymer 21, dye 22, and quenched 23 are retained in cell 13 under the conditions of analysis. The light enters cell 14 via optical fiber 12. Within the active portion of 14Aof cell 14, thepolymer21, dye 22 and quenched 33, contact analyte 24 which has selectively entered the cell causing a quantitative and reproducible change in the spectrum. This modified light signal travels optical fiber 15 to photomultiplier 17 to be analyzed. One skilled in the art will recognize that the serving moieties of this invention can be used in other implantable fluorescence sensing devices known in the art. EXPERIMENTAL Reagents and solvents are used as received from commercial supplier unless otherwise noted. (See Chem Sources USA which is published annually.)
The following examples are provided to be descriptive and exemplary only. They not to be construed to limiting in any manner or fashion.
PROCEDURE A
FLUORESCENCE SPECTROSCOPY ANALYSIS OF THE APPARENT STERN- VOLMER QUENCHING CONSTANT OF METHYL VIOLOGEN WITH A
FLUORESCENT DYE
The apparent Stern- Volmer quenching constant is derived from the slope of a Stern- Volmer plot of relative fluorescence intensity (F0/F) versus concentration of quenched (M).
See J.R. Lakowicz, (1999) Principles ofFluorescence Spectroscopy Second Edition, Kluwer
Academic/Plenum Publishers, New York, pp. 237-289. One skilled in the art is in general able to perform this analysis for any fluorescent dye/quenched pair in a particular solvent of interest. This general Stern- Volmer analysis is used in determining the Stern- Volmer quenching constants in 0.1 ionic strength pH 7.4 phosphate buffer.
In order to avoid concentration quenching effects, the concentration of the dye is generally adjusted so that the optical density of the dye, at excitation λmax<0.5 absorption units. Once the desired dye concentration is determined, a stock dye solution is prepared in which the concentration is 5 times greater than that desired in the final measurements. For example, a dye for which the desired final concentration, which gives an optical density of excitation λmax<0.5 absorption units, is 1 x 10"5 M, would require a stock solution in which the concentration is 5 x 10"5 M.
Once determined, as is described above, 10 mL of dye stock solution of the appropriate concentration is made by weighing out the appropriate mass of dye and placing the solid into a 10 mL volumetric flask. The flask is then filled to the 10 mL mark with 0.
1 ionic strength pH 7.4 phosphate buffer.
A stock solution of methyl viologen (25 mL, 0.0025 M) was prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0. 1 ionic strength). Seven different solutions containing methyl viologen were then prepared in pH 7.4 phosphate buffer as described below in Table 1 :
TABLE 1
Figure imgf000030_0001
Each sample is then in-turn analyzed in a luminescence spectrometer set at the appropriate excitation wavelength and the appropriate emission wavelength range for the corresponding dye. The instrumental settings (slit widths, scan speed, optical filters, excitation wavelength, emission wavelength range) are held constant throughout the analysis of the series of samples). The emission fluorescence intensity is then determined as the integration of the fluorescence intensity over the emission wavelength range by the trapezoidal rule approximation method. The integrated values are plotted on the y-axis and the quenched concentrations are plotted on the x-axis and the slope of the resulting line is calculated by linear regression as the Stern- Volmer quenching constant. One skilled in the art will realize that based on quenching mechanism the Stern- Volmer plot may not result in a linear relationship. However through the use of the appropriate mathematical relationships, which is known and understood by one skilled in the art, the apparent Stern- Volmer quenching constant is calculated and used for comparison.
PREPARATION A
SYNTHESIS OF DIMETHYL-r4-BROMOMETHYLVBENZENEBORONATE An oven-dried, 100-mL round bottom flask was cooled under argon, fitted with a magnetic stirring bar, and charged with (4-bromomethyl)-benzeneboronic acid (12.49 mrnols, 2.684 g). The flask was sealed with a septum and charged with pentane (55 mL). The suspension was stirred at room temperature and upon addition of freshly distilled CH3OH (3.16 g, 4 mL, 97 mmols) the solution instantly clarified. After stirring for 20 minutes, the solution was dried over MgSO4, then over CaCl2 (to remove excess CH3OH). The supernatant was cannulated, under argon, through a glass-fritted funnel (medium), and the pentane subsequently removed in vacuo. The remaining yellow oil was further dried under reduced pressure (0. 1 torr, I hr). Yield: 1.6 g, 6.59 mmols (56 %). "H-NMR (CD3OD, ppm): 4.5 (s, 2H), 7.4 (d, 2H), 7.55 (d, 2H). UB-NMR (CH3OH, ppm): 29 (s). Similar procedures were used to prepare the corresponding 2- and 3-isomers. The products were used to make the boronic acid- viologen compounds of Examples 1-3, 5 and 6.
PREPARATION B SYNTHESIS OF 8-ACETOXY-PYRENE-1.3.6-TRISULFONYL CHLORIDE
Trisodium-8-acetoxy-pyrene-l,3,6-trisulfonate (acetoxy-HPTS, 11.33 g, 20 mmol) was suspended in 30 mL of thionyl chloride to which 5 drops of dimethylformamide was added. The suspension was refluxed for 3 hr. , during which time it became a brown solution. The solution was then cooled to 25°C under an argon atmosphere. Thionyl chloride was then distilled off under vacuum (2 Torr) leaving a yellow residue. The yellow residue was transferred to three separate centrifuge tubes along with 60 mL of dichloromethane. The suspensions were then centrifuged and the supernatant solutions transferred to a dry round bottom flask. The residue remaining in the centrifuge tubes was washed an additional four times each with 10 mL portions of dichloromethane. The supernatant solutions were combined and left overnight under an argon atmosphere and some precipitation was observed. The dichloromethane solution was added to 250 mL of pentane causing precipitation of a large amount of yellow solid. The supernatant was removed by a double ended needle and the yellow solid was dried on high vacuum (0.2 Torr). Yield: 8.62 g, 15.5 mmol (78 %), Η-NMR (500 MHz, CDC13, ppm): 2.682 (s, 3H), 8.833, (d, J=10Hz, IH), 8.915 (s, IH), 9.458 (d, J=10Hz, IH), 9.509 (d, J=10Hz, IH), 9.630 (s, IH), 9.685 (d, J= 10Hz, IH). This product was used in Examples 7, 9, 13, 14 and 15. PREPARATION C SYNTHESIS OF 4-(4-PYRIDYL)-N-(BENZYL-4-ETHENYL)-PYRIDINIUM
CHLORIDE
An oven-dried, 100-mL round bottom flask was cooled under argon, fitted with a magnetic stirring bar, and charged with 4,4'-dipyridyl (12.50 g, 80 mmols). The flask was sealed with a septum and charged with CH3OH (20 mL). The homogenous solution was stirred at room temperature while 4-(chloromethyl)styrene (2.82 mL, 20 mmols) was added dropwise via syringe. After stirring the solution at room temp for 48 hours, the solvent was removed in vacuo. Dry tetrahydrofuran (50 mL) was added to the reaction flask via cannula and the mixture stiffed for three days, at which point the stirring was stopped, the solids allowed to settle, and the solvent was removed as much as possible via cannula. This process was repeated two more times, in each case reducing the mixing time to 24 hours. After the third trituration the mixture was filtered under nitrogen and washed with dry diethyl ether
(200 mL) via cannula. The cake was dried by passing dry nitrogen tlirough it under pressure for I hour, and finally by applying vacuum (0.1 torr, 1 h). Yield: 5.56 g, 18 mmols (90%), !H-
NMR (D20, ppm); 9.12 (d, 2H), 8.86, (d, 2H), 8.48 (d, 2H), 7.98 (d, 2H), 7.67 (d, 2H), 7.57
(d, 2H), 6.87 (dd, IH), 5.92 (s, 2H), 5.45 (d, IH). This compound was used in Examples 5 and 6.
PREPARATION D
SYNTHESIS OF N-BENZYL-4-ETHENYL-4,7-PHENANTHROLINIUM
CHLORIDE (4.7-PHE SV) A flame dried, side armed 100-mL round bottom flask, equipped with a magnetic stirring bar, was cooled under argon and charged with 4,7-phenanthroline (2.14 g, 11.86 mmols). The flask was equipped with a reflux condenser attached to an argon (g) line and charged with 4-(chloromethyl)styrene (0.905 g, 0.836 mL, 5.93 mmols) and anhydrous CH3CN (20 mL) through the side arm. The solution was heated to reflux under argon (g) for 17 h, then cooled to room temperature and precipitated with diethyl ether (30 mL). The suspension was allowed to settle and the supernatant removed via cannula. The remaining residue along with 15 mL of solvent was cannulated into a centrifuge tube, triturated with acetone (20 mL), and centrifuged (process repeated 4 times). The brownish/pink solid was triturated with diethyl ether (3 x 20 mL) and dried under reduced pressure. Yield: 0.376 g, 1.13 mmols (19%). Η NMR (250 MHz, CD3OD, ppm): 5.266 (d, IH, 11 Hz), 5.80 (d, IH, J=17.75 Hz), 6.482 (s, 2H), 6.708 (dd, IH, J,=l l Hz, J2=17.75 Hz), 7.374 (d, IH, J=8 Hz), 7.496 (d, IH, J=8 Hz) 8.00, (dd, IH, J^4 Hz, J2=8.5 Hz), 8.453 (dd, IH, J,=6 Hz, J2=8.5 Hz), 8.60 (d, IH, J=10 Hz), 8.697 (d, IH, JM10 Hz), 9.20 (d, IH, J=4 Hz), 9.50 (d, IH, J=8.25 Hz), 9.65 (d, IH, J=5J5 Hz), 10.188 (d, IH, J=8.5 Hz). 13C NMR (62.5 MHz, CD3OD); 62.40, 121.344, 124.899, 126.023, 128.454, 129.031, 130.778, 132.161, 133.893, 134.242, 137.205, 139.848, 140.410, 140.699, 144.041, 147.976, 149.541, 154.661. This compound was used in Examples 25.
EXAMPLE 1
SYNTHESIS OF 4,4'-N,N'-BIS-(BENZYL-3-BORONIC ACID) DIPYRIDINIUM DIBROMIDE An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 4,4'-bipyridyl (0.469 g, 3 mmols). The tube was sealed with a septum and charged with CH3OH (7 mL). The homogenous solution was stirred at room temperature while freshly prepared dimethyl-(3-bromomethyl)- benzeneboronate (1.82 g, 7.5 mmols) was added via syringe. After stirring the solution for 15 hours, the reaction vessel was centrifuged (4 min at 3200 RPM) and the CH3OH cannulated to a separate flask. The remaining yellow solid was triturated with acetone:water (24: 1, VN, 25mL), stirred vigorously on a vortex mixer and centrifuged. The acetone solution was removed by cannula and the trituration process repeated two more times. The solid was then triturated with diethyl ether using the same process. The pale yellow solid, in the centrifuge tube, was then dried on the high vacuum (0.6 torr, 2 hr). Yield: 0.956g, 1.63 mmols (54%). MP: decomposition > 230°C. Η-ΝMR (D2O, ppm): 6.093 (s, 4H), 7.715, (dd, 2H, j,=7.5 Hz, J2=7.5 Hz), 7.788 (d, IH, j=7.5 Hz), 7.984 (s, IH), 8.002 (d, IH, J=7.5 Hz),
8.662 (d, 4H, J=7 Hz), 9.293 (d, 4H, J=7 Hz).uB-ΝMR (CH3OH , ppm): 29 (s). This compound was used in Examples 16-18 and Figure 6 below.
EXAMPLE 2 SYNTHESIS OF 4,4'-N,N'-BIS-(BENZYL-4-BORONIC ACID)
DIPYRIDINIUM DIBROMIDE An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 4,4' -dipyridyl (0.234 g, 1.5 mmols). The tube was sealed with a septum and charged with anhydrous CH3OH (7 mL). The homogenous solution was stirred at room temperature while freshly prepared dimethyl-(4-bromomethyl)-benzeneboronate (1.09 g, 4.5 mmols) was added via syringe. After stirring the solution for 15 hours, the reaction vessel was centrifuged (4 min at 3200 RPM) and the CH3OH cannulated to a separate flask. The remaining yellow solid was triturated with acetone:water (24: 1, VV, 25mL), stirred vigorously on a vortex mixer, and centrifuged. The acetone solution was removed by cannula and the trituration process repeated two more times. The solid was then triturated with diethyl ether using the same process. The pale yellow solid, in the centrifuge tube, was then dried under reduced pressure (0.6 torr, 2 hr). Yield: 0J23 g, 1.63 mmols (82%). MP: decomposition greater than 230°C. Η-NMR (D2O ppm): 6.116 (s, 4H), 7.670 (d, 4H, J=8.25 Hz), 8.017 (d, 4H, J=8.25 Hz), 8.698 (d, 4H, J=6.5 Hz), 9.325 (d, 4H, J=6.5 Hz). UB-NMR (CH3OH, ppm): 29 (s). See Examples 17 and 18 and Figure 6.
EXAMPLE 3
SYNTHESIS OF 4,4'-N,N'-BIS-(BENZYL-2-BORONIC ACID)
DIPYRIDINIUM DIBROMIDE
(a) An oven-dried, 50-mL centrifuge tube was cooled under argon and fitted with a magnetic stirring bar. 4,4'-Bipyridyl (1.5 mmol, 0.234 g) was weighed out into the tube which was then sealed with a septum and charged with CH3OH (7 mL). The homogenous solution was stirred at room temperature while mixing. Freshly prepared dimethyl-(2- bromomethyl)benzeneboronate (4.5 mmols, 1.2 mL, 1.09 g) was added via syringe to the reaction tube and the resulting brown/orange solution was stirred at room temperature
(ambient) for 15 hrs. The reaction vessel was then centrifuged (4 min at 3200 RPM) and the CH3OH cannulated to a separate flask. The remaining yellow solid was triturated with diethyl ether (25 mL), stirred vigorously using a vortex mixer, and centrifuged. The ether solution was removed by cannula and the trituration process repeated three more times. The pale yellow solid, in the centrifuge tube, was then dried under reduced pressure (0.6 torr, 2 hr). The yield was 70 %. 'HNMR (D2O, ppm): 6.21 (s, 2H), 7.72, (m, 3H), 7.91 (d, IH), 8.60 (d, 2H), 9J8 (d,2H). πBNMR (CH3OH, ppm) 30.2 (broad s).
This compound was found to quench the fluorescence of the dye of Example 8 and to respond to glucose. See Example 17. EXAMPLE 4 SYNTHESIS OF l,7-N,N'-BIS(BENZYL-3-BORONIC ACID)- PHENANTHROLINIUM DIBROMIDE An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 1,7-phenanthroline (0.288 g, 1.6 mmols). The tube was then sealed with a septum, charged with CH3OH (4 mL), and freshly prepared dimethyl-(3- bromomethyl)-benzeneboronate (0.972 g, 4 mmols) was added via syringe. The homogenous solution was stirred at room temperature for 15 hrs, and then refluxed for 2 hrs. The reaction mixture was cooled to room temperature under argon and the CH3OH was removed in vacuo. The yellow/orange solid was triturated overnight with acetone:water (40 mL, 24: 1, V/V), then with diethyl ether (2 x 40 mL). The suspension was filtered through a glass-fritted funnel (medium), and the solid isolated under argon. Yield: 0.495g, 0.812 mmols(51%). MP:>230°C. 1H-NMR(D2O, ppm): 6.504(lH)J.638(lH),8.025(m,2H), 8.2505 (d, IH, 8.5 Hz), 8.483 (in, 6H) 8J38 (d, IH, J=8.5 Hz), 9.315 (d, IH, J=5J5 Hz), 9.605 (d, IH, J=5J5 Hz), 10.098 (d, IH, J=8.5 Hz) 10.269 (d, 111, J=8.5 Hz). πB-NMR (CH3OH, ppm): 28 (s). This compound was found to quench the fluorescence of the dye of Example 8 and respond to glucose.
EXAMPLE 5 SYNTHESIS OF 4-N-(BENZYL-4-BORONIC ACID)-4'-N'-
(BENZYL-4-ETHENYDDIPYRIDιNIUM BROMIDE CHLORIDE fp-SBBV)
An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 4-(4-pyridyl)-N-(benzyl-4-ethenyl)-pyridinium chloride (0.463 g, 1.5 mmols). The tube was sealed with a septum and charged with acetonitrile (6 mL). The resulting pink/orange suspension was stirred at room temperature while freshly prepared dimethyl-(4-bromomethyl)-benzeneboronate (0.486 g, 2 mmols) was added via syringe.
After stirring the suspension for 23 hrs the reaction vessel was centrifuged (4 min at 3200
RPM) and the acetonitrile cannulated to a separate flask. The remaining yellow solid was triturated with acetone: water (25mL, 24: 1, V/V), stirred vigorously on a vortex mixer, and centrifuged. The acetone solution was removed by cannula and the trituration process repeated two more times. The solid was then triturated with diethyl ether using the same process. The bright yellow solid, in the centrifuge tube, was then dried under reduced pressure (0.5 torr, 1 hr). Yield: 0.43 1 g, 0.824 mmols (55%). MP: > 200°C. Η-NMR (D2O ppm): 5.405 (d, IH, J = 11.5 Hz), 5.929 (d, 2H, J = 17.5 Hz), 5.934 (s, 2H), 5.981 (s, 2H), 6.832 (dd, 2H, J, = 17.5 Hz, J2 =1 1 Hz), 7.523 (d, 2H, J = 9 Hz), 7.562 (d, 2H, J = 8 Hz), 7.626 (d, 2H, J = 8 Hz), 7.8815 (d, 2H, J = 8.5 Hz), 8.566 (dd, 4H, J, = 3.6 Hz, J2 =1.5 Hz), 9.1855 (dd, 4H, J, = 6.5 Hz, J2= 6 Hz). 1 'B-NMR (CH3OH, ppm): 28 (s).
This compound was used to quench the fluorescence of the dye of Example 8 and to respond to glucose.
EXAMPLE 6 SYNTHESIS OF 4-N-(BENZYL-3-BORONIC ACIDM'-N'-
(BENZYL-4-ETHENYLVDIPYRIDINIUM BROMIDE CHLORIDE (m-SBBV An oven-dried, 50-mL centrifuge tube was cooled under argon, fitted with a magnetic stirring bar, and charged with 4-(4-pyridyl)-N-(benzyl-4-ethenyl)-pyridinium chloride (0.463 g, 1.5 mmols). The tube was sealed with a septum and charged with acetonitrile (6 mL). The resulting pink/orange suspension was stirred at room temperature while freshly prepared dimethyl-(3-bromomethyl)-benzeneboronate (0.486 g, 2 mmols) was added via syringe. After stirring the suspension for 23 hours the reaction vessel was centrifuged (4 min at 3200 RPM) and the acetonitrile cannulated to a separate flask. The remaining yellow solid was triturated with acetone: water (25mL, 24: 1, V/V), stirred vigorously on a vortex mixer, and allowed to sit overnight. The acetone solution was removed by cannula and the solid then triturated with diethyl ether (3 x 25 mL); each time the triturant was removed via cannula. The remaining bright yellow solid, in the centrifuge tube, was then dried under reduced pressure (0.015 torr, 3 hr). Yield: 0.584g, 1.12 mmols (74%). MP: decomposition greater than 150°C. Η-NMR (D2Oppm): 5.5165 (d, IH, J = 10.75 Hz), 6.0435 ppm (d, IH, J = 17.8 Hz), 6.095 (s, 2H), 6.049 (s, 2H), 6.9433 (dd, IH, J„ = 11.5 Hz, J2 =17.9 Hz), 7.626 (m, 4H), 7.724 (m, 2H), 7.979 (s, IH), 7.994 (d, IH, J=7.5 Hz), 8.648 (d, 4H), 9.280 (d, 4H). UB-NMR (CH3OH, ppm): 28 (s).
This compound was used to make the polymers of Examples 10, 11, 12, and 14.
EXAMPLE 7
SYNTHESIS OF 8-ACETOXYPYRENE - 1,3,6-N, N', N" -TRIS- fMETHOXYPOLYETHOXYETHYL fn~125) SULFONAMIDE^) A 250-mL round bottom flask was equipped with a magnetic stirring bar and charged with 170 mL of dry tetrahydrofuran (THF). Methoxy-polyethyleneglycol (PEG)-amine (5.65 g, 5630 g/mol, 1 mmol) was added to the flask along with 0.5 grams of granular CaH2. The mixture was heated to 30°C for 24 hr with stirring. Diisopropylethylamine (0.6 mL, 129.24 MW, 0J42 g/mL, 3.4 mmol) was added to the flask and the mixture allowed to stir for an additional hour. The flask was cooled to room temperature and filtered through an air sensitive glass fritted filtration apparatus to remove excess CaH2 and Ca(OH)2. The THF solution was placed back into a 250 mL round bottom flask with magnetic stir bar and heated to 30°C with stirring. 8-acetoxy-pyrene- 1,3,6-trisulfonyl chloride (0. 185 g, 624.8 g/mol, 0.3 mmol) was added to the warm THF solution. The solution immediately turned a deep blue color and faded to a red wine color over 15 min. The reaction was stirred at 30°C for 24 hr. The solvent was removed by rotary evaporation and the residue was dissolved in 100 mL of 1 M HCl. The aqueous solution was extracted with methylene chloride (3 x 100 mL). The methylene chloride fractions were combined and the solvent was removed by reduced pressure evaporation to yield compound as a red solid. Yield: about 5.5 g (-97%). FTIR (KBr pellet, cm"1): 842, 963, 1060, 1114, 1150, 1242, 1280, 1343, 1360, 1468, 1732, 2525, 2665, 2891. 1. This product was then used in Examples 8 and 11, 16 and 17.
EXAMPLE 8 8-HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS- (METHOXYPOLYETHOXYETHYL (n-125^ SULFONAMIDE^)
8-Acetoxypyrene - l,3,6-N,N',N-tris-(methoxypolyetlioxyethyl (n~125) sulfonamide) (5.5 g, 0.32 mmols) was dissolved in 100 mL of 1 M NaOH and stirred for 2 hr. The aqueous solution was neutralized to pH 7 and extracted with methylene chloride (3 x 100 mL) . The methylene chloride fractions were combined and reduced to approximately 10 mL by rotary evaporation. The concentrated methylene chloride solution was then added dropwise into 400 mL of vigorously stirred diethyl ether in an Erlenmeyer flask. The diethyl ether was filtered using a Buchner funnel. The product was isolated as an orange powder. Yield: 5.425 g, 0.31 mmol (94%). FTIR (KBr pellet, cm"1): 842, 963, 1060, 1110, 1150, 1242, 1281, 1343, 1360, 1468, 2888. This compound was identified as the trisubstituted sulfonamide derivative by Fourier Transform Infrared (FTIR). The sulfonic acid IR stretch occurs at 1195J cm"1. There is no 1195.7 cm"1 stretch in the FTIR of this compound. Instead a stretch of 1110 cm"1, assigned to the sulfonamide, is observed. When dissolved in pH 7.4 buffer, the fluorescence of this compound is quenched by methyl viologen with an apparent Stern- Volmer quenching constant of 319M"1.
This was quenched by the products of Examples 1, 2 and 3 and used in Examples 11, 16, 17, 18 and 19.
EXAMPLE 9
8-ACETOXYPYRENE-l,3,6-N, N\ N"- TRIS(METHACRYLAMIDOPROPYLSULFONAMIDE) (ACETOXY-HPTS-MA^) A 100-mL round bottom flask was charged with aminopropyl-3 -methacrylamide- HCl salt (2.68 g, 15 mmol) and 50-mL of acetonitrile to give a white suspension. Water was added dropwise while stirring until all of the white suspension had disappeared producing two layers. Potassium carbonate was added and the suspension was stirred for 15 minutes. The supernatant was transferred to a 500-mL round bottom flask and the potassium carbonate was washed with 50-mL acetonitrile which was then combined in the 500-mL round bottom flask. A yellow solution of acetoxy-HPTS-Cl (1.03 g, 1.8 mmol), 200-mL acetonitrile, and 20-nιL dichloromethane was added under argon to the 500-mL round bottom flask containing the free amine in acetonitrile causing the solution to turn dark red with precipitate formation. The solution was stirred for 1 hr and the supernatant was transferred and concentrated under vacuum to give a dark residue. The residue was extracted with water (1000 mL) and a 50:50 acetonitrile/ethyl acetate solution (700 mL). The organic extract was washed with an additional 1000 mL water. The organic extract was dried over magnesium sulfate and concentrated on a rotary evaporator to give a red residue which was dissolved in methanol. The methanol solution was concentrated and the resulting red residue was dried under high vacuum to give a red solid which was the unprotected HPTS-MA. Yield: 420 mg, 0.5 mmol, 28 %.1H-NMR(500MHz,D4-methanol,ppm): 1.617 (p,J=6.5Hz, 8H), 1.781 (s, 3H), 1.767 (s, 6H), 2.934 (p, J=6.5Hz, 9H), 3.158 (mult. 8H), 5.211 (t, J=1.5Hz), 5.229 (t, J=1.5Hz), 5.488 (s, IH), 5.510 (s, 2H), 8.290 (s, IH), 8.837 (d, J=9.5Hz, IH), 8.913 (d, J=9.5Hz, IH), 8.988 (d, J=1.5Hz IH), 9.201 (d, J=9.5Hz, 111), 9.222 (s, IH). Unprotected HPTS-MA (100 mg, 0. 1 mmol) was then suspended in 10 ml, acetic anhydride and a catalytic amount of sodium acetate was added and the suspension refluxed for 2 hr. Acetic anhydride and acetic acid were removed under vacuum and the resulting brown residue was extracted with 20 mL acetonitrile. The extract was dripped into 150 mL, diethyl ether causing the precipitation of a brown solid. Yield: 75 mg, 0.09 mmol (86 %). This monomer was used in Examples 13, 14 and 15.
EXAMPLE 10 COPOLYMERIZATION OF 4-N-(BENZYL-3-BORONIC ACID)-4'-N'-(BENZYL-4 ETHENYL)-DIPYRIDLNIUM BROMIDE CHLORIDE INTO A
WATER-SOLUBLE POLYMER
A 50-mL cone-shaped round bottom flask was charged with 2-hydroxyethyl methacrylate (1.50g, 11.5 mmols), 4-N-(benzyl-3-boronic acid)-4'-N'-(benzyl-4-ethenyI)- dipyridinium bromide chloride (0. 1 g, 0. 191 mmols), and 3-((methacryloylamino)propyl)) trimethyl ammonium chloride (0.50 g, 2.27 mmols). After the flask was sealed with a septum, the solution was vigorously stirred on a vortex mixer. The vessel was then charged with isopropyl alcohol: water (8 mL, 1:1, V/N) and deoxygenated with argon for one hr.
Concurrently, in a separate 100-mL, side-armed round bottom flask, a solution of 2,2'- azobisisobutyronitrile (AIBΝ, 100 mg, 0.609 mmols) in isopropyl alcohol: ater (5 mL) was prepared. The flask was equipped with a magnetic stir bar and a condenser, and deoxygenated with argon for one hour. The entire manometric solution was taken-up by syringe and 1 mL was added, through the sidearm, to the AIBΝ solution. The AIBΝ reaction vessel was then placed in a 70°C oil bath and the remaining manometric mixture added via syringe pump over 6 hrs (1.5 mL/hr). The resulting orange solution was cooled to room temperature under argon and the solvent carefully removed in vacuo. The amorphous solid was dissolved in CH3OH (20 mL) and quantitatively transferred to a centrifuge tube via cannula. After addition of diethyl ether (20 mL) and formation of a white precipitate, the product was isolated via centrifugation (4 min at 3200 RPM). It was washed with diethyl ether (30 mL), dried under reduced pressure (0.5 torr 3 hrs), and isolated under an inert atmosphere of argon. Yield: 1.345g, (67 Wt %). The amount of viologen moiety incorporated into the polymer was determined, by UN absorbance, to be greater than 99% of the expected value.
This product was used in Example 19. EXAMPLE 11 SEMI-IPN: THE THIN FILM COPOLYMERIZATION OF 4-N-(BENZYL-3- BORONIC ACID)-4*-N-(BENZYL-4-ETHENYL)-DIPYRJDLNIUM BROMIDE CHLORIDE USING HPTS-PEG A 10-mL volumetric flask was charged with 2-hydroxy ethyl methacrylate (3.525 g,
27.08 mmols), 4-N-(benzyl-3-boronic acid)-4'-N-(benzyl-4-ethenyl)-dipyridinium bromide chloride (0.039 g, 0.075 mmols), 3-((methacryloylamino)propyl) trimethyl ammonium chloride (0.3 g, 1.36 mmols), polyethylene glycol dimethacrylate (1.11 g, 1. 11 mmols), 2,2'- azobis (2-(2-imidazolin-2-yl)propane)dihydrochloride (0.025 g, 0.077 mmols), and 8- hydroxypyrene - 1,3,6-Ν, Ν', Ν" -tris-(methoxypolyethoxyethyl (n~125) sulfonamide) (0.013 g, 7.5 x 10"4 mmols); it was filled to the 10-mL mark with isopropyl alcoho water (1:1, VN). After the solution was vigorously stirred on the vortex mixer it was transferred, via pipette, to a 50-mL, cone-shaped round bottom flask and deoxygenated with argon for one hour. The monomer solution was taken-up by syringe and the syringe attached to the polymerization chamber. The solution was then inserted into the cell, under argon, to fill the entire cavity of the cell. The chamber was sealed with Teflon plugs and wrapped in two ZIPLOC® freezer bags. The entire unit was submerged in a 40°C waterbath and heated for 17 hrs. The polymerization chamber was removed from the bath and the bags, and subsequently disassembled to afford a thin green polymeric film. The polymeric film was leached and stored under pH 7.4 phosphate-buffer. This product was used in Example 12. * The polymerization chamber was comprised of (1) An IR cell-holder: two stainless steel plates fashioned to contain the cell and the LUER LOC® ports; (2) A Cell: two glass plates containing a TEFLON® 0.02" spacer in between, with holes drilled through the top plate and spacer; and (3) A Gasket: a precision-cut rubber spacer used to the seal the cell to the cell-holder.
EXAMPLE 12 FLUORESCENCE SPECTROSCOPY ANALYSIS OF SEMI-IPN COPOLYMER OF 4-N-(BENZYL-3-BORONIC ACID)-4,-N'-(BENZYL-4-ETHENYL)-DIPYRIDINIUM BROMIDE CHLORIDE fm-SBBV) USING HPTS-PEG
A 10-mm path length, 5 -mL glass cuvet, which was open on both sides was equipped with two disposable polyethylene cuvet caps. Holes were drilled through the caps such that the threads of a 10/32 standard thread, 1/8" I.D. hose end adapter were screwed into place. A thin sheet of plastic was then cut into a 35 x 9 mm rectangle and a window 6x 15 mm was cut out of the center. Two fittings were constructed from small septa to put pressure on the plastic mask to hold the polymer in place within the cuvet. The height of the septa was 9 mm. The flow-through-cell was then assembled such that the polymer film was in the center of the cuvet and the plastic mask directly over it, effectively framing the film with its window. The pressure fittings were then put in place using tweezers, one at the bottom of the cell and one at the top. The outside walls of the cuvet caps, which sits inside the cuvet, were coated with vacuum grease and inserted into the cuvet to seal the cell. The cell was placed into a Perkin-Elmer LS50B spectrophotometer equipped with a front surface adapter. The cell was oriented so that its side, touching the polymer, was facing the excitation beam of the instrument (face-first in the front surface adapter). 1/8" TYGON® PTFE tubing was connected to the hose adapters of the flow-through-cell. The orientation of the front surface adapter was optimized so that the emission detector was sensing only the surface of the polymer. A peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0J) through the cell at a rate of 30 mL per minute. The time drive function of the Perkin- Elmer LS50B software was used to acquire fluorescence intensity readings every ten sec for an integration time of two sec. The excitation frequency was set at 475 nm and the emission slit width at 536 nm. The excitation and emission slit widths were set at 2.5 nm. A base line value of 358 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 1800 mg/dl glucose in pH 7.4 phosphate buffer.
The fluorescence intensity increased 127 units to a value of 485, corresponding to a 35%) signal increase (S/N ratio = 72). After switching back to buffer the signal approached the expected baseline value of 358.
EXAMPLE 13 8-HYDROXYPYRENE-1.3.6-N. N'. N"- TRISfMETHACRYLAMIDOPROPYLSULFONAMIDE) HYDROGEN POLYMER A 16-mm NMR tube modified with a female 14/20 ground glass joint was charged with a mixture of isopropyl alcohol/water (1:1, 1.5 mL), HEMA (750 mg), polyethylene glycoldimethacrylate (PEGDMA, n~25) (200mg), 3-(methacrylamido) propyltrimethyl ammonium chloride (TMAC) (50 mg), 8-acetoxyρyrene-l,3,6-N, N', N"- tris(methacrylamidopropylsulfonamide) (acetoxy-HPTS-MA) (1 mg, 1.2 x 10"6 mols), and (2,2'-azobis-2(2-imidazolin-2-yl) propane) hydrochloride (VA-044 free radical initiator) (5 mg). All solids were dissolved with the aid of a vortex mixer. The NMR tube was then fitted with a male 14/20 ground glass joint TEFLON® stop cock to vacuum adapter. The mixture was then de-oxygenated via 4 freeze/pump/thaw cycles (-78°C, 1 torr, 5 min. and thawed under nitrogen. The NMR tube was then heated in a water bath at 40°C (±0.5°C for 12 hr . The glass NMR tube was carefully broken to free the polymer plug. The polymer was dialyzed in 200 mL of de-ionized water with triethylamine (5 drops) (de-ionized water and amine solution was changed every 24 hr for 7 days) to remove the acetoxy protecting group on the acetoxy-HPTS-MA. The resulting polymer plug was cut into about 5-mm slices and analyzed by fluorescence spectroscopy.
Excitation and emission spectra of the gels are substantially identical to spectra obtained for the PEG adduct (Example 12). Samples of the polymer gel suspended in pH 7.4 buffer are visibly fluorescent when examined in daylight. The fluorescence is noticeably diminished when m-SBBV, o-SBBV, or p-SBBV was added to the aqueous phase. The fluorescence was recovered when glucose is added to the solution. Similar gels were prepared with dye concentrations of 0.05 to 5 mg/g polymer (dry weight). All were yellow- green to orange in color and were visibly fluorescent when examined in day (natural) light. The fluorescence was quenched when the hydrogels were exposed to aqueous o-, m-, and -BBV (benzyl boronic acid viologens).
EXAMPLE 14 IPN: COPOLYMERIZATION OF 4-N-(BENZYL-3-BORONIC ACID) -4'-_V- (BENZYL-4-ETHENYL)-DIPYRIDLNIUM BROMIDE CHLORIDE (m-SBB > USING HPTS-MA POLYMER Manometric quenched solution: A 10-mL volumetric flask was charged with 2- hydroxy ethyl methacrylate (27.08 mmols, 3.525 g), 4-N-(benzyl-3-boronic acid)-4'-N'- (benzyl-4-ethenyl)-dipyridinium bromide chloride (0.197 mmols, 0.103 g), 3- ((methacryloylamino)propyl) trimethyl ammonium chloride (1.36 mmols, 0.30 g), polyethylene glycol dimethacrylate (1. 11 mmols, 1. 11 g), and 2,2'-azobis (2-(2-imidazolin- 2-yl)propane)dihydrochloride (0.077 mmols, 0.025 g); it was filled to the 10-mL mark with isopropyl alcohol: water (1: 1, VN). The solution was vigorously stirred on the vortex mixer until homogenous.
Polymeric Dye Powder: A 10-mL volumetric flask was charged with 2-hydroxy ethyl methacrylate (27.08 mmols, 3.525 g), 3-((methacryloylamino)propyl) trimethyl ammonium chloride (1.36 mmols, 0.3 g), polyethylene glycol dimethacrylate (1. 11 mmols, 1. 11 g), 2,2'-azobis (2-(2-imidazolm-2-yl)propane)dihydrochloride (0.077 mmols, 0.025 g), and 8- Acetoxypyrene- 1,3,6-N, N', N"-tris(methacrylamidopropylsulfonamide) (7.5 x 10"4 mmols, 6.6 x 10"4 g); it was filled to the 10-mL mark with isopropyl alcohol: water (1:1, V/V). After the solution was vigorously stirred on the vortex mixer it was transferred, via pipette, to a 50-mL round-bottom flask and the flask was sealed with a rubber septum. It was deoxygenated with argon for 30 minutes. The manometric solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber. The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity. The chamber was sealed with TEFLON® plugs and wrapped in a ZIPLOC® freezer bag. The entire unit was transferred to an oven and heated to 40°C for 14 hrs. The polymerization chamber was removed from the oven and the bags, and subsequently disassembled to afford a thin green polymeric film. The film was leached with 500 mL of distilled water (pH 5) for six hours; fresh water was replaced every two hours. The thin film was then dried under reduced pressure (40°C, 20 in Hg, 3 hours), brought to -196°C and crushed into a fine powder using a mortar and pestle.
Interpenetrating network copolymer: A 50-mL round-bottom flask was charged with manometric quenched-solution (5.2 mL) and polymeric dye-powder (0.169 g). The mixture was vigorously stirred on the vortex mixer for 10 minutes to allow the liquid to be imbibed by the dye particles and then deoxygenated with argon for 15 minutes. The heterogeneous solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber* (*See Example 11). The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity. The chamber was sealed with TEFLON® plugs and wrapped in a ZIPLOC® freezer bag. The entire unit was transferred to an oven and heated to 40°C for 14 hrs. The polymerization chamber was removed from the oven and the bag, and subsequently disassembled to afford a thin, orange, gel-integrated polymeric film. The film was placed in a pH 8-NaOH solution for 12 hours, then leached and stored in pH 7.4 phosphate-buffer.
This product was used in Example 20. EXAMPLE 15 TWO COMPONENT SYSTEM: THE THIN FILM COPOLYMERIZATION OF 4-N (BENZYL-3-BORONIC ACID)-4'-N-(BENZYL-4-ETHENYL)-DIPYRIDLNIUM BROMIDE CHLORIDE (m-SBBN USING HPTS-MA A 10-mL volumetric flask was charged with 2-hydroxyethyl methacrylate (3.525 g,
27.08 mmols), 4-N-(benzyl-3 -boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridinium bromide chloride (0.039 g, 0.075 mmols), 3-((methacryloylamino)propyl) trimethyl ammonium chloride (0.3 g, 1.36 mmols), polyethylene glycol dimethacrylate (l.ll g, 1.11 mmols), 2,2'- azobis (2-(2-imidazolin-2-yl)propane)dihydrochloride (0.025 g, 0.077 mmols) and 8- acetoxypyrene- 1, 3, 6-Ν, N', N"-tris(methacrylamidopropylsulfonamide) (6.6 x 10"4 g, 7.5 x 10"4 nmols) it was filled to the 10-mL mark with isopropyl alcohol: water (1:1, V/V). After the solution was vigorously stirred on a vortex mixer it was transferred, via pipette, to a 50- mL, cone-shaped round bottom flask and the flask was sealed with a rubber septum; it was deoxygenated with argon for 30 minutes. The manometric solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber* (*See Example 11). The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity. The chamber was sealed with TEFLON® plugs and wrapped in two ZIPLOC® freezer bags. The entire unit was submerged in a 40°C water-bath and heated for 12 hrs. The polymerization chamber was removed from the bath and the bags, and subsequently disassembled to afford a thin green polymeric film. The polymeric film was placed in a pH 8 NaOH solution for 12 hours, then leached and stored in pH 7.4 phosphate buffer. This product was used in Example 21.
EXAMPLE 16
FLUORESCENCE SPECTROSCOPY ANALYSIS OF 4,4'-N,N'-BIS(BENZYL-2, 3, or 4-BORONIC ACID)-BIPYRIDLNIUM DIBROMIDE WITH 8-HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS- (METHOXYPOLYETHOXYETHYL CN-125 SULFONAMIDE HPTS-PEG A stock solution of HPTS-PEG (10 mL, 5 x 10"s M) was prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0J ionic strength). Similarly, a m-BBN solution (25 mL, 0.0025 M) was prepared. Seven different solutions containing HPTS-PEG and m-BBN were then prepared in pH 7.4 phosphate buffer as described below in Table 2. TABLE 2
Volume Volume Volume Final Final
HPTS-PEG BBV standard standard buffer (HPTS-PEG) (m-BBV)(M)
(M) (mL) (mL) (M) (me / DL
1 0.00 4.00 1. 00E-05 0. OOE+00
1 0.20 3.80 1. 00E-05 1.005-04
1 0.30 3.70 1. 00E-05 1.505-04
1 0.50 3.50 1.00E-05 2.505-04
1 1.00 3.00 1. 00E-05 5.005-04
1 1.50 2.50 1. OOE-05 7.505-04
1 2.00 2.00 1. 00E-05 1.005-03
Each sample was then analyzed on the Perkin-Elmer LS50-B luminescence spectrometer. The instrumental settings were: Excitation Wavelength - 473 nm Emission Wavelength Range - 480-630 nm Excitation Slit Width - 0 nm (Instrumental dependent minimum) Emission Slit Width - 0 nm (Instrumental dependent minimum)
Optical filter - none Scan Speed - 100 nm/sec
The instrumental settings (slit widths, scan speed, optical filters, excitation wavelength, emission wavelength range) were held constant throughout the series analysis. The emission fluorescence intensity was then quantified by integration (the trapezoidal rule approximation method) of the fluorescence intensity curve between 480 and 630 nm. The apparent Stern-Nolmer quenching constant was determined to be 520 M"1 (see Figure 7).
EXAMPLE 17 GLUCOSE SENSING ABILITY OF 4,4'-N,N'-BIS(BENZYL-2,3 or 4-BORONIC
ACID)-BIPYRIDLNIUM DIBROMIDE WITH 8 -HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS-(METHOXYPOLYETHOXYETHYL (N-125) SULFONAMIDE) (HPTS- PEG ANALYZED BY FLUORESCENCE SPECTROSCOPY (a) A stock solution of HPTS-PEG (10 mL, 5 x 10"5 M) was prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0J ionic strength). Similarly, a m-BBV solution (25 rnL, 0.0025 M) and α-D-Glucose (10 mL, 0.250 M) solution were prepared. Seven different solutions containing HPTS-PEG, m-BBV, and α-D-Glucose were then prepared in pH 7.4 phosphate buffer as described below in Table 3:
TABLE 3
Volume Volume Volume Volume Final Final Final
HPTS-PEG in- -BBV Glucose buffer (HPTS-PEG) (m-BBV) (Glucose) stock (mL) stock (mL) s t o c k (mL) (M) (M) (mg/dL)
• (mL)
1 2 0 2 1.00E-0S 1.00E-03 0.00
1 2 0.02 1.98 1.00E-05 1.00E-03 18.02
1 2 0.04 1.96 1.00E-05 1.00E-03 36.03
1 2 0.2 1.8 1.00E-05 1.00E-03 180.16
1 2 0.4 1.6 1.00E-05 1.00E-03 360.32
1 2 1 1 1.0QE-05 1.00E-03 900.80
1 2 2 0 1.00E-05 1.00E-03 1801.60
The pH of each sample was independently determined using a pH meter to assure that the pH was constant throughout the series to within ± 0.02 pH units. Each sample was then analyzed on the Perkin-Elmer LS50-B luminescence spectrometer. The instrumental settings were the same as Example 16.
The relative integrated values, were then used to construct a calibration curve: plotting F/F0 vs. glucose concentration (mg/dL), where F0 is the integrated fluorescence intensity of the first sample in Table 3 containing 0 mg/dL glucose. (a) Evaluation of glucose sensitivity with HPTS-PEG. The glucose sensing ability of benzyl viologen was compared to that of 4,4'-N,N'-bis(benzyl-3-boronic acid)-
- bipyridinium dibromide in the presence of HPTS-PEG dye. The apparent Stern- Volmer quenching constant for benzyl viologen with HPTS-PEG was determined as described in
Procedure A, and found to be 559M"1. The glucose sensitivity of benzyl viologen in the presence of HPTS-PEG was determined in the same manner. The signal from the benzyl viologen/HPTS-PEG solution did not respond to changes in glucose concentration. The glucose sensitivity of 4,4'-N,N'-bis (benzyl-3-boronic acid)-bipyridinium dibromide is shown in Figure 5 together with the glucose sensitivity of benzyl viologen.
(b) Similarly, (a) is repeated except that the 4,4'-N,N'-Bis (benzyl-3- boronic acid)- bipyridinium dibromide is replaced with 4,4'-N,N'-bis -(benzyl-4-boronic acid) dipyridyl dibromide. The ortho and para iosmers were analyzed in the same way. The results for glucose sensitivity are comparable. The results are plotted in Figure 6. EXAMPLE 18 COMPARISON OF GLUCOSE SENSITIVITY OF BENZYL VIOLOGEN VS. 4,4' N,N'-BIS(BENZYL-3-BORONIC ACID)-BIPYRIDINIUM DIBROMIDE
WITH HPTS-PEG The glucose sensing ability of benzyl viologen was compared to that of 4,4'-NN'- bis(benzyl-3-boronic acid)-bipyridinium dibromide in the presence of HPTS-PEG dye. The apparent Stern- Volmer quenching constant for benzyl viologen with HPTS-PEG was determined as described in Procedure A, and found to be 559 M"1. The glucose sensitivity of benzyl viologen in the presence of HPTS-PEG was determined as in example 17. The signal from the benzyl viologen/HPTS-PEG solution did not respond to changes in glucose concentration. The glucose sensitivity of 4,4'-N,N'-bis(benzyl-3-boronic acid)-bipyridinium dibromide, as found in Example 17, is shown in Figure 5 together with the glucose sensitivity of benzyl viologen.
EXAMPLE 19
FLUORESCENCE SPECTROSCOPY ANALYSIS OF WATER SOLUBLE COPOLYMER OF 4-N-(BENZYL-3-BORONIC ACID)-4'-N'-(BENZYL-4
ETHENYD-DIPYRIDINIUM BROMIDE CHLORIDE (m-SBB V) m-SBB V (50 mL, 2.5 mM) copolymer from Example 10 was prepared in pH 7.4 phoshate buffer and pH balanced (± 0.02 pH units) with NaOH solution. Six different solutions of poly m-SBBV (the analyte, 0, 0.10, 0.15, 0.25, 0.50, 0.75, 1.0 mM) containing
HPTS-PEG (dye, 1 x 10"5 M) were then prepared and analyzed on the spectrofluorimeter.
The analyte/dye solutions were contained in a standard 10-mm path length, quartz cuvet, and the spectrofluorimeter was set to an excitation and emission frequency of 473 and 533, respectively. The excitation and emission slit widths were set to 0 nm. After the fluorescence spectra were obtained for the solutions mentioned above, additional spectra of the analyte/dye solutions were obtained in the presence and absence of glucose and fructose. The apparent differences in spectra were quantified as areas under the curve. The difference in areas was then determined to be representative of the polymer response to glucose or fructose, e.g., in the absence of glucose or fructose the representative area under the curve was determined to be 26479.45. Upon addition of different concentrations of glucose, the areas changed accordingly as indicated in Table 4. TABLE 4
Change in Fluorescence Intensity of 1.0 rnM poly m-SBBV/HPTS-PEG Solutions After Addition of Glucose; Represented as the Area Under the Curve
(Glucose) (mq/dl) Area Under Curve
0 26479.45
18 26934.93
36 27163.92
180 27988.86
360 28221.08
900 28810.57
1800 29434.23 Thus, the fluorescence intensity increase by 11% upon addition of 1800 mg/dl of glucose and 14.6% upon addition of 1800 mg/dl of fructose.
EXAMPLE 20 FLUORESCENCE SPECTROSCOPY ANALYSIS OF IPN: COPOLYMER OF 4-N (BEΝZYL-3-BOROΝIC ACID)-4,-N'-BENZYL-4-ETHENYL)-DIPYRIDLNIUM
BROMIDE CHLORIDE (M-S BV) USING DISPERSED HPTS-MA HYDROGEN See Example 12 for procedures.
A peristaltic pump was used to circulate 7.4 phosphate buffer (ionic strength 0.1) through the cell at a rate of 30 mL per minute. The time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten seconds with an integration time of two seconds. The excitation frequency was set at 475 nm and the emission frequency was set at 536 nm. The excitation and emission slit width were set at 15 nm and 20 nm, respectively. A base line value of 249 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 1800 mg/dl glucose in pH 7.4 phosphate buffer.
The fluorescence intensity increased 25 units to a value of 274, corresponding to a 10% signal increase (S/N ratio=43). After switching back to buffer the signal approached the expected baseline value of 249. EXAMPLE 21 FLUORESCENCE SPECTROSCOPY ANALYSIS OF TWO COMPONENT
SYSTEM: THIN FILM COPOLYMER HYDROGEN OF 4-N-(BENZYL-3- BORONIC ACID)-4'-N'-(BENZYL-4-ETHENYL)-DIPYRIDINIUM BROMIDE CHLORIDE (M-SBBV) USING ACETOXY-HPTS-MA
See Example 12 for analysis procedures.
A peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0.1) through the cell at a rate of 30 mL per minute. The time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten sec with an integration time of two sec. The excitation frequency was set at 475 nm and the emission frequency was set at 536 nm. The excitation and emission slit widths were set at 7 nm. A base line value of 490 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 400 mg/dl glucose in pH 7.4 phosphate buffer. The fluorescence intensity increased nine units to a value of 499, corresponding to a 1.5% signal increase (S/N ratio = 6.5). The process of switching solutions was repeated. The buffer gave an expected base line of 490. After changing to 1800 mg/dl glucose in pH 7.4-phosphate buffer the fluorescence intensity rose 35 units to a value of 525, corresponding to a 7.6% signal increase (S/N = 15.0). Finally, the base line dropped to the expected value of 490 when buffer was pumped through the system.
EXAMPLE 22 FLUORESCENCE SPECTROPHOTOMETRIC DETERMINATION OF GLUCOSE CONCENTRATION IN AN AQUEOUS SAMPLE WITH 4,4'-N,N'-BIS(BENZYL-3- BORONIC ACID)-BIPYRIDLNIUM DIBROMIDE (m-BBV) AND 8-
HYDROXYPYRENE - 1,3,6-N, N', N" -TRIS-(METHOXYPOLYETHOXYETHYL CN-125) SULFONAMIDE) (HPTS-PEG) A stock solution of HPTS-PEG (10 ml, 5 x 10"5 M) is prepared in a 10-mL volumetric flask with pH 7.4 phosphate buffer (0J ionic strength). Similarly, a m-BBV solution (25 mL, 0.0025 M) and α-D-Glucose (10 mL, 0.250 M) solution are prepared. Seven different solutions containing HPTS-PEG, m-BBV, and α-D-Glucose are then prepared in pH 7.4 phosphate buffer as described below in Table 5. TABLE 5
Volume Volume Volume Volume Final Final Final
HPTS-PEG m-BBV Glucose buffer [HPTS-PEG] [m-BBV] [Glucose] stock stock stock (mL) (M) (M) (mg/dL)
(mL) (mL) (mL)
1 2 0 2 1.00E-05 I.OOE-03 0.00
1 -2 0.02 1.98 1.00E-05 1.00E-03 18.02
1 2 0.04 1.96 i.OOE-05 i.OOE-03 36.03
1 2 0.2 1.8 1.00E-05 1.00E-03 180.16
1 2 0.4 1.6 1.00E-05 I.OOE-03 360.32
1 2 1 1 1.00E-05 1.00E-03 900.80
L 2 2 0 I.OOE-05 1.00E-03 1801.60
The pH of each sample is independently determined using a pH meter to assure that the pH is constant throughout the series to within +.0.02 pH units. See Example 17 for the analysis procedures.
Two mL of an aqueous glucose solution of unknown concentration are placed in a 5-mL volumetric flask to which is added 1 mL of HPTS-PEG stock solution and 2 mL of m-BBV stock solution. The sample is mixed, placed into an appropriate cuvet and the fluorescence emission intensity of the sample is analyzed as previously described. The fluorescence emission intensity is then quantified by integration (using the trapezoidal rule approximation method) of the fluorescence emission intensity curve between 480 and 630 nm. The glucose concentration for the unknown can be determined by comparison of the quantified value for the fluorescence emission intensity of the sample of unknown glucose concentration to the calibration curve on the y-axis and reading the corresponding glucose concentration on the x-axis. The glucose concentration read off the calibration chart is then adjusted-for the 5/2 dilution factor to determine the glucose concentration of the unknown sample.
EXAMPLE 23 FLUORESCENCE SPECTROPHOTOMETRIC DETERMINATION OF GLUCOSE CONCENTRATION IN AN AQUEOUS SAMPLE WITH THE THIN FILM COPOLYMER OF 4-N-(BENZYL-3 -BORONIC ACID)-4'-N'- (BENZYL-4 ETHENYL)-DIPYRIDINIUM BROMIDE CHLORIDE USING HPTS-PEG (SEMI-IPN THIN FILM) The thin film copolymer is prepared as described in Example 11 and mounted in the fluorescence spectrometer as described in Example 12. Seven 100 ml stock solutions of α~ D-Glucose (0, 18, 36, 180, 360, 900, and 1800 mL/dL) are then prepared in pH 7.4 phosphate buffer. The 7 solutions are sequentially circulated through the flow through cell and the fluorescence emission intensities analyzed as described in Example 13. In each case the fluorescence emission intensity is allowed to stabilize prior to changing solutions. A calibration curve is constructed plotting the stabilized fluorescence intensity values vs. the corresponding glucose concentrations. The pH value of an aqueous glucose sample of unknown concentration is determined with a pH meter and adjusted to pH 7.4 + 0.02 with concentrated acid or base. The unknown sample is circulated through the flow through cell and the fluorescence emission intensity observed until it stabilizes. The glucose concentration for the unknown sample is circulated through the flow through cell and the fluorescence emission intensity observed until it stabilizes. The glucose concentration for the. unknown can be determined by comparison of its quantified value for the stable fluorescence emission intensity to the calibration curve on the _v-axis and reading the corresponding glucose concentration on the -axis. The final determined glucose concentration for the unknown sample is adjusted for any dilution factor caused by adjusting the pH of the sample.
EXAMPLE 24 SYNTHESIS OF 4-N-(BENZYL-3-BORONIC ACID)-4,7- PHENANTHROLLNIUM BROMIDE (4J-Phen-m-BV)
Figure imgf000051_0001
An oven-dried, 250-mL round bottom flask equipped with a magnetic stirring bar was cooled under argon, and charged with 4J-phenanthroline (6.16 g, 34.2 mmols). The flask was equipped with a reflux condenser attached to an argon (g) line and charged with N,N-dimethylformamide (80 mL). The suspension was dissolved by heating and kept at 90°C while freshly prepared dimethyl-(3-bromomethyl)-benzeneboronate (5.562 g, 22.8 mmols) was added via syringe. The reaction was monitored by TLC and after three hours showed the disappearance of the boronate ester. The reaction mixture was cooled to room temperature under argon (g) and the orange suspension transferred, via cannula, to a moisture sensitive fritted funnel. The salmon colored solid was collected, washed with acteone (4 x 50 mL) and dried under reduced pressure overnight. Yield: 3.652 g, 17J mmols (78%).. Η NMR (500 MHz, CD3OD, ppm): 3.31 (s, 6H). 6.487 (s, 2H), 7.427 (mult, 2H), 8.002 (dd, IH, J = 10 Hz), 8.451 (dd, lHm J, = 6 Hz, J2 = 8.5 Hz). 13C NMR (125 MHz, CD3OD): 61.48, 119.825, 123.258, 124.429, 124.493, 128.279, 128.472, 129.194, 132.161, 132.707, 133.990, 138.161, 139.107, 142.428, 146.358, 147.947, 153.080, 163.379. "B NMR (80 MHz, MeOH, ppm): 27.4 (s, broad). This compound was used in Example 31.
EXAMPLE 25 SYNTHESIS OF 4-N-(BENZYL-3-BORONIC ACID)-N-7-(BENZYL-4-ETHENYL) -4J-PHENANTHROLiNIUM BROMIDE CHLORIDE (4J-Phen-m-SBBV)
Figure imgf000052_0001
N-Benzyl-4-ethenyl- 4,7-phenanthrolinium chloride (0.243 g, 0J30 mmols) was suspended in CH3CN (2 mL) in a flame dried, sidearmed 25-mL round bottom flask, equipped with a magnetic stirring bar and reflux condenser. Dimethyl-(3-bromomethyl)- benzeneboronate (2.8 g, 11.5 mmols) was added via syringe through the side area and the suspension heated to reflux for 64 h under argon (g). The solution was cooled to room temperature and precipitated with diethyl ether (10 mL). The suspension was allowed to settle and the supernatant removed via cannula. The remaining residue along with 3 mL of solvent was cannulated into a centrifuge tube, triturated with acetone water (50/50, V/V, 20 mL), and centrifuged (process repeated four times). The beige/yellow solid was triturated with diethyl ether (3 x 20 mL) and dried under reduced pressure. Yield: 0.354 g, 0.615 mmols (84%). 'H NMR (250 MHz, D2O, ppm): 5.223 (d, IH, 11.25 Hz), 5.715 (d, IH, j = 17.75 Hz), 6.434 (d, 4H), 6.605 (dd, IH, J, = 11.25 Hz, J2 = 17.75 Hz), 7.446 (mult, 8H), 8.604 (mult, IH), 8.92 (d, 2H, J = 3.5 Hz), 9.698 (d, 2H, J = 5.75 Hz), 10.214 (d, 2H, J = 9 Hz). CH3OH, ppm): 29.5 (s, broad). This compound was used in Example 26.
EXAMPLE 26 TWO COMPONENT SYSTEM: THE THIN FILM COPOLYMERIZATION OF
4-N-(BENZYL-3-BORONIC ACID)-7-N'-(BENZYL-4-ETHENYL)-4J- PHENANTHROLINIUM BROMIDE CHLORIDE (4,7-PHEN-m-SBBV) AND ACETOXY- HPTS-MA
Figure imgf000053_0001
A 10-mL volumetric flask was charged with 2-hydroxy ethyl methacrylate (3.525 g, 27.08 mmols), 4,7-phenanthrolinium -(benzy 1-3 -boronic acid)- N'-(benzyl-4-ethenyl) bromide chloride (m-SBB V) (0.086g, 0.15mmols), 3-((methacryloylamino)propyl) trimethyl ammonium chloride (0.3 g, 1.36 mmols), polyethylene glycol dimethacrylate (1.11 g, 1.11 mmols), 2,2*-azobis (2-(2-imidazolin-2-yl)ρropane)dihydrochloride (0.025 g, 0.077 mmols) and 8-acetoxypyrene- 1 ,3 ,6-N, N\ N"-tris(methacrylamidopropylsulfonamide) (6.6 x 10"4 g,-7.5 x 10"4 mmols); it was filled to the 10-mL mark with isopropyl alcoho water (1:1, V/V). After the solution was vigorously stirred on a vortex mixer it was transferred to an argon-filled glove box along with the polymerization chamber. * (*See Example 11.) The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity. The chamber was sealed with LUER-LOC® plugs and wrapped in two ZIPLOC® Freezer bags. The entire unit was transferred to a 40°C oven and heated for 18 hrs. The polymerization chamber was removed from the oven and allowed to reach room temperature. It was disassembled and the orange film was leached with a pH 8-NaOH solution for 7 hours effectively turning it green. The green film was stored in pH 7.4 phosphate-buffer for 14 hrs. This polymer is characterized in Example 32. EXAMPLE 27
PREPARATION OF 8-ACETOXY-l,3,6-PYRENE-TRISCARBOXYPROPYL-
SULFONAMIDE (HPTS-CO.) DISODIUM SALT
Isomers
Figure imgf000054_0001
A 100-ml round bottom flask equipped with a stir) bar and rubber septum was charged with ( 1 -acetoxy-3 , 6, 8-pyrene trisulfonyl chloride) (0.5 mmols 272.91 mg) and 40 ml of THF. A sample of sodium 4-amino-butyrate (1 mmol, 125. 10 mg) was placed into a small test tube with 2 ml of THF and 0.26 ml deionized water. The suspension was vortexed for a short period and taken up into a 3 ml plastic syringe. A sample of N-(3- aminopropyl) methacrylamide HCl was placed into a small test tube with 5 ml of THF and 0.55 ml of I M aqueous NaOH. The suspension was vortexed for a short period and taken up into a 10 ml plastic syringe. The solution in the 100 mL round bottom flask was stirred rapidly and charged with 5.2 ml deionized water, followed by dropwise addition of the
- sodium 4-amino-butyrate suspension to produce a bright red solution which faded to yellow after 10 -min. of stirring. The flask was then charged with the N-(3-aminopropyl) methacrylamide. HCl suspension by dropwise addition again producing a red solution which faded to yellow. The solution was stirred for 4 hr. After this period, the solvent was removed by rotoevaporation and then high vacuum. The solid in the flask was taken up into a minimum amount of methanol and precipitated with diethyl ether. The precipitate was collected by centrifugation and the preciptation repeated to produce the final product(s). Η- NMR (500 MHz, CD3OD ppm): 1.601 (M, J=8 Hz), 1.829 (Q, J=5Hz), 2.392 (T, J=2.5Hz), 2.584 (S), 2.890 (T, J=7.5 Hz), 2.933 (T, MHz), 5.519 (1), J=176.5 Hz), 8.306 (S), 8.526 (S), 8.616 (1), J=9.5 Hz), 9.062 (13, J=9.5 HZ), 9.130 (13, J=9.5 HZ), 9.225 (1), J=10 Hz), 9.305 (S), 9.317 (S), 9.338 (S), 9.358 (S), 9.440 (S). These are mixtures of specific isomers. This product was used in Example 37. EXAMPLE 28
PREPARATION OF 8-ACETOXY-l,3,6-PYRENETRICARBOXYPROPYL
SULFONAMIDE (ACETOXY-HPTS-CO )
Figure imgf000055_0001
A round bottom flask was charged with 4-aminobutyric acid (5.156g, 50 mmols). Methanol (50 mL) was added followed by sodium hydroxide (2g, 50 mmols). The solution was stirred until it became homogeneous, at which point the methanol was removed on a rotary evaporator. The tan solid was further dried by coevaporations with acetonitrile to remove water.
Preparation of HPTS-CO^: An oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with 8-acetoxy-l,3,6-pyrene trisulfonylchloride (460 mg, 0.83 mmols), and sealed with a septum. DMSO (20 mL) was added to give a homogenous yellow solution. A second oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with the 4- aminoso-ϋumbutyrate (415 mg, 3.32 mmols), and sealed with a septum. DMSO (20 mL) was added via double ended needle, and after a few minutes of stirring, the first solution containing 8-acetoxy-l,3,6-pyrene trisulfonylchloride in DMSO was cannulated in drop wise to give a deep red homogeneous solution. After six hours approximately one third of the solution was removed, and DMSO was distilled off under vacuum. The resulting brown material was washed with a small amount of acetonitrile, which was filtered through cotton and dripped into Et2O to precipitate a small amount (48 mg) of brown/red hygroscopic solid. Η-NMR (250 MHz, D2O, ppm): 2 (p, 6H), 2.4 (t, 6H), 2.61 (s, 3H), 3 (t, 6H), 8.2 (d, lH),8.4(s, IH), 8.6 (d, IH), 9.2 (d, IH), 9.4 (s, IH).
The acetoxy protecting groups was removed by treatment with aqueous NaOH. The pKa value was then determined to be around 6.8. m-BBN and gave a Stern-Nolmer quenching constant of 25419.
Following the Stern-Nolmer study the HPTS-CO2/m-BBV combination was used in a glucose response study. This combination showed sensitivity to small changes in glucose concentration, with a fairly linear response to glucose in the physiological range (0-400 (0- 400 mg/dL). See Figure 14.
A glucose concentration study was performed using HPTS-CO2 with 4, 7-phen-BB V utilizing the Ocean Optics Inc. Model# SF 2000. Fiber Optics, 380 Main Street, Dunedin, FL 34698, spectrophotometer for fluorescence with a computer controller ADC 1000 Rev B and again it was observed that increasing glucose concentration gave increased fluorescence intensity.
EXAMPLE 29 PREPARATION OF 2-(3.5-BIS-BROMOMETHYL-PHENYL)-(1.3.2)-
DIOXABORLNANE
Figure imgf000056_0001
Preparation of the Boronic Ester: An oven dried round bottom flask with side arm was cooled under nitrogen, fitted with a magnetic stir bar, and charged with 3,5 - dimethylphenyl boronic acid, (5 g, 33 mmol) followed by pentane to produce a 0.5M heterogeneous solution. The flask was then fitted with an oven-dried reflux condenser, sealed with septum, and purged with nitrogen. The solution was stirred while 1,3- propanediol (14.5 mL) was added via double ended needle, then the solution was heated to reflux until it became homogenous (approximately 20 min.). The solution was cooled to room temperature under a nitrogen atmosphere. Magnesium sulfate and calcium chloride were quickly added, the apparatus was purged with nitrogen, and the solution was gently heated for 1 hr. The solution was then cooled to room temperature under nitrogen and stirring was stopped. The supemate was transferred to a separate oven dried round bottom flask, which had been cooled under nitrogen and sealed with a septum. The remaining solids heated for 1 hr. The solution was then cooled to room temperature under nitrogen and stirring was stopped. The supemate was transferred to a separate oven dried round bottom flask, which had been cooled under nitrogen and sealed with a septum. The remaining solids were washed with pentane, and this was combined with the first pentane layer. The pentane was removed in vacuo on a rotary evaporator with an argon bleed to yield a yellow solid. MP:58-60°C.
Dibromination: An oven dried round bottom flask with side arm was cooled under nitrogen, fitted with a magnetic stir bar, charged with N-bromosuccinimide (13.4 g, 73.26 mmol) and AIBN (1.094 g, 6.66 mmol), fitted with a reflux condenser, sealed with a septum, and purged with nitrogen for several minutes. The boronic ester was dissolved in chloroform (250 mL, distilled over CaH2) and cannulated into the round bottom containing N-bromosuccinimide and AIBN. The apparatus was vented through a nitrogen bubbler attached to an HBr trap consisting of aqueous sodium sulfite, and the solution was heated to a vigorous reflux while stirring. After 3.5 hr., the pale yellow solution was removed from heating and cooled to room temperature under nitrogen. The solution was concentrated in vacuo on a rotary evaporator with an argon bleed to give an orange solution from which succinimide byproduct was removed by filtration under argon. The filtrate was further concentrated on a rotary evaporator with an argon bleed to give a viscous, deep orange liquid. Pentane (~250 ml) was slowly added to this viscous liquid while stirring to precipitate the crude product. The pentane supemate was filtered and the solids were collected on a medium glass fritted filter under argon atmosphere. The solid was dried in
- vacuum to 60 millitorr. Yield: 71%. MP:124-125°C. 'H-NMR (500 MHz, CDC13 2.059-
2.081 (quint, 2H, J=5.5 Hz), 4.163-4.185 (t, 4H, J=5.5 Hz), 4.5 (s, 4H), 7.479 (t, Η), 7.721-
7.725 (d, 2H, J=2 Hz). 13C-NMR (500 MHz, CDC13_ ppm): 27.476, 33.262, 62.162, 131.845,134.459,137.694. "B NMR(250 MHz,CDCl3, ppm): 25.52. This compound is used in Example 30 and 35. EXAMPLE 30 SYNTHESIS OF 3-(3-BROMOMETHYL-5-(1.3.2)DIOXABORΓNAN-2-YL-
BENZYLOXYVPROP AN- 1 -PL
OH OH CH3CN OH ONa
Figure imgf000058_0001
. An oven-dried, 250-mL round bottom flask equipped with a magnetic stirring bar and reflux condenser was cooled under argon and charged with NaH (0.800 g of 60% in mineral oil, 20 mmols). The powder was washed with pentane (3 x 100 mL) and dried in vacuum. Acetonitrile (50 mL) was added by syringe and the mixture stirred at room temperature. 1,3-Propane diol (10 mL) was added dropwise over ten min. to form a white insoluble precipitate. The suspension was vigorously stirred for one hour at which time 20 mL was taken up by syringe and added dropwide to a 250-mL round bottom flask charged with 2- (3,5-Bis-bromomethyl-phenyl)-(l,3,2)dioxaborinane (2.865 g, 8.2 mmols) and acetonitrile (50 mL). The mixture was stirred for 12 hr at room temperature. A reflux condenser was attached along with a vacuum adapter and the reaction mixture was heated to reflux under argon for two hours. The acetonitrile was removed in vacuo and the residue purified by flash chromatography (EtOAc:hexane, 2:1). Removal of solvents gave a suspension of white solids in a yellow oil, which when analyzed by thin layer chromatography showed no starting material. The crude mixture containing 1 ,3-propane diol was used without further purification.
This compound was used in Example 31.
EXAMPLE 31 SYNTHESIS OF 4-N-(BENZYL-3-(DIMETHYL)BORONATE)-7-N-(BENZYL-3-
( 1.3.2J)DIOXABORrNAN-2-YL)-5-METHYLENOXY-PROPANOL-4J- PHENANTHROLINIUM DIBROMIDE (4J-PHEN-m-BBVOH)
Figure imgf000059_0001
The material from Example 30 was retained in a 100-mL round bottom flask with a side arm, and the flask was equipped with a magnetic stirring bar and a reflux condenser. The flask was charged with 4-N-(benzyl-3-(dimethyl)boronate)-4,7-phenanthrolinium bromide (4,7-Phen-m-BV) (0.797, 1.88 mmols), DMF (4 mL), and CH3OH (3 mL). The suspension was heated to 100°C for 48 hrs and kept under a blanket of argon throughout the reaction. The reaction mixture was cooled to room temperature under argon and kept stirring. The suspension was cannulated into ice cold diethyl ether (100 mL) and allowed to precipitate over one hr. The supernatant was cannulated to a separate vessel and the beige/red residue was triturated with THF (50 mL). The mixture was sonicated at 40°C for 120 min and the resultant fine powder was washed with diethyl ether (3 x 50 mL). The solids were collected on a fritted funnel under argon and dried under reduced pressure (0.929 g, 49.4% yield).
This compound was used in Example 34.
EXAMPLE 32
FLUORESCENCE SPECTROSCOPY ANALYSIS OF TWO COMPONENT
SYSTEM: THIN FILM COPOLYMER HYDROGEN OF 4-N-(BENZYL-3-
BORONIC ACID)-7-N-(BENZYL-4-ETHENYL)-4J-PHENANTHROLrNIUM CHLORIDEBROMIDE (4J-PHEN-m-SBBV) USING HPTS-MA
Figure imgf000059_0002
The fluorescence was measured according to the procedures of Example 17.
Abase line value of 441 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 400 mg/dl glucose in pH 7.4 phosphate buffer. The fluorescence intensity increased twelve units to a value of 453, corresponding to a 2.7% signal increase. The process of switching solutions was repeated. The solution was changed to 400 mg/dl fructose in pH 7.4 phosphate buffer. The buffer gave a base line of 443. The fluorescence intensity increased fourteen units to a value of 457, corresponding to. a 3.2% signal increase. Finally, pH 7.4 phosphate buffer was pumped through the system to achieve a baseline of 446. These results are found in Figure 11.
EXAMPLE 33 SYNTHESIS OF 4J-N.N-BIS(BENZYL-3-BORONIC ACID)-4-7- PHENANTHROLINIUM DIBROMIDE (4J-PHEN-m-BBV)
ArLOven-dried, 100-mL round bottom flask equipped with a magnetic stirring bar and reflex condenser was cooled under argon, and charged with 4,7-phen-m-BV (0.814 g, 1.92 mmols) and 3-bromomethylphenylboronic acid (1.77 g, 8.24 mmols). The system was purged with argon and charged with dry DMF (35 mL). The suspension was heated to 80°C for 48 hours under a blanket of argon. The mixture was cooled to room temperature under argon and dripped into ice-cold diethyl ether.acetone (1:1, 500 mL) containing 1 M HCl (10 drops). The precipitate was filtered and washed multiple times with cold acetone and subsequently dried under reduced pressure. Yield: 0.913 g, 1.50 mmols (78%). 'H NMR (250 MHz, CD3OD, ppm): 6.526 (s, 4H), 7.668 (m., 4H), 7.426 (m, 4H), 8.660 (q, 2H, J = 4.5 Hz), 9.833 (d, 2H, J, = 6 Hz), 9.117 (s, 2H,), 10.387 (d, 2H, J= 9 Hz). "B NMR (80 MHz, CD3OD, ppm): 30 (s, broad). This compound quenched the dye of Example 28 and responded to glucose.
This compound was evaluated according to the procedures of Example 17. The Stem- Volmer quenching constant was 2598M"1.
The glucose response was measured using 180 mg/dL, the fluorescence intensity changed from 257 to 291.
EXAMPLE 34 SYNTHESIS OF 4-N-(BENZYL-3 -(BORONIC ACID)-7-N- BENZYL-3- (METHYLENE-(l-OXY-3-(OXYBENZYLVINYL)-PROPANE))-5-BORONIC ACID1-4J-PHENANTHROLLNIUM DIBROMIDE
An oven-dried, 100-mL round bottom flask equipped with a magnetic stirring bar was charged with 4,7-phen m-BB VOH (0.491 g, 0.641 mmols) and 4-vinylbenzylchloride (0.137 g, 0.9 mmols). Freshly activated NaH (0.048 g, 2 mmols) was suspended in DMF (10 mL) and cannulated into the 100-mL flask. The mixture was stirred at room temperature for 46 hr then quenched with acetone (30 mL) and 1 M HCl (10 drops), and allowed to stir overnight (~20 hr). The suspension was dripped into cold diethyl ether (200 mL) and the precipitate allowed to settle. The supernatant was removed after centrifugation and the residue dissolved in the minimum amount of methanol. Acetone: diethyl ether ( 1 : 1 , 20 mL) was added and the precipitate was kept at 4°C overnight. The suspension was filtered and washed with diethyl ether multiple times and dried under reduced pressure. Yield: 0.201 g, 0.247 mmols, 38.5%).'H-NMR(500 MHz, D2O, ppm): 1.73 (d, 2H), 3.581 (d, 2H), 3.707 (d, 2H) , 4.7 (s, 4H), 5.565 (d,lH), 6.090 (d, IH), 6.554 (m, 8H), 6.980(dd, IH), 7.66 (m, 7H), 8.150 (d, IH), 8.737 (d, IH), 8.804 (d, IH), 9.261 (d, IH), 9.515 (d, IH), 9.605 (d, IH), 10.024 (d, IH), "B NMR (80 MHz, CD3OD, ppm): 30 (s, broad). This compound quenched the dye of Example 28 and showed a response to glucose. EXAMPLE 35
PREPARATION OF 4.4'-N.N-BIS-rBENZYL-(3-BROMOMETHYL)-5-
(BORONIC ACID)l-DIPYRIDιNIUM DIBROMIDE (m-BBVBBr)
. An oven-dried, 100-mL round botttom flask equipped with a magnetic stirring bar was cooled under argon, and charged with 4,4'-dipyridyl (0.394 g, 2.52 mmols) and 2-(3,5- bis-bromomethyl-phenyl)-[l,3,2]dioxaborinane (2.63 g, 7.56 mmols) and sealed with a septum. The flask was purged with argon and charged with N,N-dimethylformamide (10 mL). The solution was stirred at room temperature for 72 hr and the resultant suspension cannulated, via a plastic cannula, to an acetone: diethyl ether solution (1:1, 300 mL). The precipitate was filtered through an air sensitive fritted funnel and washed multiple times with diethyl ether under a blanket of argon. The bright yellow solids were dried under reduced pressure and isolated under argon. Yield: 1.632 g, 1.92 mmols, 76%. The compound was used in Example 36.
EXAMPLE 36 SYNTHESIS OF 4.4'-N.N-BIS-rBENZYL-(3-METHYLENE-4NINYL- PYRID NIUM BROMIDE)-5-(BORONIC ACID)1-DIPYRIDΓNIUM DIBROMIDE)
(m-BBVBP) An oven-dried, side-armed 50-mL round botttom flask equipped with a magnetic stirring bar and reflux condenser was cooled under argon, and charged with m-BBVBBr (500 mg, 0.587 mmols). The solid was dissolved in the minimum amount of anhydrous CH3OH (6 mL) and 4-vinylpyridine (63 mg, 0.60 mmols) was added through the side arm. The solution was stirred at room temperature for 15 h and then heated to reflux for six hr. Additional 4-vinylpyridine (63 mg, 0.60 mmols) was added and the mixture refluxed for 4 days. The dark green solution was cooled to room temperature under argon and the CH3OH removed in vacuum. The crude oil was vigorously stirred with acetone: water (40: 1) along with 1M HCl (5 drops) 4 x 30 mL for ten min and the supernatant decanted. The residue was recry stallized from boiling methanol : ethanol (1:1, 50 mL) to yield dark green crystals . The solids were collected onto a fritted funnel and washed with ice-cold ethanol (95% in water) and diethyl ether. Subsequent drying under reduced pressure gave a pea-green powder. Yield: 0.446 g, 0.506 mmols, 86%. 'HNMR(500 MHz, D2O, ppm): 5.87 (m, 2H), 6.055 (m, 8H), 6.400 (m, 2H), 7.44 (d, 2H), 7.899 (m, 6H), 8.612 (d, 8H), 9.225 (d, 8H). HB NMR (80 MHz, CD3OD, ppm): 30 ppm (s, broad). The compound was used in Examples 37 and 40.
EXAMPLE 37 TWO COMPONENT SYSTEM: THE THIN FILM COPOLYMERIZATION OF m-BBVBP WITH HPTS-CO, MA HYDROGEN
A 10-mL volumetric flask was charged with 2-hydroxyethyl methacrylate (3.525 g, 27.08 mmols), m-BBVBP (0.617 mg, 7.5 x 10"4 mmols), polyethylene glycol dimethacrylate
(1.11 g, 1.11 mmols), 2,2'-azobis [2-(2-imidazolm-2-yl)propane]dihydrochloride (0.025 g,
0.077 mmols) and HPTS CO2 MA (1.26 mg, 1.5 x 10"3 mmols); it was filled to the 10-mL mark with methano water (1 : 1, V/V). After the solution was vigorously stirred on a vortex mixer, it was transferred to a 50-mL round bottom flask and the flask was sealed with a rubber septum. It was deoxygenated with argon for 20 minutes. The manometric solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber described in Example 16,
The green film was stored in pH 7.4 phosphate buffer until used in Example 38.
EXAMPLE 38
FLUORESCENCE SPECTROSCOPY ANALYSIS OF TWO COMPONENT SYSTEM: THIN FILM COPOLYMER HYDROGEN OF 4.4'-N.N-BIS-(BENZYL-
(3-(METHYLENE-4-VINYLPYRIDINIUMBROMIDE)-5-(BORONIC ACID))l-
DIPYRIDINIUM DIBROMIDE USING HPTS-CO, MA
The fluorescence was measured according to the procedures of Example 12. The time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings every ten seconds with an integration time of two seconds. The excitation frequency was set at 463 nm and the emission frequency was set at 518 nm. The excitation slit width was set at 15 nm and the emission at 4.3 nm. A base line value of 451 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 360 mg/dl glucose in pH 7.4 phosphate buffer. The fluorescence intensity increased 29 units to a value of 458, corresponding to a 1.6% signal increase. The process of switching solutions was repeated. The buffer gave an expected base line of 451. EXAMPLE 39 A SINGLE COMPONENT VIOLOGEN SENSOR HPTS-BV
(a) - An oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with 4-chloromethylbenzoylchloride (1.89 g, 10 mmols), and sealed with a rubber septum. Dichloromethane (25 mL) was added and the solution was stirred and cooled on an ice water bath. 1,3-Propanediamine (0.89 g, 12 mmol) was added drop wise causing an immediate white precipitate. The white solid was collected under argon on a medium fritted glass filter and washed with cold dichloromethane. The white solid was dried under vacuum (100 mtorr, 3 h) to give 2.61 grams (99 % yield) of 4- chloromethylbenzoyl-(l-amidopropyl-3-ammonium chloride). 'H NMR (500 MHz, D2O, ppm): 1.7-1.8 (m), 2.5, 2.8 (t), 3.3 (q), 4.8 (s), 7.5 (d), 7.8 (d), 8.6 (t).
(b) ( m-BV) - - An oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with 3-bromomethylphenylboronic acid (0.64 g, 3 mmols), and sealed with a rubber septum. THF (50 mL) was added to give a slightly cloudy yellow solution. A second oven dried round bottom flask was cooled under argon, fit with a magnetic stir bar, charged with 4,4'-bipyridine (1.87 g, 12 mmols), and sealed with a rubber septum. THF -(5 mL) was added via double ended needle, and after a few minutes of stirring, the solution containing 4,4'-bipyridine in THF was added drop wise to the 3- bromomethylphenylboronic acid solution. After 30 minutes some yellow precipitate begins to form, the solution was stirred at room temperature overnight and a large amount of precipitate formed. The solution was then centrifuged and the supernatant transferred via double ended needle. The yellow solid was washed with THF (3x10 mL) and dried under vacuum- (100 mtorr, 3 h) to give 0.88 grams (79% yield) mBV. Η NMR (500 MHz, CD3OD, ppm): 5.9 (s), 7.46 (m), 7.6 (m), 8.0 (m), 8.5, 8.7, 9.2; "B NMR (250 MHz, CD3OD, ppm): 30.8
(c) m-ABBV- - An oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with 4-chloromethylbenzoyl-(l-amidopropyl-3- ammonium chloride) (263 mg, 1 mmol) and sealed with a rubber septum. Methanol (30 mL) was added and the solution stirred. mBV (371 mg, 1 mmol) was dissolved in methanol (10 mL) and added drop wise to the solution containing 4-chloromethylbenzoyl-(l- amidopropyl-3-ammonium chloride). The solution was heated to reflux. After 48 hours the solution was cooled to room temperature under argon. 10 mL of the solution was removed with a syringe and precipitated in acetone (100 mL). The supernatant was decanted off and the white solid collected and dried under vacuum to give 44 mg of m-ABBN. Η ΝMR (500 MHz, D2O, ppm): 2.1, 2.2, 3.45, 4.9, 6.0, 7.6, 8.6, 9.2; nB ΝMR (250 MHz, CD3OD, ppm): 31.7. (d) AIO - - An oven dried round bottom flask was cooled under argon, fitted with a magnetic stirring bar, charged with m-ABBV (44 mg, 0.075 mmol) and sealed with a rubber septum. Methanol ( 10 mL) was added followed by water (2 mL). K2CO3 was added and the solution stirred. l-Acetoxy-3,6-8-trisulfonylchloride (acetoxy-HPTS-Cl) (38 mg, 0.068 mmol) was dissolved in methanol (15 mL) to give a yellow suspension, acetone (5 mL) was added to give a homogeneous solution. The acetoxy-HPTS-Cl solution was added to the m-ABBV dropwise via syringe. The solution immediately became red and after a few minutes of stirring a precipitate began to form. The solution was. stirred at room temperature overnight, then transferred to a centrifuge tube. After centrifugation the supernatant was transferred to a round bottom flask and concentrated on a rotary evaporator. Residual water was removed by co-evaporation with acetonitrile, and the resulting black solid was dried under vacuum to give 55 mg (70% yield) of 8-acetoxy- 1-m-ABBV-pyrene- 3,6-bissulfonic acid(AIO). Η NMR (500 MHz, D2O, ppm): 2.01-2.08, 2.14, 2.8, 3.1, 3.4, 5.7, 5.88, 7.45; 7.55, 7.7, 7.8, 7.99, 8.07, 8.17, 8.6, 8.7, 8.8, 8.9, 9.05.
(e) The final isolated material was then used in a glucose study as described in Example 17. First a 5X10"4 M stock solution of AIO was prepared in a 25 mL volumetric flask, but before diluting completely with pH 7.4 (0.1 ionic strength) phosphate buffer the solution was made basic (pH 10) to ensure all the acetoxy protecting group was removed. The solution was then adjusted back to pH 7.4 and diluted to 25 mL. Next a 5xl0'5M stock solution- was then used to prepare seven 5 ml samples with varying amounts of glucose. The analysis.was done on a Perkin-Elmer LS50-B luminescence spectrometer with the following instrument settings:
Excitation Wavelength 463 nm Emission Wavelength Range 450-650 nm
Excitation Slit Width 15 nm
Emission Slit Width 15 nm
Emission Filter 1 % T attenuator
Scan Speed lOO nm sec This compound was highly responsive to glucose. Addition of 18 mg/dL resulted in a signal increase from 827 to 908. See Figure 14. Addition of more concentrated glucose solutions did not cause any additional increase in fluorescence intensity due to the material being saturated with small amounts of glucose.
EXAMPLE 40
TWO COMPONENT SYSTEM: THE THIN FILM COPOLYMERIZATION
OF m-BBVBP WITH HPTS MA
A 10-mL volumetric flask was charged with 2-hydroxy ethyl methacrylate (3.525 g, 27.08 mmols), m-BBVBP (12.3 mg, 0.015 mmols), polyethylene glycol dimethacrylate (l.ll g, 1.11 mmols), 2,2"-azobis [2-(2-imidazolin-2-yl)propane]dihydrochloride (0.025 g, 0.077 mmols) and HPTS MA ( 1.32 mg, 1.5 x 10"3 mmols). It was filled to the 10-mL mark with methanol: water (1:1, V/V). After the solution was vigorously stirred on a vortex mixer it was transferred to a 50-mL round bottom flask and the flask was sealed with a rubber septum; it was deoxygenated with argon for 20 minutes. The manometric solution was taken-up by syringe and the needle was capped with a rubber stopper. It was then transferred to an argon-filled glove box along with the polymerization chamber.* (*See Ex.11) The syringe was attached to the polymerization chamber and the solution was inserted into the cell, under argon, to fill the entire cavity. The chamber was sealed with LUER-LOCK® plugs and wrapped in a ZIPLOC® freezer bag. The entire unit was transferred to a 40° oven and heated for 10 hrs. The polymerization chamber was removed from the oven and allowed to reach room temperature. It was disassembled and the film was leached with a pH 8 NaOH solution for four hours. The film was stored in pH 7.4 phosphate buffer until analyzed in Example 41. EXAMPLE 41
FLUORESCENCE SPECTROSCOPY ANALYSIS OF TWO COMPONENT
SYSTEM: THIN FILM COPOLYMER HYDROGEL OF 4,4'-N,N-BIS-[BENZYL-
(3-METHYLENE-4-VrNYLPYRIDINIUMBROMIDE)-5-(BORONIC ACID)]- DIPYRIDINIUM DIBROMIDE (m-BBVBP) USING HPTS-MA
See Example 12 for analysis procedure.
A peristaltic pump was used to circulate pH 7.4 phosphate buffer (ionic strength 0J) through the cell at a rate of 30 mL per minute. The time drive function of the Perkin-Elmer LS50B software was used to acquire fluorescence intensity readings. The sample was irradiated using the pulse function (every two seconds) and readings captured every ten seconds with an integration time of two sec. The excitation frequency was set at 475 nm and the emission frequency was set at 525 nm. The excitation slit width was set at 15 nm and the emission at 4 nm. A base line value of 464 (fluorescence intensity) was established with buffer solution. The peristaltic pump was stopped and the pumping solution was changed to 360 mg/dl glucose in pH 7.4 phosphate buffer. The fluorescence intensity increased 29 units to a value of 493, corresponding to a 6.3% signal increase. The process of switching solutions was repeated. The buffer gave an expected base line of 464. After changing to 100 mg/dl glucose in pH 7.4 phosphate buffer the fluorescence intensity rose 20 units to a value of 484, corresponding to a 4.3% signal increase. Finally, the base line dropped to the expected value of 464 when buffer was pumped through the system. The results are found in Figure 14. While only a few embodiments of the invention have been shown and described herein, it will become apparent to those skilled in the art that various modifications and changes can be made in a glucose sensor and its components including the fluorophore dye, quencher and optimal polymer matrix for monitoring polyhydroxyl-containing organic analytes, primarily for in vivo glucose monitoring, without departing from the spirit and scope of the present invention. All such modifications and changes coming within the scope of the appended claims are intended to be carried out thereby.

Claims

WE CLAIM:
1. An optical method for the in vivo detection of polyhydroxyl-substituted organic molecules as the analyte between about 430 and 600 nm detection, which method comprises:
A. obtaining a fluorophore dye D, which is compatible with the analyte solution, wherein D is selected from:
(a) D1 which is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 600 nm, iii. Resistant to photobleaching under the conditions of analysis, iv. A Stokes shift of about or greater than 30 nm, v. Compatibility with said analyte solution, and wherein said vi. Dye D1 is quenched by methyl viologen to produce an experimentally determined apparent Stem- Volmer quenching constant (Ksv) greater than or equal to 50, wherein the fluorophore dye D1 which is neutral or negatively charged is: (i) a discrete compound having a molecular weight of 1,000 daltons or greater, with the proviso that if the dye is substituted with negatively charged groups the molecular weight is 500 daltons or greater;
(ii) a pendant group or chain unit in a water-soluble or dispersible polymer having a molecular weight greater than about 10,000 daltons, and optionally said polymer is non-covalently associated with a water-insoluble polymer matrix M1 and is physically immobilized within said polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte solution; and optionally where D1 is negatively charged and the polymer is immobilized as a complex with a cationic water-soluble polymer, said complex formed is permeable to or in contact with said analyte solution;
(b) D2 is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 800, iii. A Stokes shift of about or greater than 30 nm, iv. Resistant to photobleaching under the conditions of analyses, v. Compatibility in the analyte solution, and wherein vi. Said Dye D2 is quenched by methyl viologen to produce an apparent Stem- Volmer quenching constant (Ksv) greater than or equal to 50, wherein D2 is covalently bonded to an insoluble polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte; wherein said fluorophore dye D2 is a part of the structure: M'-L'-D2 with the proviso that D2 which is polyfunctional is bonded to matrix M1 at one, two or three sites; L1 is a hydrolytically stable covalent linking group selected from the group consisting of a direct bond, lower alkylene having 1 to 8 carbon atoms optionally ten- ninated with or including one or more divalent connecting groups selected from sulfonamide, amide, ester, ether, sulfide, sulfone, phenylene, urethane, urea, and amine, and B. Combining with a boronic acid-containing quencher moiety Q, wherein Q is comprised of a conjugated nitrogen-containing heterocyclic, aromatic bis-onium salt having the properties of compatibility in said analyte solution and produces a detectable change in the emission of the dye in the presence of said analyte, selected from: (i) quencher Q1 which is a discrete compound having a molecular weight of about 400 daltons or greater or is a pendant group or a chain unit in a water-soluble or water-dispersible polymer having a molecular weight greater than 10,000 daltons and said polymer optionally is non- covalently associated with the optional polymer matrix M1 when present, and is physically immobilized in said polymer matrix, or optionally said polymer is immobilized as a complex with a negatively charged water-soluble polymer, or
(ii) quencher Q2 which is covalently bonded by linking group L2 to M1 or to a second water insoluble polymer matrix M2 producing M2 -L2-Q2 wherein L2 is selected from the group consisting of a direct bond, a lower alkylene having 1 to
8 carbon atoms optionally terminated with or including one or more divalent connecting groups selected from sulfonamide, amide, quaternary ammonium, pyridinium, ester, ether, sulfide, sulfone, phenylene, urea, thiourea, and urethane, or amine, wherein said quencher Q1 or Q2 is mixed at a molecular level with said fluorophore dye D1 or D2, and with the proviso that Q2 when polyfunctional is linked to the matrix M2 at one or two sites, C. contacting a physiological fluid which contains analyte, a dye and a quenched in vivo with an excitation light source coupled with a detector;
D. producing a detectable and quantifiable signal in the range of about 430 to 600 nm; and
E. determining the concentration of saidpolyhydroxyl-substituted analyte in said physiological fluid.
2. The method of claim 1 where the Dye D is selected form the group consisting of pyranine derivatives having the structures of:
Figure imgf000073_0001
where R1, R2 and R3 are each -NHR4 is -CH2-CH2(-O-CH2-CH2) .-X1; wherein X1 is selected from -OH, -OCH3 -CO2H, -CONH2,-SO3H, or -NH2; and
_u is between about 70 and 10,000.
3. The method of claim 1 wherein the dye D1 is selected from the group consisting of pyranine derivatives having the structure of
Figure imgf000073_0002
' where R1, R2 and R3 are each -NH-CH2-CH2(-O-CH2-CH),-X1, and X1 is selected from -OH, -OCH3, -CO2H, -CONH2, -SO3H, or -NH2, n is about 100 to 10,000.
4. The method of Claim 1 wherein the Dye D1 or D2 is prepared from pyramine derivatives having the structure:
Figure imgf000074_0001
or from a dye monomer selected from the group consisting of:
Figure imgf000074_0002
where R4 = -H and
R5 is selected from -R6-NH-(C=O)-(C=CH2)-R7, -R6-O-(C=O)-(C-R7=CH2) or -CH2-C6H4-CH=CH2 or -CH2-CH=CH2 , and where R6 is lower alkylene having 2 to 6 carbon atoms and
where R7 is -H or; -CH3 and
Z is a blocking group that can be removed by hydrolysis selected from:
-(C=O)-R8-Y where R8 is a lower alkylene having I to 4 carbon atoms and Y is selected from -H, -OH, -CO2H, -SO3H, -(C=O)-NH-R9, or -CO2-R9, where R9 is a lower alkyl having 1 to 4 carbon atoms.
5. The method of Claim 1 wherein the precursors of quenchers Q1 and Q2 are selected from the group consisting of:
Figure imgf000075_0001
where (V)2+ is a nitrogen containing conjugated heterocyclic aromatic group selected from isomers of dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, or diazafluorenes; and where Zl or Z2 is either a polymerizable ethylenically unsaturated group selected from:
(i) -R10-CO2-C(RU)=CH2, -R10-NH-(C=O)-C(R2)=CH2, or -CH2-C6H4- CH=CH2, where R10 is a lower alkylene or hydroxyalkylene of 2 to 6 carbon atoms and where R11 = -H or -CH3; or
(ii) a coupling group selected from: -R12-Z3 where R12 is -CH2C6H4- or alkylene of 2 to 6 carbon atoms and
Z3 is -OH, -SH, -CO2H, or -NH_.
6. The method of claim 5 where the precursors are selected from:
Figure imgf000076_0001
4 X"
wherein X is chloride, bromide or combinations thereof.
7. The method of Claim 1 wherein in substep B, Q1 or Q2 is prepared from a precursor selected from:
Figure imgf000077_0001
where V3 and Z4 or Z5 are 2, 3 or 4-(CH=CH2)-pyridinium; -N- (CH2)w-O(C=O) C(CH3) =CH2); -O-(CH2)w, -O-CH2 -(CH=CH2); -
O-(CH2)w-O-(C=O)CH(=CH2); and -O-(CH2)w-O-(C=O) C(CH3)=CH2; and w is a integer from 2 to 6, or Z4 and Z5 have the same definitions as above for Z1 and Z2.
8. The method of Claim 1 wherein in substep A, the fluorophore is
D1.
9. The method of Claim 1 wherein in substep A, the fluorophore is D2.
10. The method of Claim 1 wherein in substep B, quencher Q is Q 1.
11. The method of Claim 1 wherein in substep A, D is D1 and in substep B, Q is Q1.
12. The method of Claim 1 wherein in substep A the fluorophore D1 is selected from pyranine derivatives having the structure of:
Figure imgf000078_0001
wherein n is between about 70 and 200.
13. The method of Claim 1 wherein in substep A the precursor to the polymeric dye D2 is:
Figure imgf000078_0002
and in step B the quencher is prepared from the group consisting of
Figure imgf000079_0001
Figure imgf000079_0002
wherein X is bromide or chloride.
14. The method of Claim 1 wherein the polyhydroxyl-substituted organic molecules are sugars selected from glucose or fructose.
15. The method of Claim 14 wherein the Dye D1 is selected from the group .consisting of
Figure imgf000080_0001
wherein n is about 70 to 200.
16. The method of Claim 14 wherein the quencher Q2 is prepared from a quencher precursor from the group consisting of
Figure imgf000081_0001
Figure imgf000081_0002
wherein X is bromide or chloride.
17. An optical device for the in vivo detection of polyhydroxyl-substituted organic molecules as the analyte between about 430 and 600 nm detection, which device comprises:
A. a fluorophore dye D, which is compatible with the analyte solution, wherein D is selected from:
(a) D1 which is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 600 nm, iii. Resistant to photobleaching under the conditions of analysis, iv. A Stokes shift of about or greater than 30 nm, v. Compatibility with said analyte solution, and wherein said vi. Dye D1 is quenched by methyl viologen to produce an experimentally determined apparent Stem- Volmer quenching constant (Ksv) greater than or equal to 50, wherein the fluorophore dye D' which is neutral or negatively charged is:
(i) a discrete compound having a molecular weight of 1 ,000 daltons or greater, with the proviso that if the dye is substituted with negatively charged groups the molecular weight is 500 daltons or greater;
(ii) a pendant group or chain unit in a water-soluble or dispersible polymer having a molecular weight greater than about 10,000 daltons, and optionally said polymer is non-covalently associated with a water-insoluble polymer matrix M1 and is physically immobilized within said polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte solution; and optionally where D1 is negatively charged and the polymer is immobilized as a complex with a cationic water-soluble polymer, said complex formed is permeable to or in contact with said analyte solution;
(b) D2 is a fluorophore dye having the properties of i. A fluorophore, ii. An excitation in the range greater than 430 nm and less than 800, iii. A Stokes shift of about or greater than 30 nm, iv. Resistant to photobleaching under the conditions of analyses, v. Compatibility in the analyte solution, and wherein vi. Said Dye D2 is quenched by methyl viologen to produce an apparent Stem- Volmer quenching constant (Ksv) greater than or equal to 50, wherein D2 is covalently bonded to an insoluble polymer matrix M1 wherein said polymer matrix M1 is permeable to or in contact with said analyte; wherein said fluorophore dye D2 is a part of the structure: M^L'-D2 with the proviso that D2 which is polyfunctional is bonded to matrix M1 at one, two or three sites; L1 is a hydrolytically stable covalent linking group selected from the group consisting of a direct bond, lower alkylene having 1 to 8 carbon atoms optionally ten- ninated with or including one or more divalent connecting groups selected from sulfonamide, amide, ester, ether, sulfide, sulfone, phenylene, urethane, urea, and amine, and B. a boronic acid-containing quencher moiety Q, wherein Q is comprised of a conjugated nitrogen-containing heterocyclic, aromatic bis-onium salt having the properties of compatibility in said analyte solution and produces a detectable change in the emission of the dye in the presence of said analyte, selected from: (i) quencher Q1 which is a discrete compound having a molecular weight of about 400 daltons or greater or is a pendant group or a chain unit in a water-soluble or water-dispersible polymer having a molecular weight greater than 10,000 daltons and said polymer optionally is non-covalently associated with the optional polymer matrix M1 when present, and is physically immobilized in said polymer matrix, or optionally said polymer is immobilized as a complex with a negatively charged water-soluble polymer, or
(ii) quencher Q2 which is covalently bonded by linking group L2 to M1 or to a second water insoluble polymer matrix M2 producing M2 -L2-Q2 wherein L2 is selected from the group consisting of a direct bond, a lower alkylene having 1 to 8 carbon atoms optionally terminated with or including one or more divalent connecting groups selected from sulfonamide, amide, quaternary ammonium, pyridinium, ester, ether, sulfide, sulfone, phenylene, urea, thiourea, and urethane, or amine, wherein said quencher Q1 or Q2 is mixed at a molecular level with said fluorophore dye D1 or D2, and with the proviso that Q2 when polyfunctional is linked to the matrix M2 at more than one site, wherein when a dye and a quencher in contact with physiological fluid which contains an analyte in vivo is contact with an excitation light source coupled with a detector;
C. produces a detectable and quantifiable signal in the range of about 430 to 600 nm; and
D. determines the concentration of said polyhydroxyl-substituted analyte, wherein the Dye D components and quencher Q components are immobilized in or attached to a polymer matrix M1, M2 or combinations thereof and said device measures the concentration of polyhydroxyl-containing molecules periodically or continuously.
18. The device of Claim 17 wherein the dye is selected from the group described in Claims 2, 3 and 4.
19. The device of Claim 17 wherein the quencher is selected from the group described in Claims 6, 7 and 16.
20. The device of Claim 17 wherein the polymer matrix is prepared from monomers selected from the group consisting of HPTS-MA and HPTS-CO2-MA.
21. The device of Claim 17 wherein the dye and the quencher is selected from the group described in Claims 2, 3, 4, 6, 7 and 16. wherein the polymer is prepared from monomers selected from the group consisting of HPTS-CO2-MA and HPTS-MA.
22. The device of Claim 17 wherein the dye is described in Claim 2. wherein the quencher described in Claim 16 is selected from
Figure imgf000085_0001
Figure imgf000085_0002
Figure imgf000085_0003
25
wherein the polymer is HPTS-MA
30
23. A composition of matter selected from the group consisting of compounds of the structure:
Figure imgf000086_0001
' wherein (V)2+ is a nitrogen containing conjugated heterocyclic aromatic group selected from isomers of dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, or diazafluorenes wherein the two nitrogen atoms are each in a different aromatic ring and the nitrogen atoms in all positions of the ring are capable of forming a quaternary salt; and
Z1 or Z2 is either a polymerizable ethylenically unsaturated group selected from: -Rls-CO2-C(R,6)=CH2 , -Rl5-NH-(C=O)-C(R)=CH2, -CH2-C6H4-CH=CH2; R15 is a lower alkylene or hydroxyalkylene of 2 to 6 carbon atoms;
R16 = -H, -CH3 or a coupling group selected from -R17-Z3, wherein R17 is -CH2C6H4- or alkylene of 2 to 6 carbon atoms, and Z3 is selected from OH-, -SH, -CO2H, or - H-- .
24. A composition of matter which comprises, a glucose responsive polymer assembly, itself comprising a fluorophore which is excited by light of
430-800nm, which is susceptible to quenching by a viologen, a viologen
including at least one boronic acid functional group as a quencher, and a glucose permeable polymer matrix.
25. The composition of matter of Claim 24 where the fluorophore is
N, N',N"-tris-(I-aminoethyl-2-polyethylene glycol (n ~125)-methoxy)-8— hydroxy-pyrene-l,3,6-tris-sulfonamide or a polymer of N, N', N"-tris-(l— aminopropyl-3-methacrylamidopropyl)-8-acetoxy-pyrene- l ,3,6-tris- sulfonamide.
26. The composition of matter of Claim 25 wherein the viologen including a boronic acid functional group is a polymer of 4-N-(benzyl-3 or 4 -boronic acid)-4'-N'-(benzyl-4-ethenyl)-dipyridinium bromide chloride (m-, or p- SBBV).
27. The composition of matter of Claim 26 wherein the polymer matrix is a hydrogen comprised of 2-hyroxyethylmethacrylate polymers, polyethyleneglycol polymers, and combinations thereof.
Figure imgf000087_0001
Figure imgf000087_0002
4 X
where X is bromide or chloride.
29. A composition of matter of the structure
Figure imgf000088_0001
4 X .©
PCT/US2001/046658 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts WO2002046752A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2002220230A AU2002220230B2 (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts
EP01999808A EP1340076A2 (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts
JP2002548438A JP4222503B2 (en) 2000-12-05 2001-12-05 Optical measurement of glucose using boronic acid adducts
CA002436590A CA2436590A1 (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts
NZ526787A NZ526787A (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts
AU2023002A AU2023002A (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts
US10/456,895 US20040028612A1 (en) 2000-12-05 2003-06-05 Optical determination of glucose utilizing boronic acid adducts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/731,323 2000-12-05
US09/731,323 US6627177B2 (en) 2000-12-05 2000-12-05 Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof

Publications (3)

Publication Number Publication Date
WO2002046752A2 true WO2002046752A2 (en) 2002-06-13
WO2002046752A9 WO2002046752A9 (en) 2002-08-29
WO2002046752A3 WO2002046752A3 (en) 2003-01-16

Family

ID=24939018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/046658 WO2002046752A2 (en) 2000-12-05 2001-12-05 Optical determination of glucose utilizing boronic acid adducts

Country Status (8)

Country Link
US (2) US6627177B2 (en)
EP (1) EP1340076A2 (en)
JP (2) JP4222503B2 (en)
CN (1) CN1479870A (en)
AU (2) AU2002220230B2 (en)
CA (1) CA2436590A1 (en)
NZ (1) NZ526787A (en)
WO (1) WO2002046752A2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000109A2 (en) 2003-06-27 2005-01-06 University Of Maryland Biotechnology Institute Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
JP2007532901A (en) * 2004-04-13 2007-11-15 センサーズ・フォー・メデセン・アンド・サイエンス・インコーポレーテッド Immobilization of non-covalent bonds of indicator molecules
US7390670B2 (en) 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
US7417164B2 (en) 2006-07-25 2008-08-26 Glumetrics Inc. Fluorescent dyes for use in glucose sensing
WO2008137604A1 (en) 2007-05-01 2008-11-13 Glumetrics, Inc. Pyridinium boronic acid quenchers for use in analyte sensors
US7751863B2 (en) 2007-02-06 2010-07-06 Glumetrics, Inc. Optical determination of ph and glucose
US8088097B2 (en) 2007-11-21 2012-01-03 Glumetrics, Inc. Use of an equilibrium intravascular sensor to achieve tight glycemic control
US8478375B2 (en) 2004-12-07 2013-07-02 Medtronic Minimed, Inc. Sensor for detection of carbohydrate
US8512245B2 (en) 2008-04-17 2013-08-20 Glumetrics, Inc. Sensor for percutaneous intravascular deployment without an indwelling cannula
US8691517B2 (en) 2004-12-07 2014-04-08 Medtronic Minimed, Inc. Flexible carbohydrate-bearing polymer
US9839378B2 (en) 2007-02-06 2017-12-12 Medtronic Minimed, Inc. Optical systems and methods for ratiometric measurement of blood glucose concentration
US10429380B2 (en) 2010-12-17 2019-10-01 Eyesense Ag Device comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein
CN110642882A (en) * 2019-10-21 2020-01-03 内蒙古大学 Fluorescent probe with hydrogen peroxide detection and photodynamic cancer cell killing activity as well as preparation method and application thereof

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6766183B2 (en) * 1995-11-22 2004-07-20 Medtronic Minimed, Inc. Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
US6627177B2 (en) * 2000-12-05 2003-09-30 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof
US7470420B2 (en) * 2000-12-05 2008-12-30 The Regents Of The University Of California Optical determination of glucose utilizing boronic acid adducts
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
US20040087842A1 (en) * 2002-05-30 2004-05-06 Lakowicz Joseph R. Fluorescent probes for saccharrides
JP4607859B2 (en) * 2003-02-19 2011-01-05 サイセル・テクノロジーズ,インコーポレイテッド In vivo fluorescent sensor, system and related methods operating in conjunction with a fluorescent analyte
US7299082B2 (en) * 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US20050233465A1 (en) * 2004-04-14 2005-10-20 Bioprocessors Corp. Compositions of matter useful as pH indicators and related methods
US20080051764A1 (en) * 2004-04-19 2008-02-28 Board Of Regents, The University Of Texas System Physiological Monitoring With Continuous Treatment
US20060088722A1 (en) * 2004-10-25 2006-04-27 Aller Robert C Optical pH sensor
WO2007033353A2 (en) * 2005-09-14 2007-03-22 Therabit, Inc. Chemical target-binding compositions
US7807473B2 (en) * 2005-10-26 2010-10-05 General Electric Company Material compositions for sensors for determination of chemical species at trace concentrations and method of using sensors
EP1949083A1 (en) * 2005-11-08 2008-07-30 Smart Holograms Limited Novel boronate complex and its use in a glucose sensor
US8133194B2 (en) 2006-02-22 2012-03-13 Henry Ford Health System System and method for delivery of regional citrate anticoagulation to extracorporeal blood circuits
JP5254043B2 (en) * 2006-02-22 2013-08-07 ヘンリー フォード ヘルス システム Topical citrate anticoagulant delivery system and method to extracorporeal blood circuit
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US20080200434A1 (en) * 2006-09-14 2008-08-21 Daniloff George Y Chemical Target-Binding Compositions
US20080161666A1 (en) * 2006-12-29 2008-07-03 Abbott Diabetes Care, Inc. Analyte devices and methods
US7824918B2 (en) * 2007-08-06 2010-11-02 Glumetrics, Inc. HPTS-Mono and BIS Cys-Ma polymerizable fluorescent dyes for use in analyte sensors
US7883898B2 (en) * 2007-05-07 2011-02-08 General Electric Company Method and apparatus for measuring pH of low alkalinity solutions
WO2008141243A2 (en) * 2007-05-10 2008-11-20 Glumetrics, Inc. Device and methods for calibrating analyte sensors
JP5517919B2 (en) * 2007-05-10 2014-06-11 グルメトリクス、 インク. Balanced non-consumable fluorescent sensor for immediate intravascular glucose measurement
US8404396B2 (en) 2007-05-14 2013-03-26 Brigham Young University Fuel cell and method for generating electric power
AU2008262388A1 (en) * 2007-06-08 2008-12-18 The Charles Stark Draper Laboratory, Inc. Sensors for the detection of diols and carbohydrates using boronic acid chelators for glucose
EP2222686B1 (en) 2007-07-11 2015-06-17 Medtronic Minimed, Inc. Polyviologen boronic acid quenchers for use in analyte sensors
US8202731B2 (en) * 2007-08-06 2012-06-19 Glumetrics, Inc. HPTS-mono and bis Cys-MA polymerizable fluorescent dyes for use in analyte sensors
JP5434088B2 (en) * 2008-01-22 2014-03-05 三菱化学株式会社 Crosslinkable organic compound, composition for organic electroluminescence device, organic electroluminescence device and organic EL display
US20090259118A1 (en) * 2008-03-31 2009-10-15 Abbott Diabetes Care Inc. Shallow Implantable Analyte Sensor with Rapid Physiological Response
JP2011519635A (en) * 2008-05-02 2011-07-14 エスアールアイ インターナショナル Optical microneedle spectrometer
CN101625344B (en) * 2008-07-10 2011-11-16 中国食品发酵工业研究院 Detection method for detecting bad smell of 2,4,6-trichloroanisole (TCA) in port wine
JP2011530082A (en) 2008-08-04 2011-12-15 ユニバーシティ オブ ユタ リサーチ ファウンデーション Application of dyes for confocal imaging of cellular microstructures
CN101643479B (en) * 2008-08-07 2012-07-18 通用电气公司 Compound containing benzene pyridine unit
CN101598708B (en) * 2009-05-19 2011-11-09 烟台杰科检测服务有限公司 Method for fast analyzing pesticide residue in fruits and vegetables
CN101598709B (en) * 2009-07-10 2011-08-24 中国烟草总公司郑州烟草研究院 Method for determining fragrance stabilizing capacity of tobacco humectant on additional flavors in cut tobaccos
CN101634648B (en) * 2009-08-21 2012-06-27 江南大学 Method for detecting six trace sweetening agents in white spirit by ultra-high pressure liquid chromatography and time-of-flight mass spectrometry
EP2483679A4 (en) 2009-09-30 2013-04-24 Glumetrics Inc Sensors with thromboresistant coating
US8467843B2 (en) 2009-11-04 2013-06-18 Glumetrics, Inc. Optical sensor configuration for ratiometric correction of blood glucose measurement
TWI402501B (en) * 2009-12-09 2013-07-21 Nat Univ Tsing Hua Immunodetection probe and method of immunodection using the same
WO2011075710A1 (en) * 2009-12-17 2011-06-23 Glumetrics, Inc. Identification of aberrant measurements of in vivo glucose concentration using temperature
JP2013519101A (en) 2010-02-08 2013-05-23 グルメトリクス, インコーポレイテッド Antioxidant protection of chemical sensors
WO2011101626A1 (en) * 2010-02-16 2011-08-25 Glysure Ltd Barrier layer for glusose sensor
US8473222B2 (en) * 2010-03-11 2013-06-25 Glumetrics, Inc. Measurement devices and methods for measuring analyte concentration incorporating temperature and pH correction
SG191164A1 (en) * 2010-12-17 2013-07-31 Eyesense Ag Use of hydrogels for biosensors having elevated sensitivity
GB201113435D0 (en) 2011-08-03 2011-09-21 Glysure Ltd Sensor calibration
CN102353660B (en) * 2011-06-20 2013-01-02 山西大学 Composition for detecting D-fructose and preparation method thereof
CA2857493C (en) 2011-07-15 2019-06-11 Glumetrics, Inc. Combinations of fluorphores and pyridinium boronic acid quenchers for use in analyte sensors
US9642568B2 (en) 2011-09-06 2017-05-09 Medtronic Minimed, Inc. Orthogonally redundant sensor systems and methods
CA2850148C (en) 2011-09-27 2020-02-25 Glumetrics, Inc. Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrombogenic agent
US8568991B2 (en) * 2011-12-23 2013-10-29 General Electric Company Photoactivated chemical bleaching of dyes
US9176032B2 (en) 2011-12-23 2015-11-03 General Electric Company Methods of analyzing an H and E stained biological sample
US9017622B2 (en) 2012-04-10 2015-04-28 Lightship Medical Limited Calibrator for a sensor
US20130344619A1 (en) 2012-06-21 2013-12-26 Lightship Medical Limited Glucose sensor
JP2016513794A (en) 2013-03-06 2016-05-16 ゼネラル・エレクトリック・カンパニイ Method for analyzing H & E stained biological sample
CN105899132B (en) 2013-12-31 2020-02-18 雅培糖尿病护理公司 Self-powered analyte sensor and devices using same
JP2015151427A (en) * 2014-02-12 2015-08-24 セイコーエプソン株式会社 Stimuli-responsive gel material and production method thereof
JP2015151426A (en) 2014-02-12 2015-08-24 セイコーエプソン株式会社 Stimuli-responsive gel material
JP2015151436A (en) 2014-02-13 2015-08-24 セイコーエプソン株式会社 Stimulation responsive gel material
CN106232606A (en) * 2014-04-23 2016-12-14 血糖测试仪股份有限公司 For measuring the non-enzymatic electrochemical sensor of analyte
US10845305B1 (en) 2015-11-20 2020-11-24 Verily Life Sciences Llc Method for increasing sensor resolution by spectrally stacking responsive dyes
DE102021127227A1 (en) 2021-10-20 2023-04-20 Endress+Hauser Conducta Gmbh+Co. Kg Sensor for measuring a pH value

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137833A (en) * 1989-09-21 1992-08-11 Russell Anthony P Method for detecting polyhydroxyl compounds
US5503770A (en) * 1993-11-07 1996-04-02 Research Development Corporation Of Japan Fluorescent compound suitable for use in the detection of saccharides
WO1997019188A1 (en) * 1995-11-22 1997-05-29 Minimed, Inc. Detection of biological molecules using chemical amplification and optical sensors
WO2001074968A2 (en) * 2000-04-04 2001-10-11 The Regents Of The University Of California Saccharide sensing molecules having enhanced fluorescent properties

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659817A (en) 1981-05-01 1987-04-21 The Children's Medical Center Corporation Reporter compounds containing boron
US4886338A (en) 1986-10-10 1989-12-12 Minnesota Mining And Manufacturing Company Optical fiber event sensor
AT390517B (en) 1988-08-04 1990-05-25 Avl Verbrennungskraft Messtech OPTICAL SENSOR AND METHOD FOR THE PRODUCTION THEREOF
NO890029D0 (en) 1989-01-04 1989-01-04 Axis Research NEW MODIFIED PEPTIDES AND PROTEINS FOR IN VITRO DIAGNOSIS (DIABETES).
US5039491A (en) 1989-01-27 1991-08-13 Metricor, Inc. Optical oxygen sensor
US5232858A (en) 1989-04-25 1993-08-03 Avl Medical Instruments Ag Method for quantitative determination of at least one chemical parameter of a sample medium
US5512246A (en) 1989-09-21 1996-04-30 Anthony P. Russell Method and means for detecting polyhydroxyl compounds
GB9024775D0 (en) * 1990-11-14 1991-01-02 Axis Research Chemical compounds
US5244562A (en) 1991-07-31 1993-09-14 Hewlett-Packard Company Use of templated polymers for analyte-activated microelectronic switching devices
US5367073A (en) 1992-03-06 1994-11-22 The Regents Of The University Of California Asymmetric synthesis of β-amino alcohols from chiral or achiral enamines
JP3200942B2 (en) * 1992-03-18 2001-08-20 日本油脂株式会社 Boronic acid group-containing monomer and polymer thereof
CA2166201A1 (en) * 1993-06-30 1995-01-12 Barry Colin Crane Biphasic material
JP2883824B2 (en) * 1993-11-07 1999-04-19 科学技術振興事業団 Fluorescent compound having a boronic acid group
US5631364A (en) 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
US5852126A (en) 1994-05-02 1998-12-22 Novartis Ag Polymerisable composition and the use thereof
US5922612A (en) 1994-05-02 1999-07-13 Novartis Corporation Optical sensor system for determining pH values and ionic strengths
US5998594A (en) * 1994-12-30 1999-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Self-assembling, chromogenic receptors for the recognition of medically important substrates and their method of use
US5517313A (en) 1995-02-21 1996-05-14 Colvin, Jr.; Arthur E. Fluorescent optical sensor
JP2799837B2 (en) 1995-03-03 1998-09-21 科学技術振興事業団 Boronic acid compounds having a binaphthyl group
US5786439A (en) 1996-10-24 1998-07-28 Minimed Inc. Hydrophilic, swellable coatings for biosensors
US5882494A (en) 1995-03-27 1999-03-16 Minimed, Inc. Polyurethane/polyurea compositions containing silicone for biosensor membranes
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US6063637A (en) 1995-12-13 2000-05-16 California Institute Of Technology Sensors for sugars and other metal binding analytes
US5894351A (en) 1997-05-13 1999-04-13 Colvin, Jr.; Arthur E. Fluorescence sensing device
DE19811963A1 (en) * 1998-03-19 1999-09-23 Ewald Terpetschnig Luminescent receptors useful for specific determination of sugars, especially glucose
JP3867400B2 (en) * 1998-05-08 2007-01-10 日本油脂株式会社 Boronic acid group-containing monomer and polymer thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
JP4689825B2 (en) 1998-08-26 2011-05-25 センサーズ・フォー・メデセン・アンド・サイエンス・インコーポレーテッド Optical detector
US6304766B1 (en) 1998-08-26 2001-10-16 Sensors For Medicine And Science Optical-based sensing devices, especially for in-situ sensing in humans
US6366793B1 (en) 1999-09-10 2002-04-02 Beckman Coulter, Inc. Minimally invasive methods for measuring analtes in vivo
US20010034479A1 (en) * 2000-04-19 2001-10-25 Ring Lawrence S. Optically based transcutaneous blood gas sensor
US6387672B1 (en) 2000-12-04 2002-05-14 Beckman Coulter, Inc. Photo-induced electron transfer fluorescent sensor molecules
US6627177B2 (en) * 2000-12-05 2003-09-30 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof
US6653141B2 (en) * 2000-12-05 2003-11-25 The Regents Of The University Of California Polyhydroxyl-substituted organic molecule sensing method and device
US20020119581A1 (en) * 2001-01-05 2002-08-29 Daniloff George Y. Detection of analytes
US20020127626A1 (en) * 2001-01-05 2002-09-12 Sensors For Medicine And Science, Inc. Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137833A (en) * 1989-09-21 1992-08-11 Russell Anthony P Method for detecting polyhydroxyl compounds
US5503770A (en) * 1993-11-07 1996-04-02 Research Development Corporation Of Japan Fluorescent compound suitable for use in the detection of saccharides
WO1997019188A1 (en) * 1995-11-22 1997-05-29 Minimed, Inc. Detection of biological molecules using chemical amplification and optical sensors
WO2001074968A2 (en) * 2000-04-04 2001-10-11 The Regents Of The University Of California Saccharide sensing molecules having enhanced fluorescent properties

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704752B2 (en) 2003-02-20 2010-04-27 Lumigen, Inc. Signalling compounds for use in methods of detecting hydrogen peroxide
US8137990B2 (en) 2003-02-20 2012-03-20 Lumigen, Inc. Compositions for chemiluminescent detection of hydrogen peroxide
EP2305690A1 (en) 2003-02-20 2011-04-06 Lumigen, Inc. Signalling compounds for use in methods of detecting hydrogen peroxide
US7390670B2 (en) 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
US8569502B2 (en) 2003-06-27 2013-10-29 Chris Geddes Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
EP1644330A2 (en) * 2003-06-27 2006-04-12 University Of Maryland Biotechnology Institute Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
EP1644330A4 (en) * 2003-06-27 2009-06-03 Univ Maryland Biotech Inst Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
WO2005000109A2 (en) 2003-06-27 2005-01-06 University Of Maryland Biotechnology Institute Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
US8338602B2 (en) 2003-06-27 2012-12-25 University Of Maryland, Baltimore County Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
JP2007532901A (en) * 2004-04-13 2007-11-15 センサーズ・フォー・メデセン・アンド・サイエンス・インコーポレーテッド Immobilization of non-covalent bonds of indicator molecules
US8478375B2 (en) 2004-12-07 2013-07-02 Medtronic Minimed, Inc. Sensor for detection of carbohydrate
US8700113B2 (en) 2004-12-07 2014-04-15 Medtronic Minimed, Inc. Sensor for detection of carbohydrate
US8691517B2 (en) 2004-12-07 2014-04-08 Medtronic Minimed, Inc. Flexible carbohydrate-bearing polymer
US7767846B2 (en) 2006-07-25 2010-08-03 Glumetrics, Inc. Fluorescent dyes for use in glucose sensing
US7417164B2 (en) 2006-07-25 2008-08-26 Glumetrics Inc. Fluorescent dyes for use in glucose sensing
US9839378B2 (en) 2007-02-06 2017-12-12 Medtronic Minimed, Inc. Optical systems and methods for ratiometric measurement of blood glucose concentration
US7751863B2 (en) 2007-02-06 2010-07-06 Glumetrics, Inc. Optical determination of ph and glucose
US8178676B2 (en) 2007-05-01 2012-05-15 Glumetrics, Inc. Pyridinium boronic acid quenchers for use in analyte sensors
US8658795B2 (en) 2007-05-01 2014-02-25 Glumetrics, Inc. Pyridinium boronic acid quenchers for use in analyte sensors
US7939664B2 (en) 2007-05-01 2011-05-10 Glumetrics Inc. Pyridinium boronic acid quenchers for use in analyte sensors
WO2008137604A1 (en) 2007-05-01 2008-11-13 Glumetrics, Inc. Pyridinium boronic acid quenchers for use in analyte sensors
US8088097B2 (en) 2007-11-21 2012-01-03 Glumetrics, Inc. Use of an equilibrium intravascular sensor to achieve tight glycemic control
US8512245B2 (en) 2008-04-17 2013-08-20 Glumetrics, Inc. Sensor for percutaneous intravascular deployment without an indwelling cannula
US10429380B2 (en) 2010-12-17 2019-10-01 Eyesense Ag Device comprising a hydrogel having a glucose-binding protein and a ligand of the glucose-binding protein incorporated therein
CN110642882A (en) * 2019-10-21 2020-01-03 内蒙古大学 Fluorescent probe with hydrogen peroxide detection and photodynamic cancer cell killing activity as well as preparation method and application thereof
CN110642882B (en) * 2019-10-21 2021-12-24 内蒙古大学 Fluorescent probe with hydrogen peroxide detection and photodynamic cancer cell killing activity as well as preparation method and application thereof

Also Published As

Publication number Publication date
US6627177B2 (en) 2003-09-30
JP4222503B2 (en) 2009-02-12
JP2004536279A (en) 2004-12-02
AU2002220230B2 (en) 2007-03-22
JP5209424B2 (en) 2013-06-12
NZ526787A (en) 2006-09-29
JP2009091357A (en) 2009-04-30
CN1479870A (en) 2004-03-03
WO2002046752A9 (en) 2002-08-29
EP1340076A2 (en) 2003-09-03
US20040028612A1 (en) 2004-02-12
CA2436590A1 (en) 2002-06-13
WO2002046752A3 (en) 2003-01-16
US20020106326A1 (en) 2002-08-08
AU2023002A (en) 2002-06-18

Similar Documents

Publication Publication Date Title
AU2002220230B2 (en) Optical determination of glucose utilizing boronic acid adducts
AU2002220230A1 (en) Optical determination of glucose utilizing boronic acid adducts
US6653141B2 (en) Polyhydroxyl-substituted organic molecule sensing method and device
EP1960779B1 (en) Optical determination of glucose utilizing boronic acid adducts-ii
JP2004536279A5 (en)
AU2001278145B2 (en) Detection of analytes in aqueous environments
AU2001278145A1 (en) Detection of analytes in aqueous environments
AU2007202790A1 (en) Optical determination of glucose utilizing boronic acid adducts

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGE 85, CLAIMS, REPLACED BY A NEW PAGE 85; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2436590

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002548438

Country of ref document: JP

Ref document number: 018201202

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2002220230

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001999808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 526787

Country of ref document: NZ

WWP Wipo information: published in national office

Ref document number: 2001999808

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002220230

Country of ref document: AU